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Abstract 
This review includes the material for the evaluation of the work of the National 
Public Health Institute (KTL), the Department of Health Promotion and Chronic Disease 
Prevention (ETEO) in 1996-2006. The main purpose of the evaluation is to guide the 
Ministry of Social Affairs and Health for the strategic management of KTL.  
A panel has been nominated to implement the evaluation. The evaluation panel 
will examine the functions, strategic importance, scientific merits and value for money 
of the scientific and expert work undertaken, and make proposals for future. A special 
emphasis is on the relevance and effectiveness of the work and of its impact on the 
health of Finnish people. 
Department aims to prevent chronic disease and improve citizens health by high 
quality scientific work, attaining and providing expertise in the field of prevention and by 
surveillance and monitoring of health, diseases risk factors, nutrition and life styles. 
In 2006, department had personnel of 130 employees, out of which 23 with KTL 
governmental funding (permanent positions) and 107 with external project funding. The 
permanent operating costs from the KTL government budget was in 2006 1.6 million 
euros, KTL project funding 0.9 million euros and external funding 3.1 million euros. 
Department produced since 1996 over 2000 articles of which 1500 have been pub-
lished in international peer reviewed journals. Altogether 50 doctoral dissertations have 
been finished during that time. 
Department has served the society by giving its expertise on chromic disease pre-
vention and health promotion to ministry of health, health professionals and to public.  
Department has eight units: Diabetes Unit, International Cardiovascular Disease Epi-
demiology Unit, Health Promotion Unit, Chronic Disease Epidemiology Unit, Nutrition 
Unit, Cancer Prevention Unit, Chronic Disease Prevention Unit and Injury Prevention 
Unit. (Key words: chronic diseases, health, evaluation, risk factors, health behaviour, 
nutrition) 
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1 EARLIER EVALUATION 
In the early 1990s the Science and Technology Policy Council in Finland encouraged 
the Ministries to evaluate research institutions in their jurisdiction. In accordance to this 
policy, the Medical Research Council of the Academy of Finland carried out an evalua-
tion of the research activities of KTL in 1994-1995, in response to a proposal put for-
ward by the Finnish National Public Health Institute (KTL) and the Ministry of Social 
Affairs and Health (STM). The objective of this evaluation was to provide information on 
the public health functions, strategic importance, scientific merit and value for money of 
the scientific work undertaken and to make proposals for future work. 
The international Evaluation Panel, chaired by Dr David Evered of the UK Medical Re-
search Council, prepared an evaluation Report to the Academy in October 1995. For 
the evaluation, KTL prepared a report describing the work in the Institute. The Evalua-
tion Panel worked via internal meetings, discussions with important stakeholders of 
KTL, and through site visits to the three divisions of KTL. On the basis of their evalua-
tion, the Panel made 35 major recommendations for further development of the organi-
zation, management and work of the Institute. 
Over the past 10 years, most of the recommendations made by the Panel have been 
implemented: the organization of KTL has been changed, several areas of research 
and public health work have been directed towards new priorities, and more emphasis 
has been put on the public health impact of the work of KTL. In addition, a renewed 
strategy was prepared for the Institute in 2001 during a thorough process involving the 
whole organization. At the end of 2003, a new Director General was appointed to KTL. 
Based on these developments, and on changes in the environment, the time is ripe for a 
new evaluation of KTL. The purpose of such an evaluation would be to evaluate the ef-
fectiveness of the work and assess the scientific and public health impact of the Institute. 
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 2  KTL IN BRIEF 
2.1 Strategy and functions 
The mission of KTL is to protect and promote the health of the Finnish people. As a 
research and expert institute belonging to the Ministry of Social Affairs and Health, KTL 
is responsible for providing decision-makers, professionals and citizens with the best 
possible health-related information for their choices. A general strategy for the Institute 
was prepared in 2001, while detailed objectives for the work are agreed upon annually 
with the Ministry. 
The three main areas of work in KTL have traditionally been: 1) infectious dis-
eases and immunizations, 2) chronic diseases and health promotion, and 3) environ-
mental health. In all these areas, both research and public health functions are carried 
out. Activities of the Institute include basic research, ranging from the detailed analysis 
of the molecular mechanisms of pathogenesis to large-scale epidemiological and pre-
ventive studies and research into factors influencing health. 
KTL monitors public health, diseases and their determinants through surveys and 
registers. Research and expert information is transferred into action by developing 
health-promoting and preventive measures and by advising and collaborating with vari-
ous stakeholders. National vaccine service, many centralized laboratory functions and 
forensic medicine investigations are some of KTL's service functions. 
Several of KTL's functions are based on laws, such as surveillance of infectious 
diseases and protection from communicable diseases by vaccinations. In the preven-
tion of chronic diseases KTL works in close collaboration with various Non-
Governmental Organizations. In promoting healthy environment and preventing dis-
eases KTL collaborates with environmental authorities and municipalities. A strong 
presence in the media is a way to reach the people. The ultimate goal is to reduce the 
human suffering and economic cost caused by illness and to help people enhance their 
quality of life. 
2.2 Organization, personnel and budget 
KTL's main facilities are located in Helsinki and three other facilities in Kuopio, Oulu 
and Turku. The Institute has 11 departments, each of which is built of various laborato-
ries and units. 
Ultimate responsibility for leading and managing the whole Institute rests on the 
Director General of KTL. He is assisted by the Deputy Director General, the Adminis-
10
 trative Director and the Steering Group, consisting of the Directors of Departments. The 
Director General is also advised by a Scientific Council of KTL, where representatives 
of the most important stakeholders are present. 
At the end of 2006, KTL had a staff of 980 persons, of whom 450 were scientists 
or experts. Women make up 73% of the staff. In addition to the permanent or tempo-
rary staff, KTL is also a working place for non-paid students or scientists who pursue 
their studies and research together with the staff of KTL. 
The total expenditure of KTL was 66 million euros in 2006, and the operating ex-
penses were 56 million euros when the acquisition of vaccines is excluded. Most part 
(62%) of the operational funding comes from the national budget, 30% from external 
sources like the Academy of Finland, the European Union, US National Institutes of 
Health, or various Foundations supporting scientific research. The rest 8% of KTL’s 
budget is covered through income from chargeable services and from miscellaneous 
other funding. 
3 EVALUATION PROCESS 
3.1 Scope and purpose of evaluation 
The objective of the review is to provide an evaluation of the work of KTL for the Minis-
try of Social Affairs and Health. The evaluation should examine the functions, strategic 
importance, scientific merits and value for money of the scientific and expert work un-
dertaken, and to make proposals for future work. A special emphasis will be placed on 
the evaluation of the relevance and effectiveness of the work and of its impact on the 
health of the Finnish people. 
The evaluation and the Evaluation Report should address the following main issues: 
a.    National relevance and effectiveness of the activities 
b.    Appropriateness and adequacy of the research, expert functions and services 
c.    Output and quality of research activities 
d.    National and international co-operation 
e.    Resource allocation 
f.    Research fundraising 
g.   Development needs, especially regarding processes and organization 
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 The main purpose of the evaluation is to guide the Ministry of Social Affairs and Health 
so that they can use it for the strategic management of KTL. The practical implementa-
tion of the results, based on the decisions made at the Ministry, is the responsibility of 
the Director General of KTL. 
3.2 Entities to be evaluated 
The first round of detailed evaluations consists of four separate, partly parallel evalua-
tions covering the main functional areas of KTL: 
1.  Environmental health 
2.  Chronic disease prevention and health promotion 
3.  Infectious diseases 
4.  Molecular medicine - the evaluation of this area will depend on whether the 
results of the planned evaluation conducted by the Ministry of Education will 
provide sufficient information for the purposes of the Ministry of Social Affairs 
and Health. 
After the first round has been completed, the entire Institute will be evaluated. This evalua-
tion will focus merely on the general strategy, function and management of the Institute, 
with less emphasis on the evaluation of individual research and expert functions. 
3.3 Information sources for the evaluation 
KTL will provide the Panels the following information: 
Published documents concerning the whole Institute 
1.  Annual Report 2006 
2.  Evaluation of the National Public Health Institute of Finland. Report of the 
Evaluation Panel 1995 
A document prepared by the Director of each relevant Department involved in the 
evaluation will be provided for the evaluation. These documents describe 1) a report on 
progress in research over the 1996-2007 period and research plans for the 2007-2011 
period, 2) the arrangement for governance and management, and 3) allocation of staff 
and resources, and 4) his/her plans for the future development of the Department. 
12
 3.4 Evaluation of the Department of Health Promotion and Chronic Disease 
Prevention 
Each Department involved in the evaluation will also provide the Panel a self-evaluation 
of 1) the appropriateness of its work to the national public health needs, 2) its role in the 
dissemination of research results and knowledge and technology transfer, 3) a descrip-
tion of the interfaces between the Department and the key players in Finland and abroad. 
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 4 DEPARTMENT OF HEALTH PROMOTION AND CHRONIC DISEASE 
PREVENTION 
4.1 Objectives and organization 
Motto: To put science into public health in chronic disease prevention and health pro-
motion 
The goal of the Department is to prevent and control chronic non-communicable 
disease and improve people's health. These goals are pursued through 1) high-quality 
scientific work, 2) surveillance and monitoring of health, diseases, risk factors, nutrition 
and health behaviour, 3) attaining expertise and providing it to decision makers, health 
professionals and the public. 
There are eight substance units in the Department. The Administrative Unit has a 
director of department, an IT-director, an IT-assistant and 4 secretaries. Most of the 
large surveillance and research projects are done in collaboration between the units 
and in collaboration with other departments. 
The Diabetes Unit provides new information on the prevalence, incidence, risk fac-
tors and prevention of diabetes. The research focuses on the genetics and environ-
mental risk factors of diabetes. The Unit participates in the Development Programme 
for the Prevention and Care of Diabetes (DEHKO). Research on the impact of preg-
nancy and early growth on disease in adulthood is carried out. 
The International Cardiovascular Disease Epidemiology Unit specializes in the 
planning, coordination, quality assurance, data management, data analysis and report-
ing of large international projects. The Unit started as the Data Centre of the WHO 
MONICA Project. The objective of the multinational MORGAM Project is to 
assess the impact of smoking, blood pressure, cholesterol, obesity and genes in the 
risk of disease in different countries and population groups. Within the Public Health 
Programme of the European Union, the unit is developing standardized health exami-
nation surveys in European countries. 
The Chronic Disease Epidemiology Unit does research on the aetiology, risk fac-
tors, occurrence and prevention possibilities of cardiovascular diseases using exten-
sive follow-up studies. Risk factors are monitored with the National FINRISK Study, 
which is carried out every five years. The occurrence of myocardial infarction and 
stroke is followed-up with continuous registration. 
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 The Injury Prevention Unit aims to provide and disseminate information on the oc-
currence, causes and prevention of injuries in Finland. Among the short-term objectives 
is to create a monitoring system of injuries, to begin a falls prevention programme 
among elderly people, to collaborate in the prevention of sports accidents and to make 
an action plan for prevention of alcohol-related injuries. 
The Cancer Prevention Unit investigates the association of risk factors, diet, genes 
and their interaction with the risk of cancer, cardiovascular disease, diabetes and de-
mentia. The research is based on extensive inquiry data and biological samples col-
lected in the ATBC Study, a controlled trial to study the effect of supplemental alpha-
tocopherol and beta-carotene on chronic diseases, especially cancer. 
The Health Promotion Unit monitors health behaviour among working and pen-
sion-age people nationally. The Unit also provides health behaviour information rele-
vant for local health promotion needs. One of the main focuses of the Unit is the identi-
fication of the health differences and their determinants, and the development of in-
struments to control them. The Good Old Age in the Lahti Region (or GOAL) project 
aims at developing novel and more efficient ways of action for the municipalities and 
health care professionals to prevent diseases. In all, the Unit studies choices - and 
ways to affect them - of people that have an impact on their own health and the health 
of their social environment. 
The Nutrition Unit examines the relationships between diet, nutrition and health, 
monitors the diet and nutritional status of Finns, develops dietary assessment methods 
and works to improve nutrition in Finland. The major research projects are the national 
Findiet surveys, dietary glycemic load, and associations between diet and diabetes, 
allergies and obesity. The Unit maintains the National Food Composition Database 
(www.fineli.fi).   
Chronic Disease Prevention carries out research, monitoring and expert activities re-
lated to chronic diseases, their risk factors and prevention. Equity in health over the life 
course and international comparisons are common themes in the research projects. By 
actively participating in international cooperation, the unit transfers the Finnish expertise 
in chronic disease prevention and monitoring to other countries and brings new ideas 
and views from abroad to Finnish prevention activities. Unit also acts as the focal point of 
tobacco control in KTL. Main areas of activities are: health, lifestyles and inequalities, 
tobacco control and research, healthy ageing and international health promotion 
15
  
4.2 Staff and resources 
The Department was established in 1977 in Kuopio and moved to Helsinki 1980. In the 
beginning the core function of the Department was the evaluation of the North Karelia 
Project, which aims at cardiovascular disease prevention. The work has expanded to 
other chronic diseases and health promotion. Total staff in 2006 was 130 persons. Staff 
with permanent service contract (funded permanently with the state budget) has been 
about 23 since 1996. Out of permanent staff 6 had professor positions, 5 were adjunct 
professors (docents), 8 had some other academic degree, and 4 were technical staff. 
In 2006 107 persons were employed by external funding or by KTL project funding, 24 
of them were post docs and 45 had university degree. 
About 30% of the budget is on permanent funding by KTL, about 15% is on tempo-
rary project funding by KTL and 55% on external funding from outside the institute (Ta-
ble 1). The most important sources of funding were the European Union, the Academy 
of Finland, tobacco tax money from the Ministry of Health and the US National Insti-
tutes of Health. 
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 4.3 Scientific impact of research 
Altogether the Department produced 2188 publications from 1997 to 2007: 1482 arti-
cles were published in refereed international journals, 112 were published in refereed 
international editions and conference proceedings, 163 articles in refereed Finnish sci-
entific journals, 29 articles in refereed Finnish edited volumes and conference proceed-
ings, 35 in scientific monographs published abroad, and 148 in scientific monographs 
published in Finland and. 217 were published in Finnish in journals popularizing sci-
ence. Our researchers are actively supervising doctoral students working at the De-
partment, and also in other institutes mainly in hospitals. Number of papers reported by 
Department of Epidemiology and Health Promotion units can not be calculated to-
gether, because several units have contributed to the same papers. The publications in 
English and Finnish are shown by year in Table 4.2 
18
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4.4 Public health impact of the Department 
4.4.1 National policy development  
In Finnish society the ministry is relatively small and institutes under the ministry are rela-
tively large. The expertise of the institutes is widely used in the ministry in planning pro-
grammes and strategies and in law-drafting. This requires that the Department cover exper-
tise quite broadly in different areas of chronic disease prevention. Experts of the Depart-
ment have participated in a number of committees and expert groups, working as chairper-
sons, secretaries or members in developing national policies, programmes and guidelines. 
The following are the most important: the ministerial advisory board on public health, the 
state consultative committee on public health nutrition, the drafting group on the school 
health services statute, the ministerial expert group on cancer and other screening, the 
health surveillance of children and adolescents, the drafting group on the tobacco law, the 
expert group on cardiovascular disease and diabetes, the expert group on asthma and al-
lergy control. 
4.4.2 Co-operation with local authorities 
Municipalities are very independent in Finland, they collect local taxes and have the re-
sponsibility to organize health services. The Department has a long history of community 
programmes starting from the North Karelia Project. At the moment there are three other 
community programmes going on: the first aims to prevent diabetes in a population of 
900,000, the second aims to prevent falling accidents among old people, and the third is a 
health promotion programme in one health district. At the moment the Department is devel-
oping a programme to build a more coherent infrastructure of health promotion on the dis-
trict level. We have participated in the minister's visits to 18 districts to promote health and 
prepared background documents on the health of the people in these areas. 
4.4.3 Reviews and guidelines 
The Department has published biannual reviews on nutrition in Finland and tobacco reports 
that summarize the latest scientific literature and nutritional and smoking development in the 
country. We have been writing several other reviews like the Economic Impact of Health 
Promotion Programmes for the prime minister's office and Health in Finland every fourth 
year to the Finnish Parliament. Several provide guidelines for clinical practice like treatment 
of nicotine dependence. 
20
  
 
4.4.4 Professional education 
Our scientists give lectures and courses in universities, colleges, seminars and confer-
ences. A great number of medical doctors and other public health workers who have got 
their doctoral-level training at KTL are now in key positions in other institutions. The De-
partment has contributed to KTL Bulletin, which is directed to health personnel. Writing arti-
cles on new findings for non-scientific professional journals is an ongoing process in the 
Department. 
4.4.5 Mass media 
The senior staff is frequently on TV, on the radio or in printed media. This is mainly done in 
four different ways: journalists contact us and want make an interview on some specific 
topic, the media want to get KTL's opinion on a new scientific finding, we organize our own 
press conference or have a press release, actively send letters to the editor or other 
broader articles to newspapers. Based on surveys among journalists, KTL is regarded as a 
very reliable source of information. 
4.4.6 Internet 
Internet pages have been vigorously developed in the past few years. Pages include sepa-
rate files for the public and for professionals. The main content areas are smoking, nutrition 
and injury prevention. Pages include information and recommendations on how people can 
improve their own health, information on how different health indicators have developed in 
the country, and new scientific findings which are of public interest. 
4.4.7 International 
In addition to scientific collaboration with numerous research teams abroad, the Department 
has had extensive international co-operation in public health.  The Department is a WHO 
Collaborating Centre on Health Promotion, Disease Prevention and Monitoring. We have 
organized the North Karelia Project International Visitor's Week twice a year and the WHO 
CINDI programme training seminar once a year. Finland has been a CINDI country since 
1987. The Department has had the responsibility of developing the WHO Non-
Communicable Disease Prevention Strategy. In the area of smoking, the International Quit 
and Win competition was organized by the Department. 
The Department ran the European Network on Young People and Tobacco for 10 
years funded by the EU Public Health Programme. We have developed recommendations 
for cardiovascular risk factor monitoring for EU countries and now we are developing health 
examination survey protocol and pilot testing.     
Senior staff members have participated in numerous consultations on public health 
funded by the World Bank, the WHO and the EU TACIS programme in various countries, 
e.g. China, Iran, Russia, Slovenia. 
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4.5 Proposal for future work and expected benefits 
Our vision in the future as well will be to put science into public health in chronic disease 
prevention and health promotion. The main strategies are: 1) to do high-level research in 
selected areas where we should be among the world leaders, 2) to have a broader exper-
tise in chronic disease prevention and health promotion which can be used to improve citi-
zens' health, 3) health monitoring, 4) to participate as experts on different levels of society 
to improve public health. 
At the moment, there is no intention to take new public health substance areas or dis-
eases into the Department. In terms of diseases we are working in coronary heart disease, 
stroke, diabetes, cancer, dementia, and in injury prevention. We also cover the main bio-
logical risk factors: blood cholesterol and other lipids, blood pressure, obesity, haemostasis 
and clotting factors and genetics. We have strong teams working in behavioural risk factors 
(smoking, nutrition, physical activity) and their behavioural, social psychological and societal 
background. The development and evaluation of community and other public health inter-
ventions remains one of the key working areas. There is a political pressure to take more 
responsibility to co-operate more with the municipalities and other local authorities. The new 
public health law also requires this of KTL. 
The Department will continue health behaviour (AVTK), risk factor (FINRISK) and car-
diovascular disease monitoring. A system for monitoring the health of children and adoles-
cents will be developed. We are also forming a strong database for research work. Survey 
data are linked to mortality and morbidity data. This makes it possible to have a new cohort 
study on new risk factors every five years. DNA samples will be used widely in various re-
search programmes. Diabetes and birth cohort databases will be used for future analyses.   
 
5 DIABETES UNIT 
5.1 Research and public health significance of the area 
In the year 2005, more than 170,000 Finns were using medication for diabetes, based on 
the National Drug Register data, with an increase from the previous year of over 5%. Ap-
proximately 80% of all diabetic cases are estimated to be type 2 diabetes. In addition to 
individuals who are on medication for type 2 diabetes, a large number of clinically undiag-
nosed type 2 diabetes cases will be found in population surveys. The increase in the preva-
lence of type 2 diabetes can mainly be attributed to changing lifestyles leading to physical 
inactivity, overweight, and obesity. Finland has the highest incidence of childhood-onset 
type 1 diabetes in the world. The incidence of type 1 diabetes appears to be increasing in 
nearly all populations worldwide, but reasons for this increase are not clear. 
Diabetes is associated with micro- and macrovascular complications such as renal failure, 
retinopathy, cardiovascular diseases, and lower limb amputations. Type 2 diabetes without 
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any prior evidence of coronary heart disease indicates a comparable or higher myocardial 
infarction and mortality risk than prior coronary heart disease in non-diabetic subjects. The 
late complications of type 2 diabetes are related to the duration of the disease and the de-
gree of metabolic control. Therefore it is important to postpone the clinical onset of the dis-
ease and to keep the metabolic profile as normal as possible. 
The Diabetes Unit of KTL provides information on the incidence, prevalence, risk factors 
and genetics of type 1 and 2 diabetes. The ultimate goal of these activities is to improve 
primary and secondary prevention of the disease. The Unit co-ordinated the Finnish Diabe-
tes Prevention Study, which showed for the first time in a controlled randomised setting that 
type 2 diabetes is preventable by lifestyle modification. This study, together with the Unit's 
development of screening methods to identify high-risk individuals, have formed the founda-
tion for several local and national diabetes prevention programmes. Through several popu-
lation-based incidence studies the Unit has provided understanding about the geographic 
variation, secular trend, host factors, familial aggregation, complications and mortality of 
type 1 diabetes. In addition, the Unit has an extensive research programme on the effect of 
fetal and childhood growth on diseases in adult life. 
5.2 The main scientific achievements 
PRIMARY PREVENTION OF TYPE 2 DIABETES 
The results of the Finnish Diabetes Prevention Study DPS provided the first convincing evi-
dence that type 2 diabetes (T2D) can be prevented by lifestyle modification. The DPS was a 
multicentre study with five participating centres in Helsinki (KTL, study co-ordination and 
data collection), Kuopio, Turku, Tampere, and Oulu. A total of 522 persons with impaired 
glucose tolerance (IGT) and thus at high risk of developing T2D were randomized to either 
an intensive lifestyle or a control intervention. The study participants were advised to lose 
weight, increase physical activity and consume a moderate-fat, high-fibre diet in accordance 
to the official dietary recommendations. For the participants in the control group, the lifestyle 
advice was given once as 'standard care counselling'. For the intensive intervention partici-
pants, study nutritionists gave individualized, detailed dietary counselling, with seven face-
to-face sessions during the first year and every three months thereafter. They were also 
offered free-of-charge supervised resistance training based physical activity sessions. 
The main results of the DPS showed that after an average of 3.2 years of follow-up, T2D 
incidence was reduced by 58% in the lifestyle group compared to the control group. During 
the first year of the study body weight decreased statistically significantly more in the inter-
vention group (4.5 kg) compared with the control group (1.0 kg). Also, indicators of physical 
activity and diet, central adiposity, fasting and post-challenge glucose and insulin, and 
HbA1c improved more in the intervention group compared with the control group at 1-year 
follow-up. The active intervention ended after a median of 4 years and the participants who 
were still free of diabetes were further followed for three years, with median total follow-up 
of seven years. The post-intervention follow-up results showed that the effect of intervention 
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on diabetes risk was sustained at least for a median of 3 years after the discontinuation of 
the intervention. 
The DPS is an outstanding clinical trial in the sense that the results were published in paral-
lel with increasing public discussion about the emerging worldwide T2D epidemic; therefore 
the findings were immediately recognised as highly important in Finland and abroad. The 
main results, published in the New England Journal of Medicine, is the most cited Finnish 
publication in the medical field during the past 10 years and has thus far been cited over 
1600 times. The DPS has led the way for diabetes prevention implementation programmes 
in Finland, most importantly the DEHKO (The Development Programme for the Prevention 
and Care of Type 2 Diabetes in Finland 2003 - 2010) and its implementation project, the 
FIN-D2D. It also forms the background for the EU-funded European diabetes prevention 
programme DE-PLAN (Diabetes in Europe - Prevention using Lifestyle, Physical Activity 
and Nutritional Intervention). 
The DREAM trial (Diabetes REduction Assessment with ramipril and rosiglitazone Medica-
tion) was a large, international, multicentre trial that tested whether rosiglitazone and/or 
ramipril prevents or reduces the incidence of the primary outcome of type 2 diabetes or 
death. 5269 people with impaired fasting glucose and/or impaired glucose tolerance were 
recruited in 191 clinical centres located in 21 countries. They were randomly allocated to 
rosiglitazone, ramipril or placebo treatment and followed for a median of 3 years. The 
rosiglitazone arm showed a greater than 60% decrease in progression to diabetes (from 
25% with placebo to 10.6% with rosiglitazone) over a 3-year period, with 70% returning to 
normal glucose tolerance. The main results were published in 2006 in the New England 
Journal of Medicine and The Lancet. The centre at KTL was among the biggest centres in 
Europe, and the institute was awarded twice during the study as the best centre in Europe 
(for participant follow-up and medication adherence in Europe). Currently, the DREAM trial 
has an open off-drug follow-up study with duration of 2 years that will end in 2008. 
 
TYPE 2 DIABETES EPIDEMIOLOGY 
The aim of the DECODE and DECODA (Diabetes Epidemiology - Collaborative analysis of 
diagnostic criteria in Europe/Asia) studies was to collect data from a large number of co-
horts with detailed information on disturbances in glucose metabolism and follow-up data for 
diabetes-related complications and mortality, and to use these to review the current diag-
nostic criteria for T2D. Currently, there are data from more than 60 cohorts in 24 countries, 
most of which are population-based. The main results unequivocally showed that non-
diabetic glucose levels, such as the category of impaired glucose tolerance, are an inde-
pendent risk for CVD morbidity and mortality, and the increased risk cannot be explained by 
the development of diabetes during the follow-up. The DECODE study made the WHO 
Consultation Group revise their recommendations on the diagnostic criteria and resulted in 
a call for a new ADA Expert Committee on Classification and Diagnostic Criteria for Diabe-
tes in 2001 with the updated report in 2003. The importance of post-load hyperglycaemia 
pointed out by the DECODE study was addressed by the recent ADA Expert Committee. In 
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addition, these studies have provided new information on the prevalence of type 2 diabetes 
and other forms of disturbances in glucose regulation in different countries. 
Since the beginning of the DECODE study in 1997 and of the DECODA study in 1998, more 
than 30 articles have been published in international peer-reviewed journals. These two 
studies have already had a major impact on the current understanding of the importance of 
fasting vs post-challenge glucose in public health and clinical research and practice. Since 
the databases are large, there is sufficient statistical power to address issues that cannot 
usually be investigated in individual studies. Further, new cohorts have been recruited and 
the existing database is updated continuously. After the successful initial phase, the basis 
for the further research on diabetes, non-diabetic hyperglycemia and other related condi-
tions has been established, in terms of the databases, research personnel and the connec-
tions with other research institutes around the world.  
Nationally, the Unit performs population-based health surveys on abnormalities in glucose 
metabolism every fifth year. These surveys are conducted in conjunction with the national 
FINRISK health surveys and provide means to monitor changes in diabetes and its risk fac-
tors in the Finnish population. 
 
DIABETES IN CHILDREN AND YOUNG ADULTS 
Finland has the highest incidence of childhood-onset type 1 diabetes (T1D) in the world. 
However, T1D can develop at any age, and it is not understood why T1D starts in adulthood 
in many people. Globally, the number of patients with type 2 diabetes (T2D) among adoles-
cents and young adults is increasing, but solid epidemiological data on T2D in Finnish chil-
dren or young adults has been missing. Although the epidemiological research will have its 
own importance, it will also provide a solid basis for research on causes of T1D and T2D in 
this age group.  
Through the Unit's work on several population-based studies on the incidence of diabetes in 
children and young adults, better understanding about the geographic variation, secular 
trend, host factors, familial aggregation, complications and mortality of the disease has 
been acquired. In addition to the burden conferred by the high incidence of T1D in Finland, 
T2D among the young adult population seems set to become an important public health 
problem in the near future. 
There is considerable global variation in the incidence of T1D among children. This variation 
appears to reflect the global distribution of major ethnic populations, which demonstrates a 
different degree of genetic susceptibility to diabetes among populations. Although genetic 
susceptibility is necessary for the development of T1D, the aetiology of this disease is a 
multifactorial one. The wide global variation in incidence between and within major ethnic 
groups suggests that environmental factors are significant in the aetiology of T1D. Still, 
most of the information regarding T1D incidence thus far has come from regions with a high 
or intermediate incidence, mostly in Europe and North America where several registries 
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have been established since the mid-1980s. The data from Asia, South America, and Africa 
are still sparse. Because of the dearth of information available and limited research on the 
public health implications of T1D, the World Health Organization began the multinational 
project for childhood diabetes, DIAMOND, in the year 1990. The primary goal was the sur-
veillance of the incidence of T1D among children worldwide using population-based regis-
tries. This large worldwide project was co-ordinated by the Unit. The total population of chil-
dren aged 14 years or under (740 million) from countries for which the incidence of T1D 
was estimated covers 41% of the world's population in that age group. The rising incidence 
of T1D is a global phenomenon. Incidence has increased by 2.8% per year during the years 
1990-1999 worldwide. The global variation in incidence (> 350-fold) appears to be stable. 
The global increase in the incidence of T1D may be partly explained by an improvement in 
case ascertainment. An underestimation is certainly inherent in all registration systems, but 
the problem was avoided in this study by measuring the degree of ascertainment on the 
basis of two or more data sources. 
The Unit has published more than 30 articles on diabetes in children and young adults in 
peer-reviewed international scientific journals during the evaluation period. 
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE 
The Helsinki Birth Cohort Study (HBCS) is focusing upon the development of health and 
disease from a life course perspective, taking into account early and childhood growth, so-
cioeconomic factors and adult lifestyle. We have been focusing upon major non-
communicable disorders of major public health impact like coronary heart disease, hyper-
tension, type 2 diabetes, stroke and depression. The cohort being followed up consists of 
over 20,000 individuals, a further 2500 individuals have been studied clinically in great de-
tail, including genetic sampling. This birth cohort born 1924-44 with excellent childhood 
growth data is unique worldwide. 
This study has produced over 50 original publications, published in peer-reviewed interna-
tional journals including the New England Journal of Medicine, Annals of Medicine, BMJ, 
Hypertension, Stroke and Diabetes. We have been able to show that non-optimal growth 
during fetal life and infancy is associated with an increased risk of coronary heart disease 
and type 2 diabetes later in life. Slow growth during fetal life and infancy is often followed by 
accelerated weight gain in childhood. These patterns of growth seem to precede the devel-
opment of CHD and type 2 diabetes in adult life. We are beginning to understand that adult 
degenerative diseases are associated with different patterns of early growth and these dis-
eases can best be focused upon from a life cycle perspective. 
From a public health point of view the studies have shown the importance of early health 
and nutrition both during pregnancy and during infancy. This knowledge is of utmost impor-
tance for early preventive measures of many non-communicable diseases. 
The Helsinki Study of Very Low Birth Weight Adults assesses the effects of very low birth 
weight (VLBW; <1500 g) on health in adult life. After birth, most VLBW infants experience a 
period of neonatal intensive care characterised by often severe immaturity-related complica-
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tions, insufficient nutrition and slow growth. They would thus be expected to be particularly 
susceptible for the long-term consequences of such adverse early life conditions. 
Since 2004, we have performed a detailed clinical examination in 170 young adults with 
VLBW, together with 170 comparison subjects born at term. We focus on 1) risk factors of 
common later-life disorders such as cardiovascular disease, type 2 diabetes, osteoporosis 
and depression; and 2) factors that affect how a young adult finds her/his position in society 
(such as temperament, personality, education and career, raising a family etc.) which may 
have major indirect effects on health. This cohort is the only European cohort which in-
cludes both VLBW adults and a comparison group born at term. 
The first publication from this project, showing impaired glucose regulation and higher blood 
pressure in VLBW as compared with term-born adults, was published in the New England 
Journal of Medicine in 2007. Ten other manuscripts are currently at different stages of proc-
essing. The results have obvious direct relevance for those 6-12% of people who are born 
preterm and those 1% who are born with very low birth weight. Also, outside the prematurity 
context, they are important in assessing the mechanisms that link early life conditions with 
adult disease.  
GEOGRAPHICAL HEALTH STUDY - SMALL AREA ANALYSIS 
Specific problems are associated with the analysis and interpretation of the regional distri-
bution of health-related data in administratively defined areas. The size of the population 
deviates greatly between small areas (for example municipalities), and therefore regional 
variation in areas with a small population tends to present random variation of the rates, 
resulting in extreme incidence rates that dominate the map. There are also complex de-
pendencies between many of the measured variables and response variables which can be 
either spatial or temporal or both. 
This project was designed to develop and apply new analytical techniques for exploring the 
regional variation of chronic diseases employing the Bayesian approach and georeferenced 
data. Thus far the developed models have been applied to research of the spatial variation 
of non-communicable diseases and analysis of the geographical variation of T1D, acute 
myocardial infarction (AMI) and Parkinson's disease and their spatial association with the 
possible environmental risk factors, such as geochemical elements of drinking water. 
The interest in spatial epidemiology is growing worldwide. In Finland, clear advantages for 
further studies are the exceptionally large records of health-related data, expert knowledge 
of spatial statistics and medical geography, and the training and experience achieved during 
this project thus far. The Unit's work in this area continues further within the framework of 
the GEO-BENE (Global Earth Observation - Benefit estimation: Now, Next and Emerging) 
project which is funded by the EU. The objective is to develop methodologies and analytical 
tools to assess the societal benefits of GEO in the domains of Disasters, Health, Energy, 
Climate, Water, Weather, Ecosystems, Agriculture and Biodiversity. The project aims at 
drawing up policy conclusions from the modelling exercise for supporting the implementa-
tion of international agreements. 
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GENETIC STUDIES OF DIABETES 
The Finland-United States investigation of non-insulin-dependent diabetes mellitus 
(FUSION) study is a long-term effort to identify susceptibility genes for type 2 diabetes and 
associated quantitative traits, such as decreased insulin secretion and decreased insulin 
sensitivity. This has involved the phenotyping and DNA analysis of thousands of individuals 
living in Finland, utilizing a study design that was originally based on affected sib pairs. The 
majority of these samples have already been subjected to a genome scan using microsatel-
lite markers. More recently, with the opportunity provided by HapMap and dramatically low-
ered genotyping costs, the original FUSION samples and thousands of other cases and 
controls were being subjected to genome-wide association (GWA) analysis. These results, 
finding novel candidate genes for type 2 diabetes and insulin secretion, have been recently 
published in Science. 
The FUSION study is a collaborative effort with an international research team. Since the 
study began in 1993, the original aim was to identify and collect Finnish nuclear families 
with at least two siblings affected with T2D, at least one of whom (the index case) was di-
agnosed between 35 and 60 years of age. From these families, the sample included all af-
fected siblings, any living parents, and a spouse and multiple offspring of the index case or 
an affected sibling. Also, we studied a sample of elderly normoglycemic Finnish controls 
and, when possible, obtained DNA samples from a spouse and up to two of their offspring. 
For FUSION 1 (recruited in 1996) and 2 (recruited in 1998) diabetes family members and 
elderly controls, we carried out clinical examinations and determined diabetes disease 
status, diabetes-related quantitative traits and clinical information, grandparental birthplace, 
and information on general health status, diet, and physical activity. In a subset of the 
spouses and offspring, we carried out over 500 frequently-sampled intravenous glucose 
tolerance tests to better assess diabetes-related metabolic parameters. In addition, we've 
obtained additional sets of unrelated Finnish cases and controls (i.e. the Finrisk-2002 and 
Health-2000 studies) to permit more powerful studies of phenotype-genotype association 
and replication of FUSION results. This was done in 2001-2003. With these main sample 
sets we've carried out careful genotyping and statistical analyses to produce over 20 peer-
reviewed publications in top journals, such as Science, PNAS, Journal of Clinical Investiga-
tion, American Journal of Human Genetics, Diabetes, Diabetologia and Diabetes Care. 
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Table 5.1. Summary of main scientific achievements during 1997-2006. 
Scientific output N Comments 
Original articles and 
reviews in international peer-
review journals  
>630  
Original articles and 
reviews in domestic peer-
review journals  
17  
Textbooks and chap-
ters in textbooks, reports and 
proceedings  
38  
Theses  PhD: 10 
Harjutsalo V (2007), Lindström J (2006), Jakovljevic D (2006), Moltchanova 
E (2005), Wang J (2005), Rytkönen M (2004), Kajantie E (2003), Onkamo P 
(2002), Lakka HM (2001), Forsen T (2000).  
Organization of scien-
tific meetings and confer-
ences  
9  
 
e.g. World Congress on Prevention of Diabetes and Its Complications 
(1999, 2002, 2005); International Diabetes Epidemiology Group Meeting (1997, 
2000, 2006), Genetics of type 2 diabetes in the Nordic countries (2002).  
Presidencies and 
memberships in scientific 
committees of international 
meetings  
44 
e.g. European Society of Cardiology congress (annually); 4th World Confer-
ence on Preventive Cardiology; 16th Int. Diabetes Federation Conference; 5th Int. 
Conference of Coronary Heart Disease; FutureForum congress (annually); 3rd 
Nordic Conference in Epidemiology; 6th International Conference on Preventive 
Cardiology; 1st and 2nd Int. Congress on "Prediabetes" and the Metabolic Syn-
drome.  
Presidencies and 
memberships in other scien-
tific committees  
30  
 
e.g. International Diabetes Epidemiology Group; ESC/EASD Task Force on 
Diabetes and Cardiovascular Disease; American Diabetes Association; IDF Con-
sensus Groups on the Metabolic Syndrome and Prevention of Type 2 Diabetes; 
Developmental Origin of Adult Health and Disease Society; European Society of 
Cardiology; European Association of Cardiovascular Prevention and Rehabilita-
tion; International Council of Fetal Origin of Adult Diseases.  
Invited lectures and 
chairmanships in interna-
tional meetings  
>450   
Lectures in domestic 
scientific meetings  >200   
Editorial tasks in inter-
national peer-review journals  
15  
 
e.g. J Human Hypertens, International Diabetes Monitor, Diabetologia, J of 
Hypertens, Eur J Cardiov Prev R, Diabetes Vasc Dis Res, Evidence-Based Prev 
Med, Diabetes-Metab Res, Eur J Clin Nutr.  
Opponent of disserta-
tion  
13  
 
 
 
Supervision of disser-
tations  18 Ongoing doctoral theses work.  
Review of PhD thesis, 
evaluation of docentship or 
professorship  
17  
 
 
 
Review of scientific 
papers  >200 
e.g. for N Engl J Med, Lancet, JAMA, BMJ, Circulation, Diabetes, Diabetes 
Care, Diabetologia, Am J Epidemiol, Int J Epidemiol, Statist. Med.  
Research visits to/from 
international research insti-
tutes or universities  
>100  
 Numerous research institutes around the world.  
29
  
 
5.3 The main public health activities and achievements 
IMPLEMENTATION OF DIABETES PREVENTION 
The Development Programme for the Prevention and Care of Diabetes (DEHKO 2000-
2010) is Finland's national diabetes programme. It aims to prevent type 2 diabetes and dia-
betes-related complications and to improve the quality of diabetes care and to support the 
self-care of people with diabetes. DEHKO constructs new action models for health care 
which are implemented throughout Finland. The programme is coordinated by the Finnish 
Diabetes Association, and KTL is one of the associated partners. DEHKO is the first na-
tional programme in the world to also include and implement the prevention of type 2 diabe-
tes. The implementation of the prevention programme, FIN-D2D, is carried out in five hospi-
tal districts in Finland during the period 2003-2007. It comprises three concurrent strategies: 
1) the population strategy covering the general population, 2) the high-risk strategy that is 
based on individual-oriented measures targeted at those at a particularly high risk of devel-
oping T2D, and 3) the strategy of early diagnosis and management of T2D directed at per-
sons with newly diagnosed T2D. 
The Unit has been actively involved in the planning and implementation of both DEHKO and 
FIN-D2D. Furthermore, the main body of the prevention programme is built around the ex-
periences from the Unit's research work on primary prevention of type 2 diabetes by lifestyle 
intervention (DPS), and screening for high risk of type 2 diabetes by the diabetes risk score 
(FINDRISC). 
In addition to Finland's national diabetes prevention programme, the Unit is working closely 
with several local projects which are implementing methods of lifestyle interventions to pre-
vent type 2 diabetes. These include a collaboration with the occupational health-care pro-
vider of the main Finnish airline to screen all employees of the corporation for high diabetes 
risk and disturbances in glucose metabolism, and to provide lifestyle intervention for those 
at highest risk. The role of KTL in the project is to provide expertise on the intervention 
methods, and to evaluate the effectiveness of these activities. Similarly, the city of Turku 
has a development project in association with several private and public occupational 
health-care providers aiming at the development of new methods for diabetes prevention 
implementation in occupational health care. 
There is a clear consensus at the EU level that action is needed now to develop targeted 
prevention programmes for type 2 diabetes. Currently, numerous prevention management 
concepts exist in various European countries, and an evaluation of these is necessary in 
order to learn how the prevention of T2D works in reality and to find out the extent to which 
the prevention of T2D will reduce direct and indirect medical care and non-medical costs 
due to the disease. DE-PLAN (Diabetes in Europe - Prevention using Lifestyle, Physical 
Activity and Nutritional Intervention) project aims at addressing the development of national 
community-based T2D prevention programmes systematically throughout European coun-
tries. IMAGE (Development and Implementation of a European Guideline and Training 
Standards for Diabetes Prevention) project will develop EU-wide intervention standards and 
strategies for diabetes prevention. The Unit is a collaborating partner in both of these EU-
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funded projects, and has the responsibility of creating the standards for evaluation and qual-
ity control of primary prevention of diabetes. 
SCREENING FOR HIGH DIABETES RISK 
The DPS and several other intervention studies have shown that T2D can be efficiently pre-
vented by relatively simple and feasible lifestyle intervention. In most prevention trials par-
ticipants with increased T2D risk were recruited based on elevated plasma glucose values 
especially after glucose load (impaired glucose tolerance). However, in health care setting, 
oral glucose tolerance testing to identify persons with high diabetes risk is not a feasible 
option. Therefore, a prediction model for future diabetes was developed using existing data 
sets from the FINRISK 1987 and FINRISK 1992 surveys. The end-point of the follow-up 
was the development of drug-treated diabetes. Baseline age, body mass index, waist cir-
cumference, history of antihypertensive drug treatment and high blood glucose, physical 
activity and daily consumption of fruits, berries or vegetables were selected into the risk 
score model. The optimal cut-off point of the risk score identified 78% of those who got dia-
betes during the follow-up (= sensitivity of the test) and 77% of those who remained free of 
diabetes (= specificity of the test). The final Finnish Diabetes Risk Score (FINDRISC) form 
includes, in addition to the predictors of the model, a question about family history of diabe-
tes and the age category of over 64 years. 
The use of FINDRISC to identify high-risk people, followed by lifestyle intervention, has 
been selected as the first line procedure in the Finnish national diabetes prevention pro-
gramme, and is also used in several other diabetes-related projects in Finland, for example 
the GOAL (Good Ageing in Lahti Region; Ikihyvä Päijät-Häme). The FINDRISC has also 
been scientifically validated in Germany, Poland, and Italy, and serves as the risk screening 
tool in the European diabetes prevention project DE-PLAN. In addition, the FINDRISC is 
validated for screening of undiagnosed T2D, and it is being used for this purpose in several 
countries around the world.
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Table 5.2. Summary table of committee memberships, coordination and proceedings with public health impact 
during 1997-2006. 
Public health out-
put  N  Comments  
Articles and reviews 
in non-peer-review jour-
nals  
41  
 
  
TV, radio, newspa-
per interviews  
150 
 
 
 
Membership in in-
ternational committees 
with public health impact  
15  
 
e.g. WHO workshop group on Screening for Type 2 Diabetes; IDF 
Metabolic Syndrome Consensus Workshop; SNEHA - India working group 
for the improvement in health of women and young children; WHO/IDF 
Consultation: Definition and diagnosis of diabetes mellitus.  
Membership in do-
mestic committees with 
public health impact  
15  
 
e.g. National CVD and diabetes committee; Nutrition Guidelines for 
Diabetes working group; several committees in association with the Fin-
nish national diabetes prevention programme.  
Organization of in-
ternational training with 
public health impact  
16  
 
e.g. 2nd Mediterranean Training Course on Epidemiology and Public 
Health Aspects of Diabetes; 2nd and 3rd Asian Pacific Diabetes Epidemiol-
ogy Course; 3rd Advanced International Diabetes Epidemiology Course; 
3rd Diabetes and Cardiovascular Risk Factors - East Meets West Sympo-
sium; 1st and 2nd International Reporting Days of the National Type 2 
Diabetes Prevention Programme; European Stroke Master Course.  
Organization of do-
mestic training with public 
health impact  
5  
 
 
 
5.4 Funding for research and public health programmes  
Currently one senior researcher gets funding from the KTL budget (Peltonen), and the other 
employees (~30) are funded with external research grants. Three senior researchers have 
fellowships from the Academy of Finland (Karvonen, Kajantie, Lakka). During the evaluation 
period, the Unit has been successful in obtaining external funds for research, and we are 
optimistic that this will continue, at least on the short term (1-3 years). However, external 
research funding is usually received for novel research ideas, whereas it is clearly more 
challenging to get appropriate funding for implementation projects with direct public health 
impact. The main sources of external financial support have been the Academy of Finland, 
the US National Institutes of Health, the European Union, the British Heart Foundation and 
the Social Insurance Institution of Finland. 
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5.5 Personnel 
During the 10-year period of evaluation, the number of employees in the Diabetes Unit has 
varied between 20 and 40. Currently, there is 1 professor, 9 senior researchers, and 10 
researchers conducting doctoral studies. In addition, about 10 nutritionists, statisticians, 
data managers and research assistants are employed. 
The current key senior researchers: 
Markku Peltonen, PhD, adjunct professor, Head of the Unit: Chronic disease epidemiology. 
Johan Eriksson, MD, professor: Life course epidemiology, prevention of T2D. 
Marjatta Karvonen, PhD, adjunct professor: Spatial epidemiology. 
Eero Kajantie, MD, adjunct professor: Life course epidemiology. 
Jaana Lindström, PhD, senior researcher: Primary prevention of T2D, nutrition, screening 
methods. 
Timo Valle, MD: Prevention of T2D, diabetes care. 
During the evaluation period, professor, MD, PhD Jaakko Tuomilehto, adjunct professor, 
MD Qing Qiao, adjunct professor, MD Hu Gang (all currently at the University of Helsinki) 
and PhD Tom Forsen have been employed by the Diabetes Unit. 
5.6 National and international collaboration 
University of Helsinki, Department of Public Health: Prof. Jaakko Tuomilehto, doc. Qing 
Qiao, doc. Hu Gang. Projects on primary prevention of type 2 diabetes (DPS), implementa-
tion of prevention of diabetes in Europe (DE-PLAN), epidemiology of diabetes and cardio-
vascular disease (DECODE/DECODA). 
University of Kuopio: rector, prof. Matti Uusitupa. Primary prevention of type 2 diabetes 
(DPS). 
Hospital districts of Pirkanmaa, South Ostrobothnia, North Ostrobothnia, Northern Savo and 
Central Finland: Implementation of the Finnish diabetes prevention programme FIN-D2D. 
Finnish Diabetes Association: Planning and implementation of the Development Pro-
gramme for the Prevention and Care of Diabetes (DEHKO) and the Finnish diabetes pre-
vention programme FIN-D2D. 
DECODE/DECODA: Coordination and collaboration with research groups in 24 countries in 
Europe and Asia. 
EU-funded projects DE-PLAN, IMAGE and GEO-BENE: A total of 68 collaborating partners 
from 25 countries in Europe. 
WHO DIAMOND project: Coordination and collaboration with research groups in 53 coun-
tries around the world. 
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Helsinki Birth Cohort Study: Collaborative research with top international groups around the 
world including David Barker (UK/USA), Peter Gluckman (New Zealand), Leif Groop (Swe-
den), Thorkild Sorensen (Denmark), Juha Kere (Sweden), Göran Roos (Sweden), David 
Phillips (UK), Clive Osmond (UK), Cyrus Cooper (UK) and a large number of researchers 
from Finland including researchers at University of Tampere, Kuopio, Oulu, Turku, Helsinki 
and the Finnish Genome Center. 
Helsinki Study of Very Low Birth Weight Adults has collaboration with Helsinki University Cen-
tral Hospital (Hospital for Children and Adolescents) University of Helsinki (Department of 
Psychology), Karolinska Institute (Juha Kere) and University of Southampton (David Phillips). 
FUSION: University of Michigan (Michael Boehnke), National Human Genome Research 
Institute, NIH (Francis Collins), USC School of Medicine (Richard N. Bergman, Thomas A. 
Buchanan). 
5.7 Proposal for future work and expected benefits 
The main justification for prevention of T2D is the supposed concurrent prevention or post-
ponement of complications related to T2D. The disease is characterised by the develop-
ment of micro- and macrovascular complications which give rise to excessive rates of car-
diovascular disease. These complications account for the majority of morbidity and mortality 
associated with diabetes. In the DPS study, the feasibility and effects of a lifestyle interven-
tion on the risk of developing diabetes among high-risk subjects was shown. However, there 
is little data on the effective prevention of macrovascular complications of T2D. Thus, in a 
follow-up study of the original DPS, we aim to determine the long-term effects of lifestyle 
intervention in high-risk subjects on vascular complications of T2D. In addition, work on the 
cost-effectiveness of the lifestyle intervention used in the DPS is underway. 
Finland is among the first countries in the world to develop a nationwide primary prevention 
programme for T2D. The Diabetes Unit is responsible for the evaluation of the effective-
ness, feasibility and cost-effectiveness of the programme. These will be assessed using 
population surveys focusing on T2D and its risk factors throughout the country at the begin-
ning and at the end of the programme, as well as cohort studies on diabetes risk in high-risk 
subjects. The main results are expected in 2008. These will provide information on whether 
screening for high risk subjects and consequent implementation of lifestyle interventions 
focusing on weight maintenance, healthy nutrition and increased physical activity can effec-
tively be implemented at population level. 
Incidence of childhood T1D is still increasing, and continuous monitoring, using updated diag-
nostic criteria and developed standardized methods, is required. In particular, it is important to 
differentiate between type 1 and type 2 diabetes, because the latter has become increasingly 
common in adolescents in some populations. The fact that prevention strategies are in pro-
gress justifies the ongoing surveillance of incidence: i.e. when these trials are performed on a 
population basis, surveillance will allow us to demonstrate their effectiveness. 
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In the Helsinki Birth Cohort Study, the present research direction focuses upon ageing and cog-
nitive functions - a huge problem worldwide, both clinically and from a public health aspect. 
The 5th World Congress on Prevention of Diabetes and its Complications (WCPD 2008) will 
be organized 1-4 June, 2008 in Helsinki, Finland. KTL and the Finnish Diabetes Organisa-
tion co-organize the congress. The scientific programme is the responsibility of KTL, and 
the chair of the scientific committee (Eriksson) and the scientific secretary of the congress 
(Lindström) are from the Diabetes Unit. 
5.8 Main publications 
Hovi P, Andersson S, Eriksson JG, Järvenpää AL, Strang-Karlsson S, Mäkitie O, Kajantie 
E. Glucose regulation in young adults with very low birth weight - Helsinki study of very low 
birth weight adults. New Engl J Med 2007; 356:2053-63, 2007. 
Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. (Valle TT, Kinnunen 
L, Tuomilehto J). A genome-wide association study of type 2 diabetes in Finns detects mul-
tiple susceptibility variants. Science 2007;316:1341-5. 
Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sus-
tained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the 
Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679. 
The World Health Organization DIAMOND Project Group (Karvonen M). Incidence and 
trends of childhood type I diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66. 
Barker DJP, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among 
children who later have coronary event. New Engl J Med 2005;353:1802-9. 
Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, 
diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New Engl J Med 
2004;351:2683-93. 
Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J. Long-term im-
provement in insulin sensitivity by changing lifestyles of people with impaired glucose toler-
ance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003; 52:2532-8. 
Lindström J, Tuomilehto J: The diabetes risk score: A practical tool to predict type 2 diabe-
tes risk. Diabetes Care 2003;26:725-731. 
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. 
Prevention of diabetes by lifestyle intervention in subjects with impaired glucose tolerance. 
New Engl J Med 2001;344:1343-1350. 
Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJP. Early growth and coronary 
heart disease in later life: longitudinal study. BMJ 2001;322:949-53. 
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The DECODE Study Group (Tuomilehto J, Qiao Q). Glucose Tolerance and Cardiovascular 
Mortality. Arch Intern Med 2001;161:397-404. 
Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte RE, Tuomilehto J for the 
World Health Organization DiaMond Project Group. The incidence of type 1 diabetes 
worldwide - the analysis of the WHO DiaMond (Diabetes Mondiale) data from 50 countries. 
Diabetes Care 2000;23:1516-1526. 
Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and child-
hood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-82. 
The DECODE Study Group (Tuomilehto J, Qiao Q). Glucose tolerance and mortality: com-
parison of WHO and American Diabetes Association diagnostic criteria. Lancet 
1999;354:617-21. 
Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et. al. Effects 
of calcium-channel blockade in older patients with diabetes and systolic hypertension. New 
Engl J Med 1999;340:677-684. 
Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of 
Type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 
1999;42:1395-1403. 
Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJP. Catch-up growth in 
childhood and death from coronary heart disease: longitudinal study. BMJ 1999;318: 427-431. 
6 INTERNATIONAL CARDIOVASCULAR DISEASE EPIDEMIOLOGY UNIT  
6.1 Research and public health significance of the area 
The Unit was established in 1984 to serve as the international Data Centre of the WHO 
MONICA (Multinational MONItoring of trends and determinants in Cardiovascular disease) 
Project. Its specialties are the planning, coordination, quality assurance, data management, 
data analysis and reporting of large international population studies and health monitoring. 
Towards the end of the 1990s, when the data collection period of MONICA was ending, the 
Unit started using its expertise in two directions. One was harmonizing and pooling data 
from population-based studies in different countries for research purposes. The other was 
facilitating standardized health examination surveys (HES) in the European countries. 
Many major aspects of the population health, such as distributions of obesity, blood pres-
sure, blood lipid profile, prevalence of most major chronic diseases, such as coronary heart 
disease (CHD) and diabetes, and functional capacity can be measured reliably only through 
a health examination survey. Although these should have a major impact on public health 
policies, data on these are available only from a few countries. The last internationally com-
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parable population-level data, although not covering the countries as a whole, comes from 
the MONICA Project. This covered obesity, blood pressure and blood lipid profile, but the 
data are already over ten years old. There are no internationally comparable survey data on 
these from the past ten years, and there have never been internationally comparable popu-
lation data on many other important health aspects. One of the objectives of the Public 
Health Programme of the European Union is the availability of comparable health data from 
all member states. The European countries would like their health data to be comparable 
over time and with data from other countries, and therefore consider international standardi-
zation of health surveys important. The Unit is well placed for developing international col-
laboration in health surveys because of the advanced health survey system in Finland and 
the experience from the WHO MONICA Project. 
In the research area, the Unit's activities focus on harmonizing and pooling data from popu-
lation-based follow-up studies on cardiovascular disease (CVD). There is a large number of 
follow-up studies in different countries, and these are being used extensively for research. 
One obstacle to deepening the research is the limited size of the studies. There is insuffi-
cient power or statistical precision to address many relevant research questions. However, 
one can create a large study by pooling many small studies. One of the relevant study 
questions is the effect of the classic cardiovascular risk factors. Their impact is fairly well 
known, but there are still open questions as to whether the impact really is similar in South-
ern Europe with low incidence and Northern Europe with high incidence, whether the impact 
is similar in men and women, whether the impact differs between the young and the elderly, 
etc. Another need for large studies has emerged with the recent developments in genetics 
and in genotyping technology. Coronary heart disease and stroke are due to the interaction 
of many genetic and environmental factors. Individually these interactions have small or, at 
most, moderate effects but may carry considerable public health significance if the genetic 
variants in question are common in the population. Reliable detection of these effects re-
quires large sample sizes and abundant statistical power, which can only be achieved in a 
large collaborative study by the use of high throughput genotyping. The same concerns 
biomarkers, where better knowledge could help focusing public health activities and medical 
treatment in the future. The Unit is involved in the pooling of follow-up studies on cardiovas-
cular disease for this purpose as the Data Centre of the MORGAM (MONICA Risk, Genet-
ics, Archiving and Monograph) Project. 
The main challenge of the data pooling is the harmonization of the data from the different 
studies. Luckily, in the cardiovascular research, the WHO MONICA Project created data 
collection standards that have been used widely also outside MONICA, and therefore the 
harmonization of data from different studies is possible, although tedious. There are two 
other large European activities for pooling follow-up data from different countries. These are 
the Prospective Studies collaboration and SCORE. Although MORGAM has much in com-
mon with these, MORGAM is complementary in the sense that it has a higher level of stan-
dardization, it has both fatal and non-fatal end-points, and it is able to measure genotypes 
and biomarkers. 
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6.2 The main scientific achievements 
WHO MONICA Project 
The MONICA (Multinational MONItoring of trends and determinants in Cardiovascular dis-
ease) Project was established in the early 1980s in 32 Collaborating Centres in 21 countries 
to monitor trends in cardiovascular diseases, and to relate these to risk factor changes in 
the population over a ten-year period. It was set up to explain the diverse trends in cardio-
vascular disease mortality which were observed from the 1970s onwards. The total popula-
tion age 25-64 years monitored was ten million men and women. As such, MONICA was 
the biggest study on cardiovascular epidemiology ever conducted. 
In each Collaborating Centre, the monitoring was conducted in a geographically defined 
population. All possible myocardial infarctions of the population were registered, detailed 
information on symptoms and diagnostic tests, necropsy findings and previous history of 
coronary heart disease were collected and the events were assigned a diagnostic category 
using standardized criteria. In about a half of the populations, there was also registration of 
strokes. Major cardiovascular risk factors, including smoking status, blood pressure, choles-
terols and obesity were monitored in the same populations using sample surveys. Inde-
pendent population samples were examined in the beginning, optionally in the middle, and 
at the end of the ten-year period. 
Quality assurance of the data received particular attention in MONICA. This involved 
• the MONICA Manual, which described the standardized data collection procedures, 
and became the standard also widely beyond MONICA; 
• training of the personnel to follow the standard procedures; 
• quality control during the data collection; and 
• retrospective assessment and documentation of the achieved quality and any cen-
tre-specific characteristics of the data. 
The quality assessment reports, which include necessary background information for any-
one analysing the data and summarize the MONICA experience for anyone planning new 
data collection, were published on the WWW. 
Despite uncertainties about the funding during the project period, the data collection was 
completed successfully by the end of the 1990s, and the main results were published in the 
years 1999-2003. MONICA provided comparable data from a large number of countries on 
four continents on the attack rates of hard coronary events and strokes, uptake of the effec-
tive cardiac treatments that were introduced in the 1980s (antiplatelets, ACE inhibitors, 
thrombolytic therapy and coronary artery revascularization), and on the major classic car-
diovascular risk factors (smoking, blood pressure, cholesterol). These confirmed major in-
ternational differences in the incidence of coronary heart disease, which were anticipated 
from mortality statistics. The trends in the attack rates were declining in most populations. 
Overall, two thirds of the decline in mortality was attributable to a decline in coronary attack 
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rates and one third to a decline in case fatality. The trends in coronary event rates were 
associated with the trends in the classic risk factors, although more than half of the event 
rate changes remained unexplained. To what extent the unexplained changes are due to 
time lags in the effect of the risk factors, which could not be assessed in this study of ten 
years only, and to what extent they are due to changes in other known or unknown risk fac-
tors remains an open question. Case fatality, and in particular mortality, were strongly asso-
ciated with changes in treatment. The association was actually stronger than could be ex-
plained by the known effects of the treatments, and the results are likely to be confounded 
by the major social and political changes that took place during the same period in Central 
and Eastern Europe. 
To date, MONICA has produced 64 collaborative publications in peer-reviewed scientific 
journals and 32 quality assessment and other reports on the WWW. The exact number of 
publications from the individual Centres is not known, but it is thousands. The collaborative 
database has been archived for easy use. All MONICA Centres have a copy of it, and out-
side investigators can participate in the analysis through collaboration with a MONICA Cen-
tre. The MONICA experience has been summarized in the "MONICA Monograph and Mul-
timedia Sourcebook", which was published by WHO in 2003. Attached to it are two CD-
ROMs, which include the basic MONICA documentation and a 20% sample of the individ-
ual-level data from the database. These are being used for educational purposes in many 
places. 
The MONICA Project was a major collaboration between WHO, MONICA Data Centre (cur-
rently the Cardiovascular Disease Epidemiology Unit of KTL), four external Quality Control 
Centres, six Reference Centres of optional studies and the 32 Collaborating Centres which 
administered the data collection in the study populations. The MONICA Data Centre was 
centrally involved in the coordination of the study, quality assurance data analysis and pub-
lication, and archiving the study core data. It had (and has) little responsibility in the optional 
studies that focused on nutrition, antioxidant vitamins and polyunsaturated fatty acids, psy-
chosocial issues, physical activity, drugs and haemostatic risk factors. 
The cardiovascular disease and risk factor monitoring of MONICA laid the basis for preven-
tive activities and related health policies in the participating countries, most of which have 
continued the monitoring activities locally after MONICA. MONICA also had a major impact 
on the training of epidemiologists in the countries. 
MORGAM 
When the MONICA data collection period had ended, it was found that many of the Centres 
had followed up the people examined in the risk factor surveys for death and cardiovascular 
end-points. It was found that pooling the follow-up data provides a unique possibility to cre-
ate a data set with: 
• representative population cohorts from the high incidence north and low incidence 
south; 
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• standardized baseline measurements of the classic cardiovascular risk factors; 
• additional baseline measurements, such as socio-economic status, use of alcohol, 
status of cardiovascular diseases and diabetes, and family history of cardiovascular 
diseases; 
• a large number of fatal and non-fatal events both in men and women in a prospec-
tive follow-up; 
This would provide the possibility to get precise estimates for the open questions listed in 
section 6.2 above, as well as for many other relevant public health questions. Furthermore, 
in most of the surveys conducted in the early 1990s, DNA had been collected also. Human 
genome mapping was at an advanced stage, genotyping technology was developing rap-
idly, and it was obvious that there would soon be need for large population cohorts for as-
sessing the impact of genetic markers on the development of cardiovascular diseases. 
The MORGAM (MOnica Risk, Genetics, Archiving and Monograph) Project was established 
for the pooling of the follow-up data and DNA in 1998. (The "Archiving and Monograph" in 
the Project's name refer to the archiving of the MONICA database and the preparation of 
the MONICA Monograph, which were described under the MONICA Project above.) The 
main objective of the risk factor component of MORGAM is to assess the similarity of risk 
coefficients for the classic cardiovascular risk factors in different parts of Europe, between 
men and women and between age groups, using large cohorts with standardized baseline 
measurements and well-validated outcomes. The objective of the genetic component is to 
determine statistically significant combinations of SNPs from the multitude of genotypic data 
which, in combination with environmental factors and possible intermediate quantitative 
phenotypes, are predictors of incident coronary and stroke events, and total mortality. 
The genetic component is carried out in a case-cohort design, where the cases as well as 
random samples of the entire cohorts are genotyped. With this design, there is no need to 
select separate sets of controls for the different disease end-points, and the design also 
allows the estimation of the population frequencies of the genotypes. 
MORGAM is a collaboration of 19 Participating Centres in 11 countries (Australia, Denmark, 
Finland, France, Germany, Italy, Lithuania, Poland, Russia, Sweden and UK) which have 
followed up cohorts, three laboratories in Finland, France and Ireland which do genotyping, 
and a biomarker laboratory in Germany and a Data Centre at the Cardiovascular Disease 
Epidemiology Unit at KTL. The MORGAM Data Centre is closely involved in the coordina-
tion of the Project together with Queen's University Belfast and has a major responsibility in 
the data harmonization, data pooling, development of statistical methods, data analysis and 
reporting of the results. 
To date, the follow-up of these data from the last cohorts is being completed and the data 
assessment reports are being published. The first set of main analyses is being completed 
for publication using the finalized data both from the general cohort component and the ge-
netic component. The first genetic results from the individual centres have already been 
published. Analysis methods for the MORGAM case-cohort design have been published in 
statistical journals. 
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There are a total of 142,000 subjects in the cohorts, with 17,000 deaths, 9,500 CHD cases 
and 4,200 stroke cases during follow-up. The cohorts with DNA have 61,000 subjects, with 
4,900 deaths, 3,200 CHD cases and 1,300 stroke cases. There are 800,000 genotypes 
from 343 single nucleotide polymorphisms from 93 genes. The analysis of 20 biomarkers, to 
assess the predictive value of biomarkers for CVD events and to look for associations with 
genotypes, is just starting. The biomarkers have been selected as representing discrete 
patho-physiological pathways i.e., inflammation, endothelial activation, metabolics, lipids, 
oxidative stress, renal function, and neurohumoral/haemodynamics. 
Summary of scientific achievements 
A summary of the Unit's main scientific achievements is presented in Table 6.1 
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Table 6.1 Summary of main scientific achievements since 1997 
Scientific output  N Comments  
Original articles and 
reviews in international 
peer-review journals  
95  
 
 
Original articles and 
reviews in domestic 
peer-review journals  
8    
Textbooks and chapters 
in textbooks, reports 
and proceedings  
53  
This includes 38 WWW-publications: international project manuals, qual-
ity assessment reports databooks and methodological appendices to 
articles published in journals 
Theses  
PhD:2 
MSc:2  
Doctoral theses: Molarius A, Tolonen H  
Organization of scientific 
meetings and confer-
ences  
10  
Most of these are international workshops of the MORGAM and EHRM 
Project  
Presidencies and mem-
berships in scientific 
committees of interna-
tional meetings  
2  
 
 
Presidencies and mem-
berships in other scien-
tific committees  
5  
Presidency of the Finnish Society of Biostatistics 1995-7, MONICA 
Steering Committee 1987-, MORGAM Management Group 1998-, Ge-
nomEUtwin Steering Group 2002-7, Swiss National Science Foundation 
Cohort Panel 2005-  
Invited lectures and 
chairmanships in inter-
national meetings  
11  
 
 
Lectures in domestic 
scientific meetings  
occasionally  
 
 
 
Supervision of disserta-
tions  
1  
 
 
Review of PhD thesis, 
evaluation of professor-
ship  
2    
Review of scientific 
papers  
35 
Lancet, Stroke, J Intern Med, Int J Epidemiol, J Clin Epidemiol, BMC 
Medical Genetics, Prev Med, IBM Systems Journal, Eur J Cardiovasc 
Prev Rehabil, Tob Control, Ethn Health, IBM System Journal, Digital 
Signal Processing, J VLSI Signal Processing Systems, Int J Adaptive 
Control and Signal Processing, IEEE Speech and Audio Processing, 
Computational Statistics and Data Analysis etc.  
Research visits to/from 
international research 
institutes or universities  
150  
Our daily research collaborators are scattered mostly around Europe. 
Short and longer-term visits are made whenever convenient  
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6.3 The main public health activities and achievements 
MONICA created standards and laid the basis for international collaboration in the monitor-
ing of the risk factors of cardiovascular diseases in the population. However, in most coun-
tries MONICA monitoring covered only the population of a relatively small area, and the 
MONICA data collection ended in the 1990s. After MONICA, the Unit has been actively in-
volved in the development of the survey part of health monitoring in the European Union. 
It had the leadership in the European Health Risk Monitoring (EHRM) Project, which was 
conducted in the years 1999-2002 within the EU Programme of Community Action on 
Health Monitoring. The Project produced a recommendation for indicators, international 
collaboration, protocol and manual of operations for chronic disease risk factor surveys. The 
primary purpose of such surveys is to gather information for the planning and evaluation of 
health promotion and disease prevention in the countries and at European level. The rec-
ommendations also updated and complemented the MONICA survey procedures which 
were already 20 years old. The Project was conducted in collaboration with the European 
Union, the World Health Organization and national experts in different countries. 
The Unit is currently (years 2006-2008) leading the Feasibility of a European Health Exami-
nation Survey (FEHES) Project within the EU Programme of Community Action in the Field 
of Public Health. The purpose of the Project is to assess the feasibility of conducting a 
health examination survey (HES) in all EU Member States. In addition to the risk factors of 
the major chronic diseases, such a survey can comprise topics such as the prevalence of 
many chronic diseases and functional capacity. The Project reviews the scope, contents, 
methods and cost of the surveys that have already been conducted, and assesses the per-
ceived interest and possible plans of the Members States to such surveys in the future. 
Based on this and other available information, the Project makes proposals for models of 
surveys for comparable information from all Member States. 
The Unit also participates in the development of international systems for interview surveys 
through memberships in the Eurostat Task Force on Health Interview Survey Methods and 
Expert Advisory group for the WHO and CDC for planning Global Adult Tobacco Surveil-
lance in middle and low income countries. The Unit is represented in the Steering Commit-
tee of the European Health Survey System, set up jointly by Eurostat and the Directorate 
General for Health and Consumer Protection (Sanco) of the European Commission. 
A summary of the Unit's main public health activities and achievements is presented in Table 6.2 
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Table 6.2 Summary table of committee memberships, coordination and proceedings with 
public health impact 
Public health output  N Comments  
Articles and reviews in  
non-peer-review journals  
3 
 
 
TV, radio, newspaper 
interviews  
few 
annually 
  
Health education ma-
terial, websites, information 
databases  
6 
MONICA, EHRM and FEHES websites. WWW-publication se-
ries of MONICA, EHRM and MORGAM.  
Membership in interna-
tional committees with public 
health impact  
7  
SC of the European Health Survey System; EU/Sanco Working 
Parties: Mortality and Morbidity, Indicators, Task Force Major and 
Chronic Diseases, Eurostat Task Force on HIS Methods, WHO/Global 
Adult Tobacco Use Surveillance expert group, EHRM Steering Com-
mittee  
Coordination and/or 
implementation of develop-
ment projects  
2  Coordination of EHRM and FEHES Projects  
Public health output  N   
Articles and reviews in  
non-peer-review journals  
3  
 
 
 
TV, radio, newspaper 
interviews  
few 
annually  
 
  
Health education ma-
terial, websites, information 
databases  
6   
 
MONICA, EHRM and FEHES websites. WWW-publication se-
ries of MONICA, EHRM and MORGAM.  
 
Membership in interna-
tional committees with public 
health impact  
7  
 
SC of the European Health Survey System; EU/Sanco Working 
Parties: Mortality and Morbidity, Indicators, Task Force Major and 
Chronic Diseases, Eurostat Task Force on HIS Methods, WHO/Global 
Adult Tobacco Use Surveillance expert group, EHRM Steering Com-
mittee  
 
Coordination and/or 
implementation of develop-
ment projects  
2  
 
Coordination of EHRM and FEHES Projects  
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6.4 Funding for research and public health programmes  
Two persons' salaries in the Unit come from the KTL regular budget. The last years of 
MONICA and the first years of MORGAM were funded by Biomed2 grants from 
EU/Research, and the past 4 years of MORGAM by a fifth Framework Programme grant 
from EU/Research. The EU funding concerned the collaborative activities of the research 
projects, such as international coordination, data pooling (including most of the Data Centre 
activities), and genotyping, whereas the data collection and local research in the Participat-
ing Centres were funded locally. The EHRM and FEHES Projects for developing European 
health surveys were funded mostly by grants from the Health Monitoring Programme and 
the Public Health Programme of the EU (DG Sanco). 
6.5 Personnel 
The number of personnel in the Unit has increased slightly from about 6 when MONICA was 
the only big activity to the current about 9. The current staff includes 
• Head of the Unit (Kari Kuulasmaa, PhD); 
• 2 persons (led by Zygmantas Cepaitis, Eng) for systems analysis and data man-
agement; 
• 2 statisticians (earlier led by Sangita Kulathinal, PhD, now by Juha Karvanen, DSc) 
for statistical methods; 
• 3 epidemiologists (including Hanna Tolonen, PhD, and Matti Niemelä, MD) for de-
veloping European health surveys and harmonizing data from MORGAM Centres; 
and 
• an administrative secretary. 
The Unit benefits substantially from, and is dependent on, work done by collaborators in 
other parts of KTL and abroad. 
6.6 National and international collaboration 
All the Unit's main activities are part of wide international collaboration. The MONICA net-
work involves 32 centres in 21 countries. The MORGAM network, including the Collaborat-
ing Centres, the Laboratories, the Data Centre and Associated Centres not contributing 
data but receiving information and invited to meetings involves 36 research groups in 17 
countries. The MORGAM Coordinator is Professor A. Evans, Queens University Belfast, 
and the MORGAM laboratories are at 
• Department of Molecular Medicine, KTL, Helsinki (MORGAM Central laboratory, 
Prof. L. Peltonen); 
• INSERM U525, Paris (Dr F. Cambien); 
• Royal College of Surgeons in Ireland (Prof. D. Shields); and 
• Johannes Gutenberg-University, Mainz (Prof. S. Blankenberg). 
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Since the year 2002, MORGAM has been part of GenomEUtwin, a Network of Expertise for 
Genomics in Europe, which also involves the twin registries of 8 countries. Within ETEO, the 
Unit collaborates closely with the Chronic Disease Epidemiology Unit and the Cancer Preven-
tion Unit, which participate in MORGAM. For the development of statistical methods, there is 
a close collaboration with the Department of Mathematics of the University of Helsinki. 
The FEHES Project on European HES is done together with a core group of investigators in 
• Department of Health and Functional Capacity, KTL, Finland 
• Istituto Superiore di Sanità (ISS), Italy; 
• Rijksinstituut voor Volksgezondheid en Milie (RIVM), the Netherlands; 
• Norwegian Institute of Public Health (FHI), Norway; and 
• University College London (UCL), UK, 
and there is a network of contact persons in 32 European countries. There are also close 
contacts with WHO, the European Commission, and other relevant projects of the Public 
Health Programme of the EU. More recently, contacts have been created with the organiz-
ers of the national HES's in the USA (NHANES) and Canada. 
6.7 Proposal for future work and expected benefits 
The Unit will continue with the two current lines: large international pooling of data for re-
search purposes and the development of international collaboration in health monitoring. 
After the long data harmonization process, MORGAM is now ready to start harvesting. 
Therefore, the focus in the next years will be on data analysis and publication. Where there 
is benefit from synergy, MORGAM will collaborate with other international projects such as 
Cardiogenics and EuroClot which are producing promising candidate genes that can be 
assessed in the MORGAM cohorts. There are great expectations for the MORGAM Bio-
marker Substudy, which has just received funding from the British Medical Research Coun-
cil. MORGAM is open for new cohorts to join, and the preparation of data for MORGAM has 
already started from large population cohorts in Norway, England and Germany. 
KTL has recently submitted a proposal to the EU for preparing a full-size national HES in 11 
countries. This would form a part of the piloting of the European HES. The objective is to 
proceed steadily to a standardized sustainable HES system in the European countries. The 
Unit is prepared to be involved in the international coordination and standardization, until 
more permanent structures are in place for this in the EU. 
A standardized national health interview survey is being carried out in over ten EU countries 
in 2007-8. Eurostat will pool the data for basic processing, but does not have the authority 
to release these for research purposes. There is a proposal by the Unit to pool these data 
on a voluntary basis, to assess their quality and comparability to see that they meet re-
search standards, and to share the data with European researcher groups of top expertise 
in related areas. 
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The Unit will continue with its responsibilities in the administration of MONICA and mainte-
nance of its archived data set, but this will have a small role in the Unit's activities. 
6.8 Main publications 
Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P, for the 
WHO MONICA (monitoring trends and determinants in cardiovascular disease) Project. 
Contribution of trends in survival and coronary-event rates to changes in coronary heart 
disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 
1999;353:1547-57. 
Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Fer-
rario M, Tuomilehto J, for the WHO MONICA Project. Estimation of contribution of changes 
in classic risk factors to trends in coronary-event rates across the WHO MONICA Project 
populations. Lancet 2000:355;675-87. 
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mähönen M, Cepaitis Z, Kuulasmaa K, Keil U, for 
the WHO MONICA Project. Estimation of contribution of changes in coronary care to im-
proving survival, event rates, and coronary heart disease mortality across the WHO 
MONICA Project populations. Lancet 2000:355;688-700. 
Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K, for the WHO MONICA Project. 
Educational level, relative body weight, and changes in their association over 10 years: an 
international perspective from the WHO MONICA Project. Am J Public Health 
2000;90:1260-68. 
Tolonen H, Mähönen M, Asplund K, Rastenyte D, Kuulasmaa K, Vanuzzo D, Tuomilehto J, 
for the WHO MONICA Project. Do trends in population levels of blood pressure and other 
cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 popula-
tions in 9 countries within the WHO MONICA Stroke Project. Stroke 2002;33:2367-2375. 
Kulathinal SB, Kuulasmaa K, Gasbarra D. Estimation of an errors-in-variables regression 
model when the variances of the measurement errors vary between the observations. Stat 
Med 2002;21:1089-1101. 
Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H and the European Health Risk Monitoring 
Project. Recommendation for indicators, international collaboration, protocol and manual of 
operations for chronic disease risk factor surveys. (October 2002). Available from 
URL:http://www.ktl.fi/publications/ehrm/product2/title.htm, URN:NBN:fi-fe20021443. 
Sarti C, Stegmayr B, Tolonen H, Mähönen M, Tuomilehto J, Asplund J, for the WHO 
MONICA Project. Are changes in mortality from stroke caused by changes in stroke event 
rates or case fatality? - Results from the WHO MONICA Project. Stroke 2003;34:1833-
1841. 
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Tunstall-Pedoe H, editor. Prepared by Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, David-
son M, Mendis S with 64 other contributors for The WHO MONICA Project.MONICA Mono-
graph and Multimedia Sourcebook. Geneva: World Health Organization; 2003. ISBN 92 4 
156223 4. 
Gostynski M, Gutzwiller F, Kuulasmaa K, Döring A, Ferrario M, Grafnetter D, Pajak A, for 
the WHO MONICA Project. Analysis of the relationship between total cholesterol, age, body 
mass index among males and females in the WHO MONICA Project. Int J Obes 
2004;28:1082-1090. 
Tolonen H, Keil U, Ferrario M, Evans A, for the WHO MONICA Project. Prevalence, aware-
ness and treatment of hypercholesterolaemia in 32 populations: results from the WHO 
MONICA Project. Int J Epidemiol 2005;34:181-192. 
Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, Perola M, Peltonen 
L, Shields D, Tunstall-Pedoe H, Kuulasmaa K, for the MORGAM Project. MORGAM (an 
international pooling of cardiovascular cohorts). Int J Epidemiol 2005;34:21-27. 
Kulathinal S, Niemelä M, Kuulasmaa K, contributors from Participating Centres, for the 
MORGAM Project. Description of MORGAM Cohorts. (2005). Available from 
URL:http://www.ktl.fi/publications/morgam/cohorts/index.html, URN:NBN:fi-fe20051214. 
Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declin-
ing blood pressure across replicate population surveys of the WHO MONICA project, mid-
1980s to mid-1990s, and the role of medication. BMJ 2006;332:629-635. 
Kulathinal S, Arjas E. Bayesian inference from case-cohort data with multiple end-points. 
Scand J Statist. 2006;33:25-36. 
7 CHRONIC DISEASE EPIDEMIOLOGY UNIT 
7.1 Research and public health significance of the area 
The Unit has existed approximately in its present form since the year 2000. The task of the 
Unit is to carry out research on the epidemiology, risk factors and aetiology of chronic dis-
eases that are of major public health significance. Research proceeds in parallel with the 
monitoring of the risk factor levels and the occurrence of major disease events such as 
myocardial infarction (MI) and stroke in the Finnish population. The aim is to produce new 
data, which could contribute to reducing the risk factor levels and improving the treatment of 
chronic diseases, thus reducing morbidity and mortality. 
The Unit has the main coordinating responsibility of the FINRISK surveys, which is one of 
the most important projects of the whole Department. This is a series of cardiovascular and 
other chronic disease risk factor surveys that have been carried out every five years since 
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1972 on random population samples of certain geographical areas of Finland. The roots of 
the FINRISK surveys are in the North Karelia Project, which then continued as part of the 
Finnish contribution to the WHO MONICA Project and has since then extended to cover 
even wider geographical areas. The number of participants in different years has varied 
from about 6,000 to about 11,000. 
The main purpose of the FINRISK surveys has been to monitor the levels of cardiovascular 
risk factors, such as smoking, blood pressure and cholesterol, in the population. However, 
each of the surveys also forms a cohort, which is being followed-up with annual record link-
age of the study data on the basis of personal identification number with the national 
Causes-of-Death Register, the Hospital Discharge Register and the Drug Reimbursement 
Register. Serum and plasma samples have been taken and stored in freezers, and DNA 
samples have been collected since the 1992 survey. This setting has enabled a wide re-
search activity and there are numerous subprojects ongoing in the FINRISK framework in 
which the research is carried out by investigators of the Chronic Disease Epidemiology Unit 
as well as other investigators of KTL, or investigators elsewhere in Finland and even 
abroad. 
Traditionally, the focus of FINRISK research has been on cardiovascular diseases, which 
are still the number one killer in Finland. The biological, behavioural and socioeconomic risk 
factors of cardiovascular diseases are covered by different projects. Other important public 
health problems covered are diabetes, cancer, asthma and allergies, effects of ageing, 
health effects of alcohol and to some extent also kidney and liver diseases. In particular it 
should be noted that there are currently DNA samples from about 32,000 FINRISK partici-
pants. Together with the follow-up information and stored serum and plasma samples this 
provides a unique setting for genetic epidemiological studies of important public health 
problems. 
The other main activity of the Unit is cardiovascular disease registers, which serve both 
research and monitoring of the occurrence of cardiovascular disease events. FINAMI fol-
lows the tradition of the FINMONICA MI register as a population-based myocardial infarc-
tion register. The idea is to record all coronary heart disease (CHD) events that occur in the 
populations of four geographically defined areas. It should be mentioned that the same ar-
eas are also covered by the risk factor monitoring of the FINRISK surveys. The registration 
of CHD events takes place in collaboration with clinical researchers working in the main 
hospitals of the study areas. The local registration teams collect data on every suspected 
CHD event, including out-of-hospital deaths, according to a standardized protocol. The data 
are then sent to KTL for checking, quality control, and analysis. The FINAMI data are annu-
ally linked to the National Hospital Discharge Register and the National Causes-of-Death 
Register to check the completeness of registration and to provide data on prognosis of MI 
patients in relation to reinfarctions, revascularizations and survival. The data are also linked 
to socioeconomic indicators, such as education level, family income and profession, to ob-
tain information on the socioeconomic position before the MI event. Since the FINAMI diag-
noses are carefully scrutinized, they can be used for validation of CHD diagnoses in Finnish 
administrative registers. In this way, the FINAMI register also serves the follow-up of 
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FINRISK cohorts as well as the country-wide monitoring of CHD events, which is done with 
administrative registers. 
Similarly to the FINAMI-register, stroke registration was continued after the end of the 
FINMONICA-Project under the name FINSTROKE. However, due to the resource limita-
tions data collection in the FINSTROKE-register ended at the end of 1998. Since then the 
collected data have been used for analysing factors related to survival and functional capac-
ity after stroke. 
An application of administrative registers is the Finnish Cardiovascular Disease Register 
(CVDR)-project, where we have on the basis of personal ID code linked together data on 
cardiovascular events from the National Causes-of-Death Register, the National Hospital 
Discharge Register and from the Drug Reimbursement Register. This database includes all 
fatal and hospitalized non-fatal cardiovascular events in Finland from 1991 currently until 
2005. Together with the population counts the event data have been used for calculating 
annual age-standardized rates of cardiovascular events for the whole country as well as for 
each hospital district. To avoid the effects of random fluctuations, the hospital district-
specific rates are expressed using three-year moving averages. These summary figures 
have been placed on the Internet, were they are freely available for anybody at 
http://www.ktl.fi/cvdr/ . The background information is provided in both Finnish and English. 
It should be noted in particular that the use of personal ID code has enabled us to check the 
Hospital Discharge Register backwards in time for earlier cardiovascular events. In this way, 
the register can produce data on the incidence of first CHD and stroke events. The CVDR 
data have been linked to the coordinates of the Geographical Information System (GIS) to 
investigate the geographical distribution of CHD and stroke events in Finland. It has also 
been linked to the drug reimbursement records to provide data on the use of secondary 
preventive drugs after a CHD event or a revascularization procedure. The database is rela-
tively easily updated annually as new versions of the Causes-of-Death Register and the 
Hospital Discharge Register become available.    
7.2 The main scientific achievements 
FINRISK 
During the past ten years, 210 original articles have been published from the FINRISK data in 
English in scientific journals following the peer-review practice. In domestic medical journals, 
18 scientific articles have been published in Finnish language. Furthermore, 4 doctoral and 9 
master's theses have been prepared. FINRISK data have played a key role in many well-
known international collaborative projects, which have published important results, such as 
the WHO MONICA Project and its successor, the MORGAM Project, the SCORE collabora-
tion and the Fibrinogen Studies Collaboration. At the end of the 1990s the MDECODE (Mo-
lecular Diversity and Epidemiology of Common Disease) collaboration published the DNA 
sequence diversity and the haplotype structure of the lipoprotein lipase gene, partly based on 
FINRISK data. These were pioneering papers at that time and are still widely cited. Other 
pioneering papers from the FINRISK data include those of the DECODE (Diabetes Epidemi-
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ology: Collaborative Analysis of Diagnostic Criteria in Europe) Study documenting the superi-
ority of oral glucose tolerance test and 2 h blood glucose value over the fasting glucose as 
predictors of all-cause mortality and cardiovascular diseases. 
FINAMI, FINSTROKE and CVDR 
During the last ten years 60 original articles have been published from the MI and stroke-
register data in English language in peer-reviewed scientific journals and 20 papers in do-
mestic journals in Finnish language. Furthermore, 4 doctoral theses have been prepared. 
Finnish MI and stroke register data were important parts of the Collaborative publications of 
the WHO MONICA project documenting the contributions of risk factors and treatment to 
the declines in CHD and stroke mortality. The Finnish data have also been reported on their 
own, and the findings have documented the prominent roles of declining recurrence and 
incidence rates in the decline of CHD mortality in Finland. Other findings have documented 
prominent socioeconomic discrepancies in the incidence, prognosis and treatment of coro-
nary events in Finland. More recently, we have used the FINAMI data to report trends in 
coronary events correcting for the effects of troponins, which are more sensitive and spe-
cific markers of myocardial injury than the previously used cardiac enzymes. This was the 
first time that the effects of widely adopted troponin determinations on CHD event trends 
could be properly quantitated. 
A summary of the Unit's main scientific achievements is presented in Table 7.1 
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Table 7.1 Summary of main scientific achievements during 1997-2006 
Scientific output  N  Comments  
Original articles and reviews 
in international peer-review journals  280  
This is the total number of papers published or 
accepted for publication from the FINRISK, FINAMI, 
CVDR and other projects between 1996 and 5/2007  
Original articles and reviews 
in domestic peer-review journals  39    
Textbooks and chapters in 
textbooks, reports and proceedings  10    
Theses  
8 doctoral the-
ses, 9 master's 
theses  
Doctoral theses: PerolaM, Kastarinen M, Su-
violahti E, Borodulin K, Ketonen M, Kaarisalo M, 
Koukkunen H, Jakovljevic D  
Organization of scientific 
meetings and conferences  5  
Paavo Nurmi Symposium  
Nordic Congress on Coagulation  
American Heart Assoc. Congress on Epidemiology 
and Prevention in 2005 and 2006,  
Nordic Congress on Cardiac Rehabilitation (upcom-
ing in 2008)  
Presidencies and member-
ships in scientific committees of 
international meetings  
2  
Co-chairman of the Scientific and Standardiza-
tion Committee on Predictive Hemostatic Variables, 
ISTH, 2005 and 2007  
Presidencies and member-
ships in other scientific committees  4  
NHLBI Workshop on CVD events, 2005;  
MORGAM Management Group;   Advisory Board, 
Prevent-it Study; Expert Workshop on MI Registers in 
2007  
Invited lectures and chair-
manships in international meetings  1-3/year  
ESC; EUROPREVENT; AHA Congress on Epi-
demiology and Prevention etc  
Lectures in domestic scientific 
meetings  
Several annu-
ally  
Meetings of the Finnish Cardiac Society, Fin-
nish Heart Assoc., Finnish Medical Assoc.  
Editorial tasks in international 
peer-review journals  1  
Associate Editor of the Eur J Cardiovasc Prev 
Rehabil  
Opponent of dissertation  3    
Supervision of dissertations  2  2 done, 6-8 ongoing  
Review of PhD thesis, evalua-
tion of docentship  17    
Review of scientific papers  Several annu-ally  
Regular reviewer for journals like Circulation, 
ATVB, Arch Int Med, EHJ, Am J Epid  
Research visits to/from inter-
national research institutes or uni-
versities  
3  School of Public Health, University of North Carolina, USA  
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7.3 The main public health activities and achievements 
The FINRISK surveys have enabled the monitoring of the cardiovascular risk factor levels in 
the Finnish population for 35 years. At the same time and in the same areas CHD and 
stroke mortality and morbidity have been monitored using specific MI and stroke registers 
and administrative registers. This has created a strong knowledge base for health-political 
decision making and public health programmes aimed at preventing cardiovascular dis-
eases. Good information on the smoking habits of the population has also contributed to the 
prevention of cancers and COPD. Investigators of the Unit, as well as other investigators of 
KTL, have presented these results in numerous educational meetings for physicians and 
other health care personnel. These data have also been used over the years as background 
material for various governmental committees as well as for the expert groups of the Finnish 
Heart Association. A recent example of these activities was the consensus conference on 
obesity organized by the Academy of Finland. 
Both FINRISK data and the FINAMI and FINSTROKE data have been widely used for ana-
lysing and reporting on socioeconomic disparities in cardiovascular risk factors and in car-
diovascular mortality and morbidity. For example, we have reported that patients belonging 
to the lowest income tertile had 2-3 times higher risk of dying within one year of the onset of 
symptoms than patients belonging to the highest income tertile. From the FINRISK data we 
have recently reported that the proportion of socioeconomic differences in CVD mortality 
and morbidity that can be explained with socioeconomic differences in the levels of classical 
risk factors (smoking, cholesterol, and blood pressure) is diminishing over time. These kinds 
of results have been directly used for the evaluation of the 'Health for All by the Year 2000' 
and now the 'Health 2015' Programme, which give great emphasis to narrowing of the so-
cioeconomic health disparities. Other public health achievements include the CVD register 
on the web-pages of KTL, which provides the annual numbers and rates of coronary and 
stroke events from 1991 to 2005 for the whole country as well as for each hospital district, 
thus helping health care planning and resource allocation. The register data have also been 
widely used by third sector organizations, such as the Finnish Heart Association, to help 
direct their activities. 
Experts of the Unit have played an important role in putting together the Social and Health 
Report of the Finnish parliament in 2006. Other functions of considerable public health im-
portance include IARC's expert group on the health effects of smoking cessation. At the 
European Union level, investigators of the Unit were in a key position in organizing a high-
level expert meeting during the Finnish EU presidency under the theme "Health in All Poli-
cies" and in documenting the relevant materials of the meeting as a booklet. The Unit has 
also actively participated in the expert groups of the Health Monitoring Programme of the 
European Union. Examples of this work include the EUROCISS (European Cardiovascular 
Indicators Surveillance Set) and IMCA (Indicators for Monitoring COPD and Asthma) pro-
jects. At the global level, it should be mentioned that the secretariat of IANPHI (International 
Association of National Public Health Institutes) started its functions in the Unit. Later on, 
when the activities grew more extensive, the secretariat was transferred under the direct 
leadership of the deputy director general.A summary of the Unit's main public health activi-
ties and achievements is presented in Table 7.2 
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Table 7.2 Summary table of committee memberships, coordination and proceedings with 
public health impact 
Public health output  N Comments  
Articles and reviews in  non-
peer-review journals  
13 
2 reports of the OECD, several reports of KTL, and in the 
journal of KTL  
TV and radio interviews  7   
Health education material, 
websites, information databases  
2 CVD Register, Tabulated data of FINRISK  
Membership in international 
committees with public health impact  
4 EUROCISS, IMCA, SCORE, PRECARD  
Membership in domestic com-
mittees with public health impact  
2 
Finnish Academy's Consensus Committee on Obesity; 
Health Report 2006; Nucleus of the WG on Prevention and 
Rehabilitations, FSC; HIAP  
Coordination and/or implemen-
tation of development projects  
1 IANPHI  
Coordination of public health 
networks  
1 IANPHI  
Organization of domestic train-
ing with public health impact  
1 
Annual series of educational events for doctors and nurses 
by the WG on prevention and Rehabilit, FSC  
7.4 Funding for research and public health programmes 
The Unit has been successful in attracting external funding from competed sources such as 
the Academy of Finland, the Sigrid Juselius Foundation and other Finnish foundations. Re-
searchers of the Unit are also co-investigators in major grants from the EU and from the 
NIH. It should be noted that some of this external funding is not included in the summary 
report of the Department, because the funds do not go through the KTL administration for 
example in cases where FINRISK samples are being analysed abroad. The clear majority of 
the funding for the research of the Unit has come from external sources, except for the field 
work of the FINRISK surveys (for example in 1997), when the Institute has made a substan-
tial 'extra' input to get the basic data and sample collection funded.  At the moment 2.2 per-
sons in the Unit receive their salaries from the budgetary funds of KTL, all others (5-8 per-
sons) are hired on project money from various temporary sources. 
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7.5 Personnel 
The staff of the Unit has varied between 5-10 persons. The current figure is eight, five of 
whom are working on a part-time basis. The true research group is, however, much larger 
due to extensive domestic and international collaborations. 
The researchers as of May 2007: 
Veikko Salomaa, MD, PhD, research professor. Head of the Unit, Cardiovascular epidemi-
ology, risk factors, genetic epidemiology. 
Pekka Jousilahti, MD, PhD, research professor. Works 20% for the Unit. Epidemiologist, 
risk factors for cardiovascular disease and cancer, obesity research, research on respiratory 
diseases 
Satu Männistö, MSc, PhD, senior researcher. Works 80% for the Unit. Nutrition and obesity 
research and cancer epidemiology. 
Kennet Harald,MA (sociology), PhD student. Socioeconomic research, analyses and man-
agement of the FINRISK data. 
Rauni Pääkkönen, MSc, Works 50% for the Unit. Construction and maintenance of the Car-
diovascular Register Database. Statistical analyses. 
Aki Havulinna, MSc, PhD student. Works 50% for the Unit. Statistical modelling of the spa-
tial distribution of CHD and stroke events. Other statistical analyses, database management 
of the FINAMI data. 
Jorma Torppa, MSc, Works 40% for the Unit. Statistical analyses of the FINAMI and 
FINSTROKE data. 
One researcher of the Unit, Katja Borodulin, PhD, is currently working as a post-doc at the 
Universityof North Carolina in the USA (exercise research). In addition, there are currently 
five PhD students working outside KTL but under the guidance of the Unit's investigators 
and using the materials of KTL. Besides researchers, the Unit has a secretary/ administra-
tive assistant, who currently works 75% of her time for the Unit. 
7.6 Collaboration 
 International 
The Unit is involved in extensive international research collaboration and many of the best 
results of the Unit have been gained through multinational collaborative projects. Below is a 
brief list of the most important collaborators and projects as of May 2007: 
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The Broad Institute of MIT and Harvard, Cambridge, MA, USA (Drs Altschuler, Hirschhorn, 
Kathiresan and others). MIGEN is a multinational case-control study on the genetics of MI in 
young patients. A large number of young MI cases and controls have been collected from 
several sources, including the FINRISK Study. A genome-wide association study of 1 mil-
lion SNPs and copy number variants is being performed using the Affymetrix 6.0 chip. This 
is one of the first large-scale studies in the world that uses such a dense genome-wide 
scan. In the FINRISK -97 cohort we are replicating the findings on obesity and lipids ob-
tained in other GWA studies of the Broad Institute. In addition to replication, in the FINRISK 
-97 cohort we aim (a) to characterize the findings and biological mechanisms in more detail 
by fine mapping of the associated loci and (b) to assess the risk at the population level in 
more detail by using the prospective cohort design. In KTL, the Department of Molecular 
Medicine is an important collaborator in these projects. 
The Queen's University of Belfast, UK, Inserm U252 Paris, France, University of Mainz, 
Germany  etc_._ (Drs Evans, Cambien, Blankenberg and others). The MORGAM-Project is 
a large multinational research project focused on cardiovascular risk and risk factors. It is 
based on the follow-up of cohorts which participated in the risk factor surveys of the WHO 
MONICA Project and other similar cohorts. FINRISK -92 and -97 cohorts are included in 
MORGAM. The project has the general risk factor arm and the genetic arm. In KTL the most 
important collaborators in this project are the International CVD Epidemiology Unit, which 
hosts the Data Centre for MORGAM, and the Department of Molecular Medicine. The 
MORGAM Biomarker Study is an adjunct to MORGAM that aims at identifying new bio-
markers of cardiovascular risk. In this framework an extensive set of biomarkers is being 
determined at the University of Mainz from the samples of the FINRISK -97 cohort. 
University of Dublin, Ireland (Dr Graham and others). The SCORE collaboration aims at 
calculating the absolute risk of cardiovascular events in European populations. FINRISK 
cohorts were by far the largest contributors in calculating the SCORE tables on absolute 
risk of cardiovascular death, which are now widely used all over Europe. Efforts are under-
way to update these risk equations to also include nonfatal events and FINRISK cohorts 
play a key role in the efforts. 
University of Cambridge, UK (Dr Danesh and others). The Fibrinogen Studies Collaboration 
is a large meta-analysis project aiming to characterize in more detail the roles of fibrinogen 
and its correlates in cardiovascular disease risk. The FINRISK -92 Haemostasis Study and 
the PAIS Project, which are subsamples of the FINRISK -92 and -97 surveys are participat-
ing in this project. The Emerging Risk Factor Collaboration is another large meta-analysis 
project, which aims to assess the roles of CRP, triglyceride concentration and several other 
'emerging' risk factors in the cardiovascular risk. 
GSF Forschungszentrum fur Umwelt und Gesundheit (Drs Peters, Illich, Koenig, and oth-
ers). The AIRGENE Study is an EU-funded study on the effects of various air pollutants on 
inflammatory reaction in MI survivors. In KTL, the study is led by the Department of Envi-
ronmental Epidemiology in Kuopio, but our Unit has contributed substantially, because the 
MI patients were recruited and investigated in Helsinki. We have also added a substudy on 
Interleukin 1 in the project and a PhD-student is working on these data. 
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Socialstyrelsen's Epidemiologisk Centrum, Sweden, the National Public Health Institute of 
Denmark, Denmark, University of Glasgow, Scotland (Drs Köster, Hammar, Madsen, Ley-
land and others). The NORDAMI Project is a collaboration between the Nordic countries 
and Scotland, all of which have built a cardiovascular disease register based on record link-
age of the national administrative registers, such as the causes of death register and the 
hospital discharge register. The Project aims at standardizing the cardiovascular event defi-
nitions and making the data as comparable as possible. Data from all countries will be 
placed publicly available on the Internet using the web-site of the Swedish Socialstyrelsens 
Epidemiologisk Centrum. Common data are also being used for scientific publications. The 
Finnish CVD Register data have already been sent to Sweden for this purpose. 
Instituto Superiore di Sanita, Rome, Italy (Dr Giampaoli and others). The EUROCISS Pro-
ject, coordinated by the National Public Health Institute of Italy, is a part of the Health Moni-
toring Programme of the European Union. Phase II of the Project has just assembled is final 
report, presenting the recommendations for monitoring CVD events in the European Union. 
IMCA is a similar project for respiratory diseases coordinated by Fundacio IMIM, Barcelona, 
Spain (Dr Duran). 
Domestic 
Kuopio University Hospital, North Karelia Central Hospital, Oulu University Hospital, and 
Turku University Hospital (Drs Pyörälä, Lehto, Mustonen, Ketonen, Kesäniemi, Airaksinen, 
Immonen-Räihä and others). The main domestic collaboration for the past ten years has 
been the FINAMI myocardial infarction register which is still ongoing. Clinical investigators 
and research nurses in three university hospitals and one central hospital have worked to-
gether with KTL investigators for many years to collect and analyse data on myocardial in-
farction events in four geographical areas of Finland. These data have been used for nu-
merous scientific reports and public health functions in the study areas and in the whole 
country. Currently, there are two PhD-students actively working on these data. 
Another very long-standing and productive collaboration has taken place in the framework 
of the Helsinki Businessmen Study, a cohort that has been followed-up since the late 
1960s. Participants in this collaboration have been the University Hospital of Helsinki and 
University Hospital of Oulu (Drs Strandberg, Miettinen, Tilvis and others). 
Of domestic collaborations it should be noted that investigators of our Unit have actively 
participated in the work of the Health 2000 Project, playing important roles in the research 
group on respiratory diseases and in the research group on cardiovascular diseases and 
diabetes. There are several other smaller-scale collaborative projects with different investi-
gators at the University Hospital of Helsinki and elsewhere. Particularly important have been 
good relations with the Finnish Heart Association and the Finnish Cardiac Society. 
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7.7 Proposal for future work and expected benefits 
FINRISK 
The prospects for the next few years are excellent. The projects and collaborations ex-
plained above give good possibilities for producing results that are of substantial scientific 
and public health significance. The first priority is to take care of the timely analysis and 
reporting of the main results of the FINRISK 2007 survey. The updated information on the 
main risk factor levels (smoking, cholesterol, blood pressure, BMI) in the Finnish population 
will be an achievement both from the public health and the scientific point of view. Besides 
the scientific audience, these results need to be communicated widely to the Finnish health 
care professionals and health policy makers. The FINRISK 2007 survey also included a 
specific subproject on obesity, DILCOM (the role of Diet, Lifestyles and Genetic factors in 
the development of Obesity and Metabolic syndrome), sponsored by the Academy of 
Finland. The purpose of the DILCOM project is to investigate in a multidisciplinary manner 
social, behavioural and biological determinants of weight gain in young and middle-aged 
individuals. If everything goes as planned, the DILCOM participants will be re-examined in 
the FINRISK 2012 survey. We expect, however, that the cross-sectional analyses of the 
2007 data and samples will already produce new information on this increasing public 
health problem. 
Another point of emphasis in the near future is genetic epidemiology. A challenge is to 
make good use of the DNAs of 32,000 FINRISK participants together with the phenotypic 
information collected at baseline and during follow-up. This process is well underway in our 
collaborative projects with the Broad Institute of Harvard and MIT. Several genetic variants 
have shown strong associations with lipids in the FINRISK -97 data and the analyses on 
their associations with CVD events are in progress. It can be realistically expected that this 
will produce substantial new information on the genetic background of unfavourable lipid 
profiles and cardiovascular risk in the Finnish population. This should lead to better identifi-
cation and treatment of individuals at high risk. Equally promising preliminary findings have 
been obtained with regard to anthropometric characteristics, such as height, weight, BMI 
and waist circumference. These will be pursued further to better understand the biological 
mechanisms and population-attributable risks. Another promising project is MIGEN, which 
includes young cases of MI and controls from the FINRISK -92, -97 and 2002 surveys. This 
is probably the first genome-wide association study in the world to use the chip containing 1 
million SNPs and copy number variants (Affymetrix 6.0). We will aim at replicating the most 
promising findings in the prospective, population-based setting of the FINRISK-cohorts. 
We aim to do as much relevant genotyping as possible in the whole FINRISK -97 of >8000 
participants, rather than using various subsamples. At the same time, about 15-20 potential 
new biomarkers of cardiovascular risk are being determined from the whole FINRISK -97 
cohort in the framework of the MORGAM Biomarker Study. Our idea is to establish a cohort 
which is exceptionally rich in genotypic and phenotypic data and can be used for versatile 
analyses and examination of new hypotheses in a prospective setting. The value of such a 
cohort will only increase as the follow-up years and event numbers increase. It should be 
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mentioned that many of the biomarkers that are being determined and genes that are being 
genotyped are related to obesity (for example, adiponectin, leptin, chrelin and resistin, and 
the FTO gene) thus serving our obesity research and helping to tackle this increasing public 
health problem. 
In addition to the Biomarker study, we will continue our active participation in the genetic 
component and in the general risk component of MORGAM as well as in the work of the 
MORGAM Management Group. The project is reaching the stage when the large database 
and careful quality control can be utilized in scientific publications. 
FINRISK will continue participating in the SCORE PLUS collaboration aiming at updating of 
the current SCORE tables of cardiovascular risk with new versions that also include nonfa-
tal CVD events. If successful, this can be a major step forward in the cardiovascular risk 
prediction and gain wide use in Finland as well as elsewhere in Europe. 
To summarize: In our future work in FINRISK we propose to focus on three targets: (1) 
Analysis and reporting of the main results of the FINRISK 2007 survey; (2) Genetic epide-
miology of cardiovascular disease and its risk factors; (3) Obesity research using a multidis-
ciplinary approach. 
     
FINAMI and CVDR 
Monitoring the occurrence, treatment and prognosis of myocardial infarction events will re-
main as an important part of our research and public health work also in the future. The 
NORDAMI collaboration has been an example for rest of the EU in the monitoring of the 
trends in CVD events. One specific topic that we will address is myocardial infarction in 
women. This topic has attracted a lot of attention lately both in Europe and in the USA. It 
has been suggested that women's MI is a problem which has been underestimated. There 
are, however, few studies extensive enough to produce reliable information on the clinical 
characteristics, prognosis and treatment of MI events in women. With the large datasets of 
the FINAMI and CVDR projects we are in the position to contribute new data on this topic. 
Another topic that we will address using the FINAMI data is the socioeconomic differences 
in coronary heart disease mortality and morbidity. We have previously reported surprisingly 
large socioeconomic disparities using the FINMONICA MI data for the period 1983-1992. 
Now we are in the process of analysing, whether these differences have changed or re-
mained the same during the FINAMI period 1993-2002. The background is that the coro-
nary heart disease mortality and morbidity have declined remarkably in Finland, but it is not 
well-known whether all population segments have benefited equally from this favourable 
development or whether there are population groups that would require special attention. 
 Stroke monitoring will be continued using CVDR, which is currently the only data source for 
stroke epidemiology in Finland. Data collection in the FINSTROKE-register has already 
ended in 1998. This situation is not ideal, since stroke is a common and very costly disease 
in an ageing population and it would be very useful to have more detailed and validated 
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information on a subsample of stroke events. There are, however, no resources in sight 
which would allow the re-establishment of the FINSTROKE register. 
To summarize: We propose to focus on following points: (1) To continue monitoring the 
trends in MI and stroke events in the Finnish population using FINAMI and CVDR registers, 
and to continue participating in international collaboration in this field with the Nordic coun-
tries (NORDAMI) and at the EU level; (2) To analyse and report in more detail about the 
epidemiology of myocardial infarction in women; (3) To analyse and report whether all 
population groups and socioeconomic groups have benefited equally from the decline in 
coronary heart disease mortality and morbidity or whether there are population groups that 
would benefit from additional attention to prevention and treatment. 
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8 HEALTH PROMOTION UNIT 
8.1 Research and public health significance of the area 
Based on the main reason for its emergence in 1994, the Unit has been responding to im-
portant national and international information needs concerning lifestyle or health behavior 
and functional ability among citizens aged 15 to 84 years. Regularly gathering comparable 
data on lifestyle, health and functional ability, and reporting the time trends and population 
group differences is essential for the national health policy evaluation and planning. The 
monitoring results of the Unit can be used for planning and evaluating nationwide health 
promotion campaigns as well as for assessing impact of lifestyle related laws and their 
amendments and they serve as models for other countries to follow. The data gathered of-
fers basis for studies on determinants of lifestyle and its development in the population and 
groups specified by gender, birth cohort/age, socioeconomic position, - and region. Some 
related local data gathering and reporting for municipal purposes has also been done - use-
ful as a model as the the Public Health Law of 2006 requires municipalities to monitor the 
health of their citizens. 
As a significant input following the proposal from the international evaluation of the institute 
in 1994-95, just after the Unit had been established as as an health behavior monitoring 
entity, a group of health psychologist from the Mental Health Department joined the Unit in 
1997. This import of behavioral science knowledge proved to be an important ingredient for 
broadening orientation of the Unit, when it was joined to the body of social science knowl-
edge already present.  From early 2000's the Unit has enlarged its domain to community 
and organizational health promotion. Adopting the North Karelia project's tradition to chal-
lenges resulting from economic, administrative and cultural changes contributing and im-
plementing advanced behavioral and social science theories to health promotion practice 
the Unit has found its niché at KTL and elsewhere. The Unit aims at continuing the lifestyle 
monitoring and at developing and implementing behavioral and social sciences based in-
struments for lifestyle and functional ability enhancement finding the goals to pursue from 
results of RCT's. 
8.2 The main scientific achievements 
The research of the Unit, albeit partly close to strategic research, is directly useful for health 
promotion. The lifestyle monitoring activity of the Unit has been adopted to many CINDI 
countries, and it has also influenced creation of modules for the EU Health Interview Sur-
veys. Its results have also been widely published internationally. Creation of the GOAL life-
style intervention instruments started in 2003. Their design precludes significant latency 
time before results can be expected. The main result paper is currently in press and others 
are being processed. The GOAL Lifestyle instruments are tried (James Dunbar) in the state 
of Victoria, Australia, too. Next, the the two study strains, and third involving genetic testing 
and mammography screening (now discontinued), will be described more in detail, main 
publications included. The Unit is been involved with research also, such as that pertaining 
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to psychosocial determinants of disease with  University of  Helsinki, Oulu, Turku, and Insti-
tute of Occupational Hygiene, not to be described here, however. 
8.2.1 Monitoring of health and lifestyle in working age 
Health related lifestyle or health behavior, and health monitoring national surveys have 
been carried out annually at KTL since 1978. When the Unit was established in 1994, taking 
possession of this monitoring and publishing results based on it became its main and al-
most sole activity. The primary purpose of the monitoring is to obtain annual information on 
the lifestyles - smoking, dietary habits, consumption of alcohol and physical activity - among 
citizens 15-64 years of age. Items on health status, health services use, exposure to health 
campaigns, psychosocial process factors and health policy opinions are also included. What 
has been found in these annual surveys mailed to a representative sample of 5000 persons, 
is that in the long term male smoking has decreased, whereas female smoking after initial 
increased has stabilized on the level reached in the mid 1980's. The differences in daily 
smoking between educational groups have increased, though. Food choices (less often 
saturated fat, more often vegetables, fruits and berries) show healthy development in indi-
cators of fat and fiber, and regional and socioeconomic differences in healthy food habits 
have diminished. Alcohol consumption has continued to increase, there are less non-users 
and weekly consumption has been elevating - partly also because of the tax lowering on 
2004. Frequency of leisure-time physical activity has increased, but proportion of over-
weight and obese men and women has increased. Overweight is most common in the low-
est educational group. Results published deal with secular trends of lifestyle and their de-
terminants, socioeconomic position included. 
8.2.2 Monitoring of health/functional ability and lifestyle among elderly 
Health behavior and health among Finnish pensioners has been monitored since 1985 us-
ing biennial postal surveys to stratified (by age and gender) random samples of 2400 Fin-
nish citizens aged 65 to 79/84 years. These mailed surveys gather information on living 
conditions, health status, lifestyle and coping with daily activities among the seniors. Results 
published deal with secular trends of lifestyle and functional ability from the viewpoint socio-
demographic and socioeconomic factors. As new cohorts get to pension age they "bring 
along" the lifestyle they have adopted while being in the working age. Selective mortality 
"takes care" of those with the most detrimental lifestyle so that smoking gets decreased as 
is decreasing when to the situation two decades ago. There are less tea-totaling pensioners 
and weekly consumption is increasing. At the population level the pensioners' alcohol con-
sumption does not cause such a health concern as that of the working age population. The 
food choices have become more healthy and Finnish pensioners have retained their tradi-
tional physically active lifestyle. Among pensioners the socioeconomic cleavage prevails, 
too. Although functional capacity  and ability have increased among both men and women, 
it is on much higher level among the better education. The latter also have healthier food 
choices than the lower educated. 
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8.2.3 Regional and local lifestyle studies 
In the province of North Karelia an extra sample has been approached annually in 1978-
1996, and thereafter sporadically. These samples of 1200 persons each have contributed to 
the North Karelia Project process evaluation as the questionnaires are comparable to the 
national ones. The data has been used, e.g., for one of the few CINDI process evaluation 
studies where factors contributing to the success of smoking cessation were identified. Re-
sults also indicate lifestyle reasons for the faster than national average health development 
in the region: diminishing of smoking and healthier diet are two of the contributing factors. 
More sporadically, other regions or municipalities have also been served. Results from 
these studies have been used in planning of local welfare services and health promotion 
actions. In 1997-2007 these studies have been done in the provinces of Kanta-Häme (1998) 
and Kainuu (1999) and in the cities of Jyväskylä (2001) Mikkeli (2002) and Kaarina (2002). 
The ongoing study in the city of Kauniainen will be finished in 2007. 
Examples of scientific use of national lifestyle monitoring data  
Impact evaluation of national tobacco control policy: Birth cohort analyzes have been done to 
examine smoking initiation and cessation. Furthermore, exposure to environmental cigarette 
smoke at worksite and homes  has been studied. Results speak for the success of the To-
bacco Control Act of 1976 and its Amendment in 1995. Smoking initiation among those, who 
reached the typical initiation age when the 1976 Tobacco Control Act (TCA) was operational, 
was clearly lower than expected based on the prediction from trends in the birth cohorts born 
before. The impact seemed socioeconomically neutral among women; among men the well-
educated benefited most. Among non-smokers exposure to environmental tobacco smoke at 
work decreased to one-third between 1985 and 2000 as a result of the worksite smoking ban 
of 1995, and the Amendment also encouraged employed smokers to quit. 
Impact of unemployment on lifestyle and health. Finland harbored in grave economic prob-
lems with massive unemployment in early 1990's that caused serious turbulence in private 
and public sector and national economy. In 1997 the Unit devised a follow-up of working 
age persons who had responded to the the health behavior surveys in 1989 and 1990. Of 
the the over 5000 persons responding close to a half indicated that the recession unem-
ployment had touched their family. Results revealed that subjective health and well-being of 
those who had been inflicted by unemployment themselves had worsened. Smokers among 
unemployed found it harder to quit than those who had remained employed. No significant 
impact of unemployment on alcohol use was revealed. Impact of unemployment on food 
choices and physical activity were dependent on the socioeconomic position. Those who 
were better educated often indicated diet improvement and increased leisure time physical 
activity.     
Impact of national drug campaign on opinions. During the late 1990s the use of illicit drugs 
was increasing in Finland. The cabinet responded with a policy statement resulting into the 
establishment of a board including all relevant sectors in public administration. The board 
was to coordinate, and monitor, e.g., a national mass media and internet campaign on illicit 
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drugs starting in 2002. The visibility of the campaign was evaluated using several data 
sources: special items in the Adult Health Behavior survey, focus group interviews among 
high school students, survey done among journalists writing about about drugs and  profes-
sionals working in prevention and treatment, and an analysis of the visibility of the campaign 
in the media. The Adult Health Behavior Monitoring surveys showed that contacts to illicit 
drugs among Finns were relatively high 2001 but diminished onwards. Accordingly, and 
also because of the fact that media was not so interested in drugs any more, worries about 
problems caused by illicit drugs were alleviated. Majority of Finns, however, still consider 
that illicit drugs are a serious problem in Finland. Most of them also find that in addition to 
prevention, diminishing harm caused by the drugs, is an acceptable health policy goal. 
Future directions of lifestyle and health monitoring 
The system of health behavior, health and functional ability monitoring has been found 
valuable which speaks for the need of its continuing maintenance. Challenges for develop-
ment arise from continuously developing local, national, EU, and international needs. Can 
Finland afford to meet these partly conflicting needs? Does it have the resources needed for 
the full scientific exploitation of the system and the extra resources needed for the system 
development in the challenging context? Perhaps the best way of summarizing future ex-
pectations is to say: the system will be maintained and used for scientific purposes, but it 
will also be adapted to changing contextual requirements.  
8.2.4 GOAL Program for Good Aging in Lahti Region, 2002-2012 
In 2001, the Health Promotion Unit began its active participation in the Good Aging in Lahti 
Region or GOAL research and development program (Ikihyvä Päijät-Häme in Finnish) in the 
Päijät-Häme province in Finland. In the province, chronic disease related morbidity and 
mortality exceed the national average, and aging is also proceeding at above average rate. 
An increase in chronic diseases such as type 2 diabetes and functional capacity restrictions 
among the aging are acute challenges that gave birth for the initiation of the GOAL Pro-
gram.  A 10-year longitudinal GOAL cohort study (original sample N=4,272) among the co-
horts born in 1946-50, 1936-40, and 1926-30 was initiated in 2002, to be repeated every 3 
years, and forms a backbone for the monitoring. It includes measures of main chronic dis-
ease risk factors (e.g., blood pressure, blood lipids, fasting glucose and insulin, weight and 
BMI, waist circumference), state of health including functional capacity, lifestyle, and use of 
social and medical services. The questionnaire gathers also information on, e.g., wellbeing, 
and perceptions and opinions about aging and health. These data together with other avail-
able information have been and are used for community diagnoses that form the basis of 
needs' assessment for the interventions. The data will also be used for evaluation of the 
development of health within the region during the research period, as well as for for 
evaluation of the three interventions studies embedded into the program. 
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Social capital, urban-rural dimension and health 
Self-rated health is a widely used indicator of an individual's health status in general and its 
socioeconomic gradient is well known. Self-rated health also associates with main compo-
nents of social capital, trust and social participation. For the  GOAL program health promo-
tion purposes and in order to acquire information on how the urban-rural dimension may 
influence the relation of social capital and health,  GOAL cohort study data from from 2002 
was used. Positive associations between indicators of SES and self-rated health were ob-
served in urban, and densely and sparsely populated rural communities.  Adequacy of in-
come showed the strongest positive association with self-rated health in urban areas. Par-
ticipation in social activities was significantly associated with good health, too. Therefore, 
promotion of social participation - leisure time activities included - and facilitating access to 
help from others should arguably be employed as instruments of community health promo-
tion, too. 
The GOAL lifestyle implementation trial 
Randomized controlled trials have shown that type 2 diabetes can be prevented by lifestyle 
modification when a sets of goals is achieved. How to do this in "real life settings" poses a 
real challenge for the health care. The GOAL Lifestyle Implementation Trial is a theory- and 
evidence-based lifestyle counseling program aiming to test whether lifestyle modification 
objectives with established efficacy in earlier type 2 diabetes trials can be effectively imple-
mented in the primary health care settings. Main research focus is on process evaluation, 
especially on changes in the psychosocial determinants of behavior and on changes in be-
havior by gender and socioeconomic position.  Feasibility of the program for primary health 
care use is another factor under evaluation. The program was tested in year 2003 with 352 
patients  in 36 groups (aged 50-65 years) with identified at lest moderate risk for type 2 dia-
betes. The subjects were followed at 3, 12, and 36 months. Trained public health nurses 
employed in the health care centers delivered the program as facilitators of group counsel-
ing aiming at workable lifestyle change plans for individuals. Anthropometric, clinical data 
and questionnaire data were collected before the intervention and at follow-ups. In addition 
to the quantitative data, qualitative data was collected  at 18 months post-intervention from  
participants who were either successful or unsuccessful in weight loss. Results were com-
pared to those received in Finnish Diabetes Prevention Study using intensive individual 
counseling. 12  months follow-up showed modest positive clinical risk factor changes, with 
better results in the mixed-gender groups achieved by men than women. Of the psychoso-
cial factors, planning and general self-efficacy were enhanced in the intervention process 
and this increase was predictive of the hoped-for behavioral outcomes. Success in in 
change was also related to motivation of the group facilitator. Almost all participants and 
facilitators expressed high acceptance of the program. Data collection has now been com-
pleted and an active reporting phase is in the process. Several publications are in press, 
many manuscripts either submitted or processed. 
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The GOAL trial to implement Current care guidelines for prevention of chronic diseases 
The aim of this implementation trial was to develop and implement a regional application of 
national current care guidelines involved with prevention of major chronic diseases including 
treatment of hypertension, dyslipidemia, adult obesity, and smoking cessation or nicotine 
dependency. The guidelines were implemented locally via workshops and lectures provided 
by the GOAL team for physicians and nurses working with metabolic syndrome disorders in 
primary and secondary care. For the evaluation of the impact of the trial questionnaires 
were distributed to physicians and nurses at the premises. The results of the evaluation are 
currently being processed. Initial results suggests that there has been positive development 
in respect of attitudes towards and use of clinical guidelines. 
The GOAL Functional Capacity Intervention 
With the rapidly aging population, healthy aging has become a major public health goal. 
Promotion of healthy aging requires identification of those at risk and a comprehensive ap-
proach addressing multiple risk factors: physical inactivity, poor diet, and social isolation. 
This intervention study seeks to promote healthy aging among over clients of the municipal 
homecare aged 70 and over. The specific objectives of the study, initialized in 2005 with 
interventions running in 2006, and 12 month follow-up data to be gathered in 2007, was to 
develop a clinical kit to measure functional capacity and to find practical methods to be used 
by social sector homecare teams for its promotion. Clients were first randomly assigned to 
one of the three study arms. These were standard care, group-based strength and balance 
exercise, or home-based strength and balance exercise. The last two being based on the 
same goal-oriented theory as the lifestyle change program. In the second phase, clients 
were randomized into one of the latter two conditions both of which now included detailed 
action planning for daily physical activity, healthy diet and active social networks. In the first 
phase, each trial arm included 40 participants, tn the second, the number of participants per 
study arm was 24. 
Future directions of the GOAL Program 
The GOAL lifestyle intervention, albeit it has been found attractive by professionals and 
administrators of the region, has also brought results giving impetus to further study and 
development. Questions such as how to awaken the interest of men for lifestyle change, 
how to improve social support for change among low-educated women, and how to en-
hance physical activity promotion are examples of challenges that should be tackled. The 
functional capacity intervention needs to be tested also among subjects with  better func-
tional capacity to learn its full potential. In addition, the GOAL program process has us 
aware about the poor health of the aging health and social care personnel which together 
with the non-modern and short professional training among the social sector workers espe-
cially prevents them from working efficiently. An intervention study to alleviate the problem 
is currently in planning phase. 
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8.2.5 DefenceNutri: Intervening food choices of conscripts in the Finnish Defence Forces, 
2007-2011 
The epidemic of male overweight and obesity is a special concern for the Finnish Defence 
Forces, and clearly a public health problem. As the service is compulsory to the males, over 
80% of the male generation participates it, typically in the age 18-20 years. For women ser-
vice is an option, taken only by few. The context offers offers an excellent chance to influ-
ence eating patterns of the most of the Finnish males. The DefenceNutri intervention study 
combines nutrition science knowledge with cultural, sociological and socialpsychological 
perspectives for food-related consumer decision-making among young males and strives to 
intervene the food choices by affecting both both the food supply and demand in the garri-
son context. 
The study aims to examine eating patterns and their changes among young Finnish men 
during the military service. The field work takes place in selected companies of the Kainuu 
Brigade and the Armoured Brigade (Parola). Social representations and prototypes bearing 
on young men's food choices involved in the decision-making process are being studied in a 
design involving first the control phase in the two garrisons in 2007, and continuing with 
supply intervention in 2008, and supply and demand intervention in 2009. The subjects will 
receive mailed questionnaires 12 months after the service, too, so the field  phase will last 
until 2010. The two main loci of food supply and consumption in the garrisons are the sol-
dier's homes and garrison canteens. Therefore the ideological and practiced nutrition re-
lated objectives and their rationale of garrison canteens and soldier's homes are analyzed. 
The intervention will include two phases: One targeting the garrison canteen and Soldier's 
Home personnel to increase the supply of healthy food choices and enhance their attrac-
tiveness, the other while maintaining the supply element, targeting the conscripts to in-
crease their demand for healthy foods. The supply phase intervention used processes 
based on theories of expansive and problem based learning in educating the personnel to 
impact the food supply. The demand phase relies on both central and peripheral routes of 
influence on conscripts' cognitions and emotions. Experimental design, using conscripts 
entering service before intervention as controls, moving over to the supply intervention, and 
implementing the demand intervention while maintaining the supply intervention, allowing 
impact and process evaluation using quantitative methodology. Data on consumption and 
sales of foods are used to validate self-reported consumption rates. Measures of participat-
ing males involve anthropometry, clinical risk factors of CVD and T2D, physical fitness, 
health behaviors, taste preferences, and cognitive-evaluative processes related to food 
choices and the intervention. 
Future directions of the DefenceNutri program 
If found successful we plan to help to implement the intervention in all garrisons of the De-
fence Forces. 
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8.2.6 GEP: Getting evidence into practice in health promotion, 2003-2005 
There is an obvious need to develop shared methods to collect, analyze and judge informa-
tion for evidence in the area of health promotion. The aim was to develop a European re-
view protocol to collect this information, and to develop a quality assurance tool to plan and 
evaluate health promotion interventions. Literature studies and Delphi rounds among ex-
perts were used to get the data. Draft review protocol and  quality assurance tools were 
developed and results published, e.g. at the EU website. Several workshops (in Europe, 
Thailand and Canada) have been organized related to the evidence base of  health promo-
tion, and journal manuscripts are being processed. Due to the lack of funding the GEP pro-
ject was cult into half: the products were created, but they remained unvalidated in many 
countries with Germany and Denmark as marked exceptions. 
Future directions of the GEP program 
At present not to be continued at the Unit. 
8.2.7 Psychological studies of testing and screening, 1992-2002 
Finnish mass screening for breast cancer, 1992-2002. Biennial mass screening for breast 
cancer among women 50-59 years by mammography was started in Finland in 1987. Even 
though the false positive rate is low, over 4,000 are annually being sent for further examina-
tions resulting presumably to cancer worries although the final verdict is mostly false posi-
tive. The aims of this study were to assess the psychological impact of the screening, and to 
examine reasons non-participation. Data was collected 1992-1994, participants were 
women aged 50 (target N=16,886),  community referents outside screening area were 
N=1,718. A baseline measurement was conducted one month before invitation to screen-
ing. A random sample  of 10% from the target area as well as all women re-called for further 
examinations were followed up three months and 12 months  post screening. Screening 
non-participants were followed up three months post screening. Mailed questionnaires were 
used to gather the data. Non-participation (10%) was predicted by expected pain. Women in 
the middle socioeconomic positions were most eager to participate. For most women 
screening was not a distressing, but those false positives reported increased screening 
specific distress. Preexisting experience of breast cancer in ones family and high perceived 
breast cancer risk on screening induced higher and longer-lasting distress. 
Genetic testing and screening: attitudes among lay people, 1996-1999. Practices of genetic 
testing and screening were taking place in Finland as well elsewhere in Europe during the 
1990s. There were public debates on how testing and screening should organized. Prenatal 
genetic screening especially aroused public interest. In order to explore lay opinions on and 
knowledge of genetic testing and screening, a survey was conducted at the National Public 
Health Institute in 1996-1997 (N=1216). In general, lay people indicated high acceptance of 
genetic testing. Some had clearly contradictory attitudes though. Those with the highest 
level of knowledge of genetics there was both more skepticism and more enthusiasm than 
among people with low level of knowledge of genetics. 
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Future directions of psychological studies on testing and screening 
At present not to be continued at the Unit. 
8.3 The main public health activities and achievements 
Research of the Unit translates straightforward to public health practice. Health behavior, 
health and physical ability monitoring results are widely used in health policy and campaign 
evaluation and planning. Evaluation results concerning the 1977 Tobacco Control Act and its 
Amendment in 1995 are good examples. Furthermore, impact of  changes made in 2004 to 
increase availability of alcohol could be assessed and as the main group where alcohol con-
sumption strikingly rose we identified the low educated middle-aged males. Similarly the 
screening studies yielded results directly relevant for evaluation of important medical screen-
ing practices. The data offers information for many working in the field of health promotion, be 
that in NGO's, companies or public officials. Ministry of Social Affairs and Health employs the 
results in their lifestyle relevant program planning and evaluation. The Cabinet's report to the 
Parliament every four years involves the monitoring information, too. Also the Province based 
round of health promotion seminars, the first of which was held in 2006, benefited from the 
monitoring information. Moreover, the Unit's monitoring system results  has been used to re-
gional (STAKES SotkaNet), national (Statics Finland) and international (EUROSTAT, OECD) 
statistical purposes. Finally, the fact that several CINDI countries use the monitoring instru-
ment widens the influence of the Unit's activity to an international domain. 
All intervention studies the unit performs are designed to be realistic in the sense that they 
involve controlled costs and challenges to human resources and organizations. Extra costs 
occur because of the the research and evaluation involved. The GOAL program is a para-
digm case where the Unit has participated in education of the health care personnel of the 
region to make it possible to implement the instruments into normal use in the local health 
centers. Group counseling has now gained ground over individual counseling, or is some-
times used in addition to it. The  municipalities in the region have now jointly hired a dieti-
tian, which is rather unique in Finland, to coordinate and support the counseling, and in the 
Spring 2007 a total of 29 groups were functioning in the area. A recent news is that the Vic-
torian version of the GOAL Lifestyle Intervention will be implemented into a statewide use. 
The Unit entails a significant body of health promotion knowledge that has been used for 
local, national and international purposes. Currently, many of the researches are engaged 
in local health promotion on a daily basis in the GOAL and DefenceNutri programs and in 
local health behavior monitoring tasks. In addition to the aforementioned grass roots work, 
the Unit's expertise is being shared by several NGO's (e.g., Finnish Center for Health Pro-
motion, Finnish Heart Association, Finnish Diabetes Association, Finnish Society for Re-
search in Sport and Physical Education, Finnish Foundation for Public Health and Physical 
Activity Promotion), and public administration (Ministry of Social Affairs and Health: e.g., 
Local activities section of the Public Health Board, HIV expert group, Coordination group for 
illegal drug use prevention, Steering group for health screening of long-term unemployed, 
and several ad hoc working groups; Ministry of Education: e.g., Health enhancing physical 
70
  
 
activity board). Current international activities include Working Party on Information on Life-
style and Specific Subpopulations of DG SANCO, Technical Group for Health Interview 
Surveys of EUROSTAT, and Steering Group for EU Action Plan for Drugs.   
8.4 Funding for research and public health programmes 
Salaries of two (until 2004 three) researchers, as well as daily expenses, are covered from 
the state budget to KTL. As the Unit is performing essential national surveillance of health 
behavior the basic costs for these functions are also covered by state funding half of which, 
however, has to be won trough applications on an annual basis. By far most significant 
funding sources are research programs of Academy of Finland. During the last decade, the 
Unit has found found funding trough the following programs: Health and Other Welfare Dif-
ferences between Populations Groups 1998-2000, Research Program for Aging 2000-2002, 
Health Promotion Research Program 2001-2004, Research Program on Health Services 
Research 2004-2007, and Research Program on Nutrition, Food and Health 2006-2010. 
Social Insurance Institution has given a substantial funding for the the GOAL Lifestyle Inter-
vention Study and its implementation in the period 2004-2008. EU funds have been raised 
for 4 research projects, dealing with genetic testing, nutrition related health inequalities, 
guidelines for public health promotion and SARS related concerns in the period 1998 to 
2005. The Unit also participated the Good Aging  Program of KTL in 2004-2006. Other fund-
ing has been received from doctoral programs (Doctoral program for public health and 
Population, health and living conditions) as well as from several private foundations. 
8.5 Personnel 
The unit has currently 14 employees; two of these (unit head and senior researcher) are 
having salaries from state budget, others working on project money. Most of the academic 
have behavioral or social science education. During the evaluation decade over 40 different 
persons have worked in the Unit. Many of those who had stayed a short period have fin-
ished dissertations and moved elsewhere for employment. Some redefining of boundaries 
within the Department have also resulted into personnel changes. Four of the current re-
searchers (including the Unit head) are PhD's, giving tuition to the juniors, who number 
seven and are preparing dissertations. In addition there are three technical persons. The 
unit has a flexible and efficient structure with the unit head, three further seniors, and seven 
juniors. The names, education and primary interests and functions of four current and one 
past key person in the Unit are listed below:  
Antti Uutela, PhD (social psychology), chief of laboratory, docent/adjunct professor (Univer-
sity of Helsinki), head of the Unit. Expert in behavioral medicine and health promotion. 
Leader, e.g., of the DefenceNutri Consortium, and KTL GOAL Program.   
Pilvikki Absetz, PhD (health psychology), senior researcher. Expert in health behavior 
change theories and methods, principal investigator in the GOAL Lifestyle Implementation 
Trial, the GOAL Functional Capacity Intervention, and the DefenceNutri Intervention study.  
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Piia Jallinoja, PhD (sociology), senior researcher. Expert in social and cultural aspects of 
health behavior, behavior change and health interventions. She is co-principal investigator 
on DefenceNutri intervention study and in the evaluation of a national mass media cam-
paign against illicit drugs and a senior researcher in GOAL lifestyle implementation trial and 
and GOAL Current Care Guideline Implementation trial. 
Satu Helakorpi, MSocSc (sociology), RN, researcher. Expert in lifestyle monitoring and 
principals investigator of liesttyle and health/functional ability monitoring. 
Dr. Arja R. Aro (Ph.D., Dr. Health Care Research), was senior researcher of the Unit till 
2005, responsible for the programs 8.2.4. and 8.2.5. She is now professor of public health 
at the University of Southern Denmark. 
8.6 National and international collaboration 
Researchers of the Unit work with several colleagues from, e.g., KTL (Chronic Disease Pre-
vention Unit,  Injury Prevention Unit, Nutrition Unit, Department of Health and Functional 
Capacity), University of Helsinki (Department of Social Psychology, Department of Social 
Policy, Department of Public Health Science, Department of of Food Technology, and Pal-
menia Center for Continuing Education), Lahti Polytechnic, and the UKK Institute for Health 
Promotion. The field work and implementation of the programs requires collaboration with 
the Päijät-Häme Hospital District and all municipalities involved, as well the Defence Forces 
General Staff, the Department of Military Medicine of the Defence Forces, the garrisons of 
Kainuu and Parola, their canteens and soldier's homes etc. 
Because of the nature of the work of the Unit both national and international collaboration are 
extensive. Out of international colleagues we collaborate most actively with Monash Univer-
sity, Melbourne, Australia (Olddenburg), Uppsala University, Sweden (Burell), University of 
Southern Denmark, Esbjerg (Aro), Jacobs University, Bremen, Germany(Renner), University 
of North Carolina at Chapel Hill, USA (Fisher), and Glascow University, UK (Leyland). 
In addition to research collaboration, another platform of cooperation involves that of inter-
national  scientific organizations. Most important ones of these to us are International Soci-
ety of Behavioral Medicine (ISBM), and the European Society of Health Psychology 
(EHPS). In ISBM postions include Board and Executive Committee memberships 1996-
2008, President elect 2002-2004, President 2004-2006, Past president (2006-2008). In 
EHPS there was Executive committee membership 2003-2005, including founding of the 
training section of EHPS, SYNERGY. The Unit members organized the International Con-
gress of Behavioral Medicine in Helsinki in 2002 (chair of local organization, program co-
chair). The first GOAL Teaching Seminar in behavioral medicine in Lahti was organized by 
the 2005. In addition, the Unit's seniors are being continuously involved in program commit-
tees of international congresses of ISBM, EHPS, EUPHA, and IUPHE since early 1990's. 
The Unit has cooperated with several international health promoting organizations, including 
WHO (Enhancement of medical treatment compliance, World Health Assembly 2002, 
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Global Conference in Health Promotion 2005), WHO/EURO (Coordination of the 1st Euro-
pean Move for Health Day, Helsinki, 2007), and European Union (several evaluator tasks of 
Public Health Resarch Programs from 1995 onwards, participation in the Tackling Health 
Inequalities Program 2000-2002, memberships in Working Party Lifestyle on Information on 
Lifestyle and Specific Subpopulations 2004-, echnical Group for Health Interview Studies 
2007-, Steering Group for Health Interview Studies 2006, and Steering group for EU Action 
Plan for Drugs 2006-2010.   
8.7 Proposal for  future work and expected benefits 
The present seems to determine largely what the Unit will be doing for the next five years. 
This being written, and having a look to the decade past, one must conclude though, that 
this signifies the Unit's current cognitive and motivational state - so significant unforeseen 
changes have taken place in the immediate past. They have, contributed to the integration 
of the Unit's research program though. Assuming that the Unit maintains the current re-
source level, lifestyle monitoring will definitely be continued and adapted to the information 
needs from local, national and international sources. Scientific publishing of results from 
both the surveys will increase, proportionally more regarding the elderly. 
Intervention studies will continue wit set and novel field phases, and a lot of publishing  of 
results will take place, too. 
Creating intervention modules focusing on the possible barriers of the disadvantaged socio-
economic groups to make the change happen will be one of the foci of our work. This 
means a new look at psychosocial factors involved, including intervention on social support 
and depression. 
The Unit will continue to collaborate with institutions and colleagues mentioned above but 
also will open new routes. We will strengthen collaboration the Department of Social Psy-
chology (with expertise in social cognition and prototypes, psychosocial factors, including 
social support), and the Department of Food Technology (with expertise sensory food sci-
ence) of Helsinki University.  The same goes for research collaboration with the University 
of Uppsala Department of Public Health and Caring Sciences (behavioral medicine, psy-
chosocial factors and clinical interventions) and the Umeå University Department of Public 
Health and Clinical Medicine (behavioral medicine, interventions to prevent diabetes) in 
Sweden. 
It is to be expected that the Unit's strong local, national and international public health activ-
ity will even increase and gain in significance as the younger seniors of the Unit gain more 
experience.  
In the longer run, the Unit will pursue to find solutions to the same kind of challenges that 
keep us occupied during the next five years. Also active public health participation will be 
continued. It can be predicted that lifestyle monitoring will continue in somewhat new form, 
and starts at least partially to use  new technology (such as electronic questionnaires) in 
data gathering. One can be sure that we will continue interventions and implementing their 
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results into practice. It can be presumed that they will also include novel technology, such 
as internet and mobile telephones. 
The research of the Unit - as it focuses on behavioral and social science aspects of lifestyle 
and interventions meant to modify it, will serve serve the public health needs of the future, 
too. It is to be expected, that when the two intervention study strains that have been initiated 
in the last five years, mature, as our research collaboration with both academic and clinical 
science advances, and finally, as our intervention program implementation activities in-
crease, we will  gain even more public health significance.   
8.8 Main publications 
Lifestyle monitoring:  
Helakorpi S, Martelin T, Torppa J, Patja K, Vartiainen E, Uutela A. Did Finland's Tobacco Con-
trol Act of 1976 have an impact on ever smoking? An examination based on male and female 
cohort trends. Journal of Epidemiology and Community Health. 2004 Aug;58(8):649-54. 
Jousilahti P, Helakorpi S. Prevalence of exposure to environmental tobacco smoke at work 
and at home--15-year trends in Finland. Scandian Journal of Work Environmental Health 
2002;28(Suppl 2):16-20. 
Laaksonen M, Luoto R, Helakorpi S, Uutela A. Associations between Health-Related Be-
haviors: A 7-Year Follow-up of Adults. Prev Med 2002;34, 162-170. 
Anttolainen M., Luoto R., Uutela, A., Boice, J.D., Blot, W.J., McLaughlin, J.K. et al.: Charac-
teristics of users and non-users of plan stanol ester margarine in Finland: An approach to 
study functional foods. Journal of American Dietetic Association 2001; 101(11): 1365-1368 
Nyman, J. Does unemployment contribute to ill-being: Results from a panel study among 
Adult Finns, 1989/90 and 1997. (Dissertation) Publications of the National Public Health 
Institute A4/2000, Helsinki. 
Korhonen, T.: Population-based smoking cessation: Process evaluation of selected strate-
gies used in the CINDI program. Publications of the National Public Health Institute 
A1/1999,  Helsinki.  
Sulander, T.T., Uutela, A.K., Obesity and education: Recent trends and disparities among 
65- to 84-year-old men and women in Finland, Preventive Medicine 2007 (Epub ahead of 
print, doi:10.1016/j.ypmed.2007.02.008)  
Sulander T, Martelin T, Sainio P, Rahkonen O, Nissinen A, Uutela A: Trends and educa-
tional disparities in BADL difficulties among people aged 65-84 years. International Journal 
of Epidemiology 2006;35:1255-1261. 
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Sulander T., Rahkonen, O., Nissinen, A., Uutela, A.: Associations of smoking status with 
obesity and diabetes among older people. Archives of Gerontology and Geriatrics 2006, 
Dec 1 (Epub ahead of print)  
GOAL program:  
Absetz, P., Valve, R., Oldenburg, B., Heinonen, H., Nissinen, A., Fogelholm, M., Ilvesmäki, 
V. Talja, M., Uutela, A.: Type 2 diabetes prevention in "real world": One year results of the 
GOAL implementation trial. Diabetes Care, in press 2007. 
Nummela OP, Sulander TT, Heinonen HS, Uutela AK. Self-rated health and indicators of 
SES among the ageing in three types of communities. Scandian Journal of Public Health. 
2007;35(1):39-47 
Pajari, P.M., Jallinoja, P., Absetz, P.: Negotiations over self-control and activity: An analysis 
of balancing in the repertoires of Finnish healthy lifstyles. Social Science and Medicine 
2006; 62(10): 2601-2611 
Uutela, A., Absetz, P., Nissinen, A., Valve, R., Talja, M., Fogelholm, M.: Health psychologi-
cal theory in promoting population health in Paijat-Hame, Finland: First steps toward a type 
2 diabetes prevention study. Journal of Health Psychology 2004; 9(1), 73-84 
Genetic testing and mammography screening: 
Jallinoja, P.: Ethics of clinical genetics. The spirit of profession and trials of suitability from 
1970 to 2000. Critical ublic Health 2002; 12(2): 103-118. 
Aro, A.R., Absetz, P., vand Elderen, T.M., Van der Ploeg, E., Van der Kamp, L.J.T.: False-
positive findings in mammography screening induces short-term distress - breast cancer 
specific concern prevails longer. European Journal of Cancer 2000; 36(9): 1089-1097 
ARO, A.R., de Koning, H.J., Absetz, P., Schreck, M.: Psychosocial predictors of first attendance 
for organised mammography screening. Journal of Medical Screening 1999; 6(2): 82-88.  
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Table 8.1 Summary of main scientific achievements during 1997-2006 
Scientific output  N  Comments  
Original articles and reviews in 
international peer-review journals  
178  
Original research papers; does not include reviews or congress ab-
stracts.  
Original articles and reviews in 
domestic peer-review journals  
45  
Original research papers; does not include  reviews or congress ab-
stracts.  
Textbooks and chapters in 
textbooks, reports and proceedings  
65  
Many are reports on ongoing lifestyle monitoring. Does not include 
proceedings.  
Theses  8  
Done while working in the Unit: Absetz, Berg, Haukkala, Heinonen, 
Jallinoja, Nyman, Laaksonen, Sulander,  
Organization of scientific 
meetings and conferences  
4  
International Congress of Behavioral Medicine, Helsinki 2002; EHPS 
and EHPS CREATE Meeting 2004, WCPD 2008  
Presidencies and member-
ships in scientific committees of 
international meetings  
18  
President ICBM 2006, Scientific committees: ICBM 1998-2008; 
EUPHA 2000-2005, EHPS 2004-2006  
Presidencies and member-
ships in other scientific committees  
13  
President elect, President, Past President ISBM 2002-2008; Board 
memberships  ISBM 1996-2008; Chair, Society of Social Medicine 2001, 
Chair, Behavioral Medicine Section of Society of Social Medicine 2007  
Invited lectures and chairman-
ships in international meetings  
35  
Congresses of  ISBM, EUPHA, EHPS, IUPHE and various and other 
national and international congresses  
Lectures in domestic scientific 
meetings  
88  
In health promotion congresses and congresses involving behavioral, 
social, nutrition, and sport sciences  
Editorial tasks in international 
peer-review journals  
10  
Psychology of Health, co-editor 2002-2005 
Editorial Board  memberships: 
Internal  Journal of Behavioral  Medicine  1994- 
Scandinavian Journal of Social Medicine 1994-1999 
Health Education Research  1997-2003 
Patient Education Counseling 1998-2005  
Opponent of dissertation  10  
Nygrén, Pohjanheimo, Poskiparta, Tarmi-Mattson, Läärä, Gerlander, 
Stengård, Kuusinen, Grönroos, Lagerlund  
Supervision of dissertations  22  
Completed: Kallio, Rahkio, Topo, Pötsönen, Korhonen, Aalto, Berg, 
Suominen-Taipale, Välimaa, Järvinen, Aktan-Collan, Nyman, Laaksonen, 
Haukkala, Absetz, Jallinoja, Palosuo, Heinonen, Sulander, Hakanen, Kallio, 
Savolainen.  
Review of PhD thesis, evalua-
tion of docentship  
13  
Reviews of PhD theses: Appelberg, Seppälä, Tynjälä, Huurre, Siner-
vo, Gerlander, Jaari, Väänänen, Grönroos, Lagerlund. Review of do-
centships: Vehkalahti, Salminen, Väänänen  
Review of scientific papers  253  Journals mentioned under editorials tasks and more  
Research visits to/from inter-
national research institutes or uni-
versities  
25  
Queensland University of Technology, Australia, University of Texas, 
Houston, University of  Leiden, University of Amsterdam, RIVM; etc.  
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Table 8.2 Summary table of committee memberships, coordination and proceedings with public health impact 
Public health output  N  Comments  
Articles and reviews 
in  non peer-review journals  
70 
Includes, e.g., Kansanterveyslehti, PROMO, national and local 
press  
TV and radio inter-
views  
39 About half nationally covering, half local  
Health education ma-
terial, websites, information 
databases  
3  
Material for the GOAL functional capacity intervention: goal setting 
video, playing cards, and introduction video to GOAL  
Membership in inter-
national committees with 
public health impact  
10 
EU: Tackling inequalities in health program 2000-2002; Working 
party on information on lifestyle and specific subpopulations 2004-
;Steering group for health interview studies 2006; Steering group for EU 
action plan for drugs 2006-2010; Technical Group for health interview 
surveys 2007-; etc.  
Membership in do-
mestic committees with 
public health impact  
26 
Committees of Ministry of Social Affairs and Health and Ministry of 
Education, several committees of NGO's including Finnis Centre of 
Health Promotion, Finnish Heart Association and others  
Coordination and/or 
implementation of develop-
ment projects  
8  
GOAL Regional Program for Primary Prevention; GOAL Functional 
Capacity Program; Lifestyle related programs to NGO's  
Coordination of public 
health networks  
    
Organization of inter-
national training with public 
health impact  
3  The Goal Teaching Seminars  
Organization of do-
mestic training with public 
health impact  
11 
Relevant university courses, Training for professional development 
in GOAL program  
9 NUTRITION UNIT 
9.1 Research and public health significance of the area 
Nutrition plays an important role in the aetiology of chronic diseases. In the past, nutrition 
research in KTL was focused on lipids, blood pressure and cardiovascular diseases, then it 
was expanded to cancers and during the last ten years the focus has shifted to obesity, 
diabetes, allergies, carbohydrate metabolism, and children. Nutrition plays an important role 
in many large epidemiological studies in KTL and only a fraction of nutrition-related re-
search is carried out in the Nutrition Unit. The Nutrition Unit was formed in 2001 when the 
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three units within the Department of Nutrition, the Nutrition Epidemiology Unit, The ATBC 
Study and the Biomarker laboratory were separated. The close cooperation with the Cancer 
Prevention Unit (The ATBC Study) has continued, and the Biomarker Laboratory is still re-
sponsible for the analyses of the main nutritional biomarkers.     
The Nutrition Unit has the following main functions: It maintains the National Food Composi-
tion database Fineli and its on-line website, monitors the diet and nutrition among adults, 
maintains and updates dietary assessment methods for all studies carried out in KTL, con-
ducts research on nutrition and health together with other Units and Departments, and func-
tions as a pool of nutrition experts for the ministries, NGOs and the public health sector.  
Thus the Unit is the centre of expertise in the field of nutrition in KTL. However, all its re-
search is carried out in close cooperation with epidemiologists, chemists, behavioural scien-
tists etc. from other units.   
9.2 The main scientific achievements 
9.2.1 National Food Composition database, FINELI  
The aim of this project is to maintain and develop the National Food Composition database 
and methodological tools for dietary assessment. During the last ten years, the structures of 
databases and methodological tools have been developed remarkably. The Windows-based 
software for dietary intake calculation and for the management of food composition data-
bases have been developed and tools for estimating the portion sizes have been modified 
during these years. The dietary intake calculation software has been applied in over 20 nu-
tritional studies at KTL, but also in collaboration studies at the University of Helsinki and the 
University of Tampere. The basis of dietary intake calculations is the regularly updated food 
composition database Fineli, which is constantly developed in order to meet international 
standards for a high quality database. The whole content of the Fineli database covers 3000 
food items, 500 dietary supplements and 300 nutrients or dietary components. Bioactive 
substances, like plant sterols and phenolic compounds, are the latest inputs into the data-
base. Scientific articles on the food composition database have been published about the 
usability of food composition data on the internet and the accuracy of portion size estima-
tion. 
9.2.2 FINDIET Surveys 
The Unit monitors the diet and nutrition in the adult population in Finland mainly by carrying 
out FINDIET studies every five years among 25-64-year old men and women in connection 
with the FINRISK Surveys. The latest Findiet 2002 and 2007 studies involved about 2000 
subjects and covered five different areas in Finland. The diet was assessed by the comput-
erized 48-hour recall method and several biomarkers of diet were assessed from blood (e.g. 
folate) and urine (e.g. sodium).  These surveys serve as the main tool to monitor the Finnish 
diet and the nutritional status of adults, for nutrition policy, for risk assessment and many 
other purposes. The analyses of FINDIET 2002 included e.g. identification of snacking pat-
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tern among adults, the intake and sources of fats, salt and sugar, the use of dietary sup-
plements and the use of functional foods. The series of surveys carried out at five-year in-
tervals have also shown the trends in the Finnish diet. 
9.2.3 Monitoring nutritional status  
During the years 1997-2002 in connection with the FINRISK/FINDIET 1997 and 
FINRISK/FINDIET 2002 Surveys, blood and 24h-urine samples were collected in sub-
populations mainly in the capital area, but also in south-western, eastern and northern 
Finland. The nutrients in focus have been: Vitamin D, Vitamin C, folates (and homocys-
teine), B12, iron, sodium and iodine. Analyses of the main dietary sources of the nutrients 
were obtained from the dietary surveys.  The biomarker analyses were carried out mainly at 
KTL (Biochemical and Biomarker Laboratories) and partly in collaboration with the Univer-
sity of Helsinki and other national and foreign laboratories.  The low vitamin D status meas-
ured in winter in Finland has been followed by increases in vitamin D fortification levels and 
the variety of fortified foods. The prevalence of anaemia as well as inadequate folate, iron 
and iodine status have all been found to be low. 
9.2.4 Nutritional Risk Assessment 
The aim of the Nutritional Risk Assessment Project is to investigate the impact of food forti-
fication and dietary supplement use on the risk of too low or too high vitamin and mineral 
intake. The other aim is to study how well the food fortification is targeted - i.e. is it possible 
to diminish the proportion of those with low vitamin and mineral intakes by optimal food forti-
fication without increasing the proportion of those with too high intakes. The Nutritional Risk 
Assessment Project produces information for the risk management of dietary supplements 
and food fortification in the Finnish Food Safety Authority Evira. The project was launched in 
2003. Since then the project has developed probabilistic and other methods for nutrient and 
contaminant intake and a model for optimal food fortification. FINDIET 2002 and an Inter-
net-based survey on the use of fortified foods have been used as the databases. We have 
modelled vitamin D, calcium, and group B vitamin intake from natural sources, dietary sup-
plements and fortified foods in the adult population. Similar risk assessment has been 
started among children. We are also a partner in an EU project (Beneris) that develops a 
benefit-risk analysis for food based on iterative value-of-information approach 
(www.beneris.eu). The tasks of the Nutrition Unit in Beneris include to provide data on the 
food consumption and nutrient intake among Finnish adults and children and to develop a 
simulation method for contaminant intake estimation. 
9.2.5 Health Indicator Maps 
Effective visual tools for illustrating population and geographical differences are useful for 
monitoring purposes. The Health Indicator Maps project produces maps on consumption of 
foods considered as dietary indicators of health (e.g. fruit and vegetables) and other nutri-
tional indicators of health (e.g. saturated fat and sodium intake, BMI). The maps illustrate 
79
  
 
the status and geographical differences of these health indicators very effectively. Data 
were collected in the Health 2000 Study and the FINRISK 1997 and 2002 Studies. Food 
and nutrient intake and risk factor levels were estimated using a Bayesian conditional auto-
regressive model.  The quality of the diet was evaluated with five dietary indicators of 
health: consumption of vegetables and fruit, whole grain bread (rye) and fish as well as in-
take of saturated fatty acids and salt. The diet was evaluated to be best in the capital area 
and in Eastern Finland. Energy intake and BMI were smaller in cities compared with other 
areas. The proportion of the population with abdominal obesity was highest in Western and 
Eastern Finland. The report (summary and names of the maps in Swedish and English) and 
maps are available on the Internet (www.ktl.fi). The usefulness of the maps was confirmed 
by an evaluation carried out by an Internet questionnaire sent to decision makers and other 
professionals in the health sector. 
9.2.6 Dietary assessment in epidemiological studies 
A self-administrative semi-quantitative food frequency questionnaire (FFQ) was developed 
for the Kuopio Breast Cancer Study from the longer questionnaire of the ATBC Study. The 
FFQ was designed to assess the participant's entire diet during the year before diagnosis. It 
included about 120 food items, mixed dishes and alcoholic beverages. Since the Kuopio 
Breast Cancer Study, the FFQ has been our key research method in epidemiological stud-
ies. The FFQ has been updated for the Health 2000 Survey, the Helsinki Birth Study and 
the Fishermen Study (called FFQ2000) and again for the SOKRAS/DILGOM Study 
(FFQ2007). When developing the food list and portion sizes in the most recent FFQs we 
have used the information from the National FINDIET Surveys. The innovation of the 
FFQ2007 is to have the portion sizes separately for both genders. The FFQ2007 will also 
be used in the National Diabetes Programme Dehko and in the Cardiovascular Risk in 
Young Finns Study (LASERI-Study). 
The FFQ and the FFQ2000 have been validated against diet records. The FFQs were found 
to be reasonably good methods for epidemiological research. The FFQ2007 will be vali-
dated in the future.  
To study the diet of pregnant and lactating women in our aetiological studies on type 1 dia-
betes and allergic diseases and asthma, we have developed and validated a 181-item food 
frequency questionnaire and a software program connecting it to food and nutrient data-
bases. This FFQ has also been validated. 
9.2.7 Kuopio Breast Cancer Study 
The Kuopio Breast Cancer Study was a cooperative project conducted by the University of 
Kuopio, Kuopio University Hospital and the National Public Health Institute. The participants 
included all women who were referred to Kuopio University Hospital for breast examination 
between 1990 and 1995. The project started as a case-control study, but all breast cancer 
cases could be followed up because of their annual visits to the same hospital. The focus 
was on risk and protective factors for breast cancer, pathogenesis, diagnosis at an early 
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stage of disease, estimation of prognosis, and improvement in treatment. The diet part con-
centrated on the associations between dietary factors, body-size indicators, and risk of 
breast cancer. The results showed that maintenance of normal body size throughout lifetime 
and avoidance of high abdominal fat and body fat percent decreased the risk of breast can-
cer. High intake of fatty acids such as n-3 and n-6 polyunsaturated fatty acids that are gen-
erally considered healthy, certain vitamins, and the consumption of oil were also related to 
decreased risk of breast cancer. On the other hand, women do not need to be worried 
about 1-3 alcohol drinks per week. The results were widely published in the media. 
9.2.8 Childhood nutrition, type 1 diabetes and allergic diseases 
Allergic diseases and asthma as well as type 1 diabetes are among the most common 
childhood chronic diseases. The incidence of these diseases is steadily increasing. Type 1 
diabetes is in Finland more common than anywhere else in the world and its incidence is 
increasing especially among very young children. The national and international birth cohort 
and intervention studies in which we collaborate provide unique possibilities to assess pre-
natal and early postnatal dietary determinants of these important childhood diseases. 
We take part in several national and international multicentre cohort studies and random-
ized clinical trials. The national Type 1 Diabetes Prediction and Prevention Study (DIPP) is 
a birth cohort of genetically high-risk individuals who are followed for signs of beta-cell auto-
immunity (pre-type 1 diabetes), viral infections, growth and nutrition at 3 to 12 month inter-
vals. Over 7500 children have been invited to the DIPP Nutrition study between 1996 and 
2004 and will be followed up to the age of 15 years. The diet of the mothers during preg-
nancy and lactation is studied by a validated food frequency questionnaire and that of the 
children with repeated 3-day food records and structured questionnaires. Vitamin E, choles-
terol, carotenoids and fatty acids are measured from serum samples. Allergy, asthma and 
atopy endpoints are measured by a validated international ISAAC questionnaire and by 
measuring specific IgE antibodies at the age of 5 years. Along the increase in the end-
points, the DIPP Nutrition and Allergy studies are coming to a rapid publication phase, the 
main results are yet to come. 
The hypothesis for the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) is that wean-
ing to an extensively hydrolysed infant formula will decrease the incidence of type 1 diabetes, 
as it does in all relevant animal models for the disease. TRIGR is the first nutritional primary 
prevention study of type 1 diabetes in the world, carried out in 78 clinical centres in 15 coun-
tries. In TRIGR a highly hydrolysed infant formula is compared to a normal cow's milk based 
one according to a double-blind randomized protocol. In KTL, we are responsible for the die-
tary intervention and the follow-up of dietary compliance in the whole TRIGR. A total 2162 
children who have increased genetic risk for type 1 diabetes and at least one first degree rela-
tive with type 1 diabetes have been recruited to TRIGR between 2002 and 2006. These chil-
dren will be followed up to the age of 10 years. The study achieved, as planned, an 80% 
power for the detection of a 40% intervention-induced difference in the development of type 1 
diabetes-associated autoantibodies and subsequent diabetes.  
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As there are large cultural differences in infant feeding and in food habits during childhood, 
it can be fruitful to study several populations at the same time.  We participate in an interna-
tional consortium on the role of environmental factors in the development of childhood type 
1 diabetes (The Environmental Determinants of Diabetes in Young, TEDDY Study), the re-
cruitment of this cohort study started in autumn 2004 in four countries and seven centres 
and will end in 2008. Our aim is to recruit 7000 children with increased genetic risk for type 
1 diabetes altogether. The children are followed at 3 to 6 month intervals up to the age of 15 
years. The nutrition of the children is followed by 24 hour recalls and repeated 3-day food 
records as well as with several biomarkers (serum, blood cells, toenails). The comparison of 
food databases and food and nutrient intakes across the four countries is challenging.  
9.2.9 Glycemic Load, Metabolism and Health (ELSA) 
Globally, both obesity and type 2 diabetes are increasing in epidemic proportions. This 
unsatisfactory development is assumed to be mainly due to excess energy intake compared 
to energy expenditure. The hypothesis, that this development could partly be related to 
dietary macronutrient, especially carbohydrate quality and quantity, is insufficiently 
documented. Certain carbohydrates may have unfavourable effects on glucose and insulin 
metabolism leading to increased hunger and decreased insulin sensitivity and other altered 
metabolic states with the development of abdominal obesity, increased risk of metabolic 
syndrome and ultimately type 2 diabetes, coronary heart disease and possibly also other 
chronic disease states. The aim of the Glycemic Load, Metabolism and Health (ELSA) 
project is to assess epidemiologically associations of dietary carbohydrate quality, 
especially glycemic load (GL), glycemic index (GI) and fibre intake, with the insulin-like 
growth factor (IGF) system, inflammatory and satiety markers, and with risk of obesity, body 
composition, type 2 diabetes, and coronary heart disease in several large study cohorts 
(e.g. ATBC Study, Helsinki Birth Cohort Study). The effects of the glycemic quality of 
carbohydrates on serum responses of glucose, insulin, lipids and satiety markers as well as 
the IGF-system are studied among normal and overweight subjects in postprandial settings. 
In addition, it is studied, whether serum markers of glucose and insulin and related 
metabolism, and obesity-related genes interact with the association between GL/GI and the 
risk of chronic diseases. To enable the epidemiologic analyses, GI databases for the dietary 
intake datasets are compiled. Since 2004 seven postprandial sub-studies of the ELSA 
project have been carried out. These studies have also provided the GI data of some 40 
Finnish foods and food combinations that are important carbohydrate sources in the diet. 
Additional GI data for the GI databases have been obtained from international published 
sources. The ELSA GI laboratory participated in the international interlaboratory testing 
between 28 centres, organized by the University of Toronto, Canada.
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9.2.10 School Intervention Project 
There is growing concern about nutrition in children and adolescents in Finland. Overweight 
and obesity in children has increased as well as the consumption of beverages and fast 
food. The Finnish Innovation Fund started a Food and Nutrition Programme and one of the 
activities it is funding is a school intervention programme among 13-year olds. The main 
aim is to study the diet of adolescents and to make a dietary intervention during one school 
year. Altogether 12 schools in three cities participate in this project. There are over 1400 7th 
graders in these schools. In the baseline survey in Spring 2007 the students and their par-
ents were asked to fill in a questionnaire on dietary habits and lifestyles. The measurements 
at school included body anthropometry, a dental checkup and a 48-hour dietary interview on 
40% of the students. After the baseline survey the schools were randomized into interven-
tion or control schools, equally many in each city. Intensive intervention during the next 
school year includes efforts to improve the school meals and snacks, involve the teachers, 
students and parents in various activities aiming at increasing their awareness and knowl-
edge of good nutrition as well as skills to make changes. The follow-up survey will be car-
ried out in Spring 2008. This project is done in cooperation with the Department of Dental 
Health in the University of Oulu, the Finnish Heart Association, the Bread Information Cen-
ter as well as several food companies.
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Table 9.1 Summary of main scientific achievements during 1997-2007. 
Scientific output  N  Comments  
Original articles and 
reviews in international 
peer-review journals  
210    
Original articles and 
reviews in domestic peer-
review journals  
20    
Textbooks and chap-
ters in textbooks, reports 
and proceedings  
40  
   
Theses  
doctors  9  
Erkkola M, Hyppönen E, Kilkkinen A, Lahti-Koski M, Maleta K, Männistö S, 
Stumpf K, Roos E, Ylönen K  
Theses, masters'  20   
Mostly in corporation with the Department of Applied Chemistry and Micro-
biology/Nutrition, the University of Helsinki  
Organization of sci-
entific meetings and con-
ferences  
25  
Symposium on berries in cancer prevention 2004 Lahti, International Con-
ference on Polyphenols 2006 Canada, Diabetes and Nutrition Study Group of the 
European Association for the Study of Diabetes 2007 Kuopio, World Diabetes 
Prevention Congress 2008 Helsinki, two symposia annually of the Finnish Society 
for Nutrition Research (1997-2007) Helsinki Kuopio and Turku 
Presidencies and 
memberships in other 
scientific committees  
15  
Academy of Finland/ Research Council for Health, Scientific Council of 
IARC,  TRIGR International Executive Committee, Chair of TRIGR Nutritional 
Intervention Committee, Co-chair of TEDDY Diet Committee, Doctoral Program-
ming  of Public Health Graduate School, EuroFIR Scientific Management Board, 
EuroFIR Covering Council, Chair of the Finnish Society for Nutrition Research, 
ABS Graduate School   
Invited lectures and 
chairmanships in interna-
tional meetings  
5-10 
annually    
Lectures in domestic 
scientific meetings  
10–15 
annually    
Editorial tasks in in-
ternational peer-review 
journals  
3  Public Health Nutrition, Nutrition Metabolism and Cardiovascular  Diseases,  Scandinavian Journal of Nutrition  
Opponent of disser-
tation  2  S Männistö Finland, I Milder Netherlands 
Supervision of dis-
sertations  30    
Review of PhD the-
sis, evaluation of docent-
ship  
14    
Review of scientific 
papers  
About 
20 annually  
Eur J Cancer,  Public Health Nutr, Eur J Clin Nutr, J Food Compos Anal, 
CEBP, Scand J Nutr, NMCD  
Research visits 
to/from international re-
search institutes or univer-
sities  
9  
Fred Hutchinson Cancer Research Center,  Harvard School of Public 
Health,ISTMA/INSERM, London School of Hygiene and Tropical Medicine, WHO 
Geneva, University of Sydney  
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9.3 The main public health activities and achievements 
The Nutrition Unit has the responsibility of detecting trends and signs of alarming changes 
in the Finnish diet. The most important tool for this is the FINDIET surveys. 
In Finland, systematic work to decrease sodium intake in the population has been going on 
since the late 1970s. We have monitored the situation in two ways: calculating sodium in-
take from diet and analysing sodium from 24-hour urines collected on subsamples of the 
FINRISK Study participants.  We have documented and published a 20% decrease and 
shown from the dietary calculations the main sources and changes in them. The major 
sources of salt are mainly manufactured foods, particularly bread and meat products. The 
share of salt used at home has decreased with the increased consumption of processed 
foods in general. 
The diet of Finnish adults is still based on the main meals (breakfast, lunch and dinner) and 
on average the energy is derived from the main meals. However, the group of people who 
have a varying meal pattern is increasing. In FINDIET 2002 it was observed that one fifth of 
men and one fourth of women obtained energy mainly from snacks. The snack-dominating 
meal pattern was energy-dense and contained more sugar, but less fibre, minerals and vi-
tamins than the average diet. 
Because of the low vitamin D status measured repeatedly in winter in Finland, vitamin D 
fortification levels in milks and fats have been increased and there is a variety of fortified 
foods available on the market. The effects of the new Vitamin D fortification programme 
launched in 2003 have been monitored in part by using the FINRISK/FINDIET data. Finland 
has not started large-scale folate fortification of foods, because a low prevalence of inade-
quate plasma folate levels has been found in the monitoring areas. However, monitoring is 
still needed in the future, and the national Nutrition Council is currently discussing potential 
folate fortification. Iodine monitoring is warranted because of the decrease in salt and milk 
intake and because food industry uses mostly non-iodized salt in food processing. Old io-
dine sources have partly been replaced by new ones, e.g. cheese. The iodine question is 
currently under discussion and a more systematic monitoring system for iodine should be 
established. 
Tools for collecting and processing dietary data, like software, databases and data collec-
tion methods, are constantly developed at the Nutrition Unit. The in-house software for en-
tering dietary records and converting food consumption to nutrient intakes has been applied 
in 20 nutritional studies at KTL, and also in collaboration studies at the University of Helsinki 
and the University of Tampere. The multi-lingual website of the Fineli food composition da-
tabase (www.fineli.fi) was launched in 1999 and has currently over 3000 visitors daily from 
lay to professional users. The usability of the site has been analysed and used for further 
development of the food composition database. The website also has a simple tool, called 
'Food Basket', for nutrient intake calculations. The website has reached its target audience 
according to the survey among professional users. The feedback from users is evaluated 
yearly and used in the development of the system. 
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The Nutritional Risk Assessment Project has produced information on the risks and benefits 
of food fortification and use of dietary supplements for the risk management. In the project it 
has been found out that food fortification has no risk of overdose in vitamin D and most of 
the group B vitamins. However, there is a risk of overdose in some group B vitamins (pyri-
doxine, folic acid) due to dietary supplement use. Also calcium fortification and dietary sup-
plement use confers a risk of overdose, because calcium intake on average is very high in 
Finland. On the other hand, food fortification and dietary supplement use were found to de-
crease significantly the proportion of the population with low vitamin and mineral intake - 
especially for vitamin D, calcium and folate. With the developed model for optimal food forti-
fication it is possible to find a fortification level for vitamins and minerals where the intake of 
the whole population is between the recommended intake and the tolerable upper intake 
level in the whole EU. The EU Commission has already shown its interest in the model. In 
addition, a product diary (corresponding food records) has been developed to collect brand 
level consumption data on fortified foods and for other food chemical exposure assessment. 
Risk communication through articles in non-scientific and scientific journals, and TV and 
radio interviews has increased the awareness of the nutritional risks and benefits of food 
fortification and dietary supplement use. 
Deeper understanding obtained through the ELSA project of the physiological and meta-
bolic responses of frequently consumed important carbohydrate sources alone, in combina-
tion with other foods and as part of dietary patterns in the Finnish diet, is expected to pro-
vide important detailed knowledge on dietary carbohydrate sources, which may be associ-
ated with the risk of overweight, and especially the metabolic syndrome and related ab-
dominal obesity, and chronic diseases. From a public health point of view, the project is of 
large importance for preventive measures of type 2 diabetes and its co-morbidities. 
Finding dietary means to prevent chronic childhood diseases (type 1 diabetes, asthma, al-
lergic diseases) would be of major impact. These aetiological studies also provide important 
descriptive information on nutrition of infants, young children and pregnant and lactating 
mothers. The previous nutritional data of these vulnerable population groups is scarce in 
Finland. We are currently doing a report on the nutrition of Finnish young children (0-6 
years). Our expertise in infant and childhood nutrition is also used in the planning of health 
monitoring of Finnish children and adolescents.
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Table 9.1 Summary table of committee memberships, coordination and proceedings with public health impact. 
Public health out-
put  N  Comments  
Articles and reviews 
in  non-peer-review jour-
nals  
10–15 
annually  
  
TV and radio inter-
views  
10–15 
annually  
  
Other media con-
tacts  
100 
annually  
  
Websites, informati-
on databases  
3  
Fineli website (www.fineli.fi), Nutrition website of KTL,  Fineli 
Food Composition database  
Membership in inter-
national committees with 
public health impact  
8  
EU Projects: EURODIET, EFCOSUM, VENUS, 
PHYTOHEALTH; Nordic projects: NORBAGREEN  
Nordic Council of Ministers:  Nordic working group for nutrition and 
toxicology  
Membership in do-
mestic committees with 
public health impact  
20  
National Nutrition Council (Ministry of Agriculture and Forestry),  
Advisory Committee on Foodstuffs (Ministry of Trade and Industry), 
Novel Food Committee (Ministry of Trade and Industry), Support 
committee for Breastfeeding, NGOs: Finnish Heart Association, Fin-
nish Diabetes Association, Central Union for the Welfare of the Aged 
 
Coordination and/or 
implementation of devel-
opment projects  
1  Fineli 2000  
Organization of in-
ternational training with 
public health impact  
5  
 
Centre for International Mobility (CIMO) Winter School on Nutri-
tion  and Epidemiology, International Postgraduate  Programme in 
Epidemiology University of Tampere, Board of the European Nutrition 
Leadership Programme, Eurofir training course, International course 
on production and use of food composition data in nutrition  
 
Lectures, in universi-
ties  
About 
50  
annually  
Over a hundred/year currently  
Universities of Helsinki, Tampere, Kuopio  
Lectures, for health 
care personnel  
20–30 
annually  
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9.4 Funding for research and public health programmes 
The Unit`s work is largely funded by external resources. From the Unit's over 30 persons 
5.3 persons are funded by KTL´s regular budget. The main sources of funding are the Min-
istry of Social Affairs and Health and the Ministry of Agriculture and Forestry, the Academy 
of Finland, The Finnish Innovation Fund, Research Foundations, the EU's Framework Pro-
grammes and the graduate schools which provide the salary currently for several doctoral 
students. 
The Nutrition Unit has not been able to get funding for the analyses of food composition. 
The Unit has built a consortium with five national food laboratories and made several appli-
cations without almost any financial result. The new food composition data have been pro-
duced for plant sterols and phenolic compounds which are standing for the interest of new 
components. Updating analyses have been carried out for minerals and trace elements in 
vegetable products only. Thus no interest for regular repeating of food analyses for basic 
composition has existed. Resources for analytical work of food composition are definitely 
needed and this is the fundamental question for Fineli in the future years. 
Monitoring nutritional status was started ten years ago by short-term funding from the Minis-
try of Social Affairs and Health. Resources for this area have been very limited and sporadic 
all these years and have not enabled long-term strategic planning of this part of monitoring. 
It is to be hoped that now that both folates and iodine are under discussion in the National 
Nutrition Council, some type of monitoring system could be established and regular funding 
for that arranged from the Ministry of Social Affairs and Health. 
Our international studies on the aetiology of type 1 diabetes, TRIGR and TEDDY, have 
been primarily funded by the National Institutes of Health (US). DIPP Nutrition and Allergy 
studies have been totally dependent on relatively small and varying funding by Finnish pri-
vate foundations and the Academy of Finland. 
9.5 Personnel 
During the past 10-year time period, the number of employees in the Nutrition Unit has 
grown from over 10 persons in the old Unit of Nutritional Epidemiology to more than 30. 
Currently, there are two professors (one only 30% of her time), senior researchers, and 10 
researchers conducting doctoral studies. In addition, we have nutritionists, statisticians, data 
managers and M.Sc. students as research assistants. Dr Virtanen`s team joined us in 2001 
and has then expanded from a few persons to more than ten. The other teams within the 
Unit are currently the Fineli team, the ELSA team, the School Project team and the Risk 
Assessment team. The FINDIET project involves periodically the majority of the personnel. 
The current key senior researchers are: 
Prof. Pirjo Pietinen, Head of Unit: School Project, FINDIET, Nutritional risk assessment, 
ATBC Prof. Suvi Virtanen (only 30%, 70% in the University of Tampere as the professor of 
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epidemiology):  Studies on childhood nutrition and on the role of nutrition in the develop-
ment of chronic childhood diseases (type 1 diabetes, allergic diseases and asthma) 
(TRIGR, DIPP nutrition and Allergy studies, TEDDY) 
Adjunct Prof. Liisa Valsta: Quality of macronutrients, metabolism and health (e.g. ELSA; 
Dilgom), FINDIET, Nutritional status monitoring, Nutritional risk assessment Project 
Adjunct Prof. Marja-Leena Ovaskainen: Dietary assessment and food composition data 
Dr Tero Hirvonen: Nutritional Risk Assessment Project, FINDIET 
M.Sc: Heikki Pakkala: Development of database systems for dietary and composition data 
M.Sc. Heli Reinivuo: Fineli food composition database, methodological tools 
9.6 Collaboration 
The Nutrition Unit works in close collaboration with many of the other units within the De-
partment, particularly with the Chronic Disease Epidemiology Unit (FINRISK and Dilgom 
Studies), the Cancer Prevention Unit (ATBC Study), the Diabetes Unit (Helsinki Birth Cohort 
Study), the Health Promotion Unit (the school intervention study), the Chronic Disease Pre-
vention Unit (LATE Children Health Behaviour) and within the Department of Health and 
Functional Capacity the Biomarker Laboratory (nutritional status monitoring), the Laboratory 
of Analytical Biochemistry (analytical collaboration). The large cohort studies need updates 
of their dietary databases concerning new dietary factors such as the GI or bioactive com-
pounds and new analyses of the relationships between these compounds and risk of dis-
eases are done in collaboration.   
In 1997-2006, the Nutrition Unit has participated in several European and Nordic projects 
focusing on method development, the estimation of dietary status and the harmonisation of 
procedures. This collaboration has strengthened and expanded the networks of the Nutri-
tion Unit as well as made the expertise of the Unit known to other European centres. 
Projects related to the quality of the European diet: Intake of Trans Fatty Acids in Western 
Europe, the TRANSFAIR Study (G. van Poppel); Nutrition & Diet for Healthy Lifestyles in 
Europe, EURODIET Project (A. Kafatos); Consumption of vegetables, potatoes, fruit, bread, 
and fish in the Nordic and the Baltic counties, NORBAGREEN (L.Valsta), Benefit and Risk 
Analysis, BENERIS (JT. Tuomisto). 
Projects related to method development, harmonization of dietary assessment tools and 
procedures: Food Consumption and Food Composition Data, COST Action 99 (C. West), 
European Food Consumption Survey Method, EFCOSUM (J.H. Brussaard, M. Löwik),  Sci-
entific Co-operation on Questions relating to Food, SCOOP (M. Gibney), European Food 
Information Resource Network, EuroFIR (P. Finglas). 
Projects related to bioactive compounds and their health effects: Dietary Exposure to Phy-
toestrogens and Related Compounds and Their Effects on Skeletal Tissues, VENUS 
(F.Branca), Improving Health Through Dietary Phytoestrogens: A Pan-European Network 
on Consumers' Issues and Opportunities for Producers, PHYTOHEALTH (F. Branca). 
We have collaboration with the Division of Nutrition and the Division of Food Chemistry in the 
University of Helsinki, the Department of Clinical Nutrition and Food and Health Research 
Centre in the University of Kuopio, the School of Public Health in the University of Tampere, 
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the Department of Dental Health in the University of Oulu, the Finnish Food Safety Authority 
Evira, the Social Insurance Institute and the MTT Agrifood Research Center. 
In the area of childhood nutrition and type 1 diabetes we have large national and interna-
tional collaborative networks through the DIPP, TEDDY and TRIGR studies. The principle 
investigators of the DIPP study are professors Jorma Ilonen (University of Kuopio), Mikael 
Knip (University of Helsinki) and Olli Simell (University of Turku), those of TEDDY profes-
sors Jeff Krischer (University of South Florida) and Marian Rewers (University of Colorado 
Health Sciences Center), and that of TRIGR professor Hans K. Åkerblom (University of Hel-
sinki). In DIPP Nutrition study we collaborate with Professor Michael G. Kenward (London 
School of Hygiene and Tropical Medicine) in the field of longitudinal data analysis and mul-
tiple imputation methods.  In addition Dr Virtanen's group collaborates with Prof. Outi 
Vaarala (National Public Health Institute) in studies related to nutrition and  T-cell mediated 
immune responses, with Prof. Mirja Salkinoja-Salonen and Dr Merja Roivainen in studies on 
the effects of food-derived toxins on beta-cell growth, with Prof. Juha Pekkanen in studies 
on the effects of fetal and childhood nutrition on T-cell mediated immune responses and on 
the development of allergic diseases, and with Prof. Leif Group on the significance of die-
tary factors in the development of insulin resistance. 
9.7 Proposal for future work and expected benefits 
The Unit actively promotes the maintaining of the Fineli food composition database, collects 
updated content data in collaboration and tries to build a consortium covering all the scien-
tific users of the compositional data. The Unit will stay up-to-date on dietary assessment 
methodologies, expand diet monitoring to children and adolescents, and continue and ex-
pand nutritional risk assessment. It will strengthen its role as a focal point of expertise in 
nutritional epidemiology and public health nutrition and continue to offer graduate students 
excellent databases for doctoral work. 
Our collaborative studies in the field of aetiology of type 1 diabetes are among the hallmark 
studies in their areas in the world. TRIGR is the first dietary randomized trial in the primary 
prevention of type 1 diabetes. Within the coming 10 years it will answer whether feeding a 
highly hydrolysed infant formula as a weaning food instead of a conventional infant formula 
prevents type 1 diabetes. The DIPP study and its nutrition component  represents the larg-
est cohort in the field of aetiologic research of type 1 diabetes in the world both in terms of 
the numbers of subjects recruited and followed and in terms of nutritional measurements 
done.  The number of endpoints of beta-cell autoimmunity (pre-type 1 diabetes) in the DIPP 
study is larger than in any of those few other cohorts that include measurements of infant 
and childhood diet. The TEDDY study will be the largest international natural history study 
of type 1 diabetes. In these large cohorts, hypotheses related to other important childhood 
outcomes, e.g., allergic diseases, asthma and obesity, can also be raised 
The ELSA Project will continue both the epidemiologic analyses related to weight change 
and obesity, type 2 diabetes, cardiovascular and other chronic diseases, and metabolic re-
sponse studies, as well as to some extent GI testing of certain special food groups. In the 
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coming years the focus is to be broadened to also include interactions of dietary macronu-
trient (e.g. carbohydrate) quality and human intestinal microbiota and associations with 
metabolic markers and risk of obesity and chronic diseases. The experimental methodology 
is planned to be expanded from postprandial studies to also include dietary interventions in 
this study area. The increased expertise in the area of glycemic and insulinemic responses 
of Finnish foods will most probably lead to increased collaborative applications with other 
research groups in the area. 
The School Project will hopefully have a successful intervention which can serve as a model 
for all schools nationwide. In addition, its baseline survey is a pilot for future, regular sur-
veys of FINRISK type among children. Hopefully the monitoring system will eventually be 
built and provide data on children´s diets systematically.  
The Nutritional Risk Assessment Project will probably expand from vitamins and minerals to 
all food chemical (contaminants, food additives, pesticide residues) exposure assessment. 
This work will be done in co-operation with the Finnish Food Safety Authority and by their 
co-ordination. 
The EuroFIR network interacts with all activities of Food Composition Databases, like Fineli. 
Harmonized methods improve data quality and boost international cooperation e.g. with 
data compilation and production of common tools. Moreover, this gives new opportunities 
for multinational research and a breeding ground for innovative ways of presenting and 
connecting nutrition information with daily life. 
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10 CANCER PREVENTION UNIT 
10.1 Research and public health significance of the area 
The Cancer Prevention Unit was established in 1994. It was first located in the Department 
of Nutrition and since 2001 in the current department, the Department of Health Promotion 
and Chronic Disease Prevention. The Unit was a continuation to the Alpha-Tocopherol, 
Beta-Carotene Cancer Prevention (ATBC) Study, a randomized, double-blind, placebo-
controlled, primary-prevention trial undertaken to determine whether supplementation with 
alpha-tocopherol, beta-carotene, or both would reduce the incidence of lung cancer and 
other cancers in 29,133 male smokers. The trial was carried out in 1985-1993 and its main 
results were published in the New England Journal of Medicine in April 1994. 
The main research of the Unit has focused on provision of interventional and epidemiologi-
cal data on chronic diseases with major public health significance, particularly on cancer 
and cardiovascular disease. The Unit has exploited the extensive exposure data collected 
during the trial such as background characteristics, medical, smoking, physical activity and 
dietary histories as well as biological samples (serum, whole blood, toenails). In addition, 
the Unit has regularly updated the endpoint data from the Finnish Cancer Registry (FCR), 
the Hospital Discharge Register, and the Register of Causes of Death. All cancer cases 
identified through FCR up to April 1999 have been reviewed for cancer diagnosis and ex-
tension by collecting hospital records and review by one or two study physicians. Compar-
ing the reviewed ATBC data with the original FCR data showed that FCR data are a reliable 
source of information for follow-up of cancer incidence but the delay in case notification 
should be taken into consideration. Thus, the Unit has used only FCR data for cancer fol-
low-up since May 1999 and reviewed the data from hospital records only for specific sub-
groups as for cancer cases without any histological or cytological verification. 
The ATBC Study is a collaborative project between the National Public Health Institute 
(KTL) and the U.S. National Cancer Institute (NCI). Accordingly NCI collaborators have fo-
cused on cancer-related analyses and reports whereas the KTL researchers have focused 
more on non-cancer endpoints. However, all NCI ATBC-related activities are based on the 
checked and updated data provided by the Unit. In recent years the ATBC Study has joined 
many international research consortia to increase the number of endpoints and thus the 
power to study risks between exposures and endpoints. 
When the trial ended, the main emphasis was to analyse and report the intervention effects of 
alpha-tocopherol and beta-carotene on specific cancers and cardiovascular diseases. At the 
same time, cohort studies to examine the association between risk factors and endpoints in-
creased in number. In recent years the whole blood samples have been exploited to study the 
association between the genetic markers and lifestyle factors and their interactions, and end-
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points. The Unit has also analysed and reported the 6-year postintervention effects of alpha-
tocopherol and beta-carotene on cancer, coronary heart disease, and stroke. 
The Cancer Prevention Unit has collaborated with many Departments and Units of KTL dur-
ing the last 10 years. The Unit has continued close collaboration with the Nutrition Unit dur-
ing the whole 10-year evaluation period; the Head of the Nutrition Unit, prof. Pirjo Pietinen, 
is the Co-Principal Investigator of the ATBC Study, and many researchers of the Nutrition 
Unit have exploited data and samples from the ATBC Study in their research. Currently, the 
most extensive collaboration with the Nutrition Unit is through the Glycemic Load and 
Health (ELSA) project that assesses carbohydrate's glycemic indexes and loads. This pro-
ject also involves examination of the association between glycemic variables, and the risk of 
type 2 diabetes and coronary heart disease in the ATBC men. 
10.2 The main scientific achievements 
Intervention-related findings of the ATBC Study 
The ATBC Study was the first prevention trial to show that supplemental beta-carotene in-
creases the risk of lung cancer in smokers. This was against the expectations raised by 
several epidemiological cohort studies that had found an inverse association between se-
rum beta-carotene concentration and the risk of lung cancer. The increased risk appeared 
approximately 4 years after starting beta-carotene supplementation and in the 6-year 
postintervention follow-up it disappeared within a similar timeframe after stopping the sup-
plementation. The effect of supplemental beta-carotene was studied also on other cancers, 
i.e. head and neck, gastric, colorectal, pancreatic, renal cell, urothelial, and prostate cancer, 
but no significant effect on these cancers was evident. 
Supplementation with alpha-tocopherol reduced the incidence of prostate cancer by 34%, 
with the preventive effect observed approximately 18 months after the start of intervention. 
The effect attenuated during the 6-year post-trial follow-up, but a nonsignificant 12% de-
crease in the risk was still evident during the follow-up. The mechanism through which al-
pha-tocopherol could influence the prostate carcinogenesis is unclear. We found that alpha-
tocopherol supplementation reduced serum androgen concentrations and serum vascular 
endothelial growth factor (VEGF) levels, which might have contributed to the observed re-
duction in prostate cancer risk. Supplementation with alpha-tocopherol had no significant 
effect on the incidence of other cancers. 
We have also studied the effect of supplemental alpha-tocopherol and beta-carotene on car-
diovascular endpoints. During the intervention period, beta-carotene seemed to increase 
coronary mortality among those who reported a history of myocardial infarction (MI) at base-
line, whereas among those without a history beta-carotene had no effect on the risk of major 
coronary events (non-fatal MI and coronary death). During the 6-year postintervention follow-
up beta-carotene supplementation seemed to increase the risk of first-ever non-fatal MI, 
whereas it had no effect on the risk of major coronary events in men with a history of MI at 
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baseline. Thus the effect of beta-carotene on coronary heart disease risk remained unclear. 
Alpha-tocopherol supplementation had no significant effects on the major coronary endpoints. 
Alpha-tocopherol supplementation decreased the risk of cerebral infarction but increased 
that of fatal haemorrhagic strokes. During the 6-year postintervention follow-up these effects 
disappeared. Supplemental beta-carotene had no preventive effect on strokes but the risk 
of intracerebral haemorrhage was increased. 
Neither alpha-tocopherol nor beta-carotene supplementation had an effect on the symptoms 
or incidence of intermittent claudication. Neither did the supplements have an effect on the 
end-of-trial prevalences of cataracts or age-related maculopathy. 
Cohort-related findings in the ATBC Study 
Lung cancer: Consumption of vegetables and fruits associated with lower risk of lung can-
cer. An interesting finding reported repeatedly also by other studies is that dietary beta-
carotene did not associate with the risk of lung cancer whereas serum beta-carotene had an 
inverse association, the multivariate relative risk = 0.81, 95% confidence level 0.69-0.95, 
highest versus lowest quintile. A new finding was that markers suggesting chronic Chlamy-
dia pneumoniae infection were positively associated with the incidence of lung cancer. 
Prostate cancer: New risk factors for prostate cancer were searched for in many analyses 
but neither serum factors of one-carbon metabolism, serum insulin-like growth factor I, nor 
serum enterolactone associated with the risk of prostate cancer. 
Stomach cancer: H. pylori was a strong risk factor for noncardia gastric cancer (OR = 7.9, 
95% CI 3.0-20.9) whereas it was inversely associated with the risk of gastric cardia cancer 
(OR = 0.31, 95% CI 0.11-0.89). Polymorphisms in inflammation-related genes were not as-
sociated with the risk of gastric cancer. 
Colorectal cancer: Of the dietary factors, high consumption of milk products and high intake 
of calcium were inversely associated with risk of colorectal cancer. The cluster of indicators 
for metabolic syndrome (hypertension and overweight and low HDL cholesterol) associated 
with the risk of colorectal cancer as well as high levels of serum glucose, insulin, and insulin 
resistance. Another interesting finding was that chronic low-grade inflammation assessed by 
C-reactive protein measurement was a marker for increased risk of colorectal cancer. 
Pancreas cancer: Dietary and serum folate associated inversely with the risk of pancreas 
cancer whereas the other factors of one-carbon metabolism had no consistent association. 
Indicators of abnormal glucose metabolism, i.e. high baseline fasting concentrations of glu-
cose, insulin, and insulin resistance were positively associated with pancreatic cancer. Se-
rum concentrations of insulin-like growth factor I and insulin-like growth factor binding pro-
tein 3 were not associated with the risk of pancreatic cancer. A novel finding was that H. 
pylori infection increased the risk of pancreatic cancer two-fold. 
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Total mortality: Although alpha-tocopherol supplementation did not influence the total mor-
tality, baseline serum alpha-tocopherol concentration associated inversely with total mortal-
ity, RR 0.82, 95% CI 0.78-0.86, highest vs lowest quintile. 
Stroke: High serum total cholesterol had a protective association with the risk of intracere-
bral haemorrhage. Serum total cholesterol was not associated with risk of cerebral infarction 
whereas HDL cholesterol had an inverse association with the risk. The associations be-
tween alcohol consumption and the different strokes were non-uniform, linear in subarach-
noid haemorrhage, U-shaped in intracerebral haemorrhage, and J-shaped in cerebral in-
farction. 
A summary of the Unit's scientific output is presented in Table 10.1 
Table 10.1 Summary of main scientific outputs of the Cancer Prevention Unit during 1997-2006 
Scientific output  N  Comments  
Original articles and reviews in in-
ternational peer-review journals  
170  
This is the total number of papers published 
from the ATBC Study material from 1997 through 
June 2007.  
Original articles and reviews in 
domestic peer-review journals  
10    
Textbooks and chapters in text-
books, reports and proceedings  
10    
Theses  
8  
 
Rapola J, Haukka J, Leppälä J, Korhonen P, 
Malila N, Törnwall M, Hirvonen T, Hemilä H 
 
Invited lectures and chairman-
ships in international meetings  
10    
Lectures in domestic scientific 
meetings  
20    
Supervision of dissertations  9  4 ongoing  
Review of PhD thesis, evaluation 
of docentship  
3    
Review of scientific papers  
Several 
annually  
  
Research visits to/from interna-
tional research institutes or universities  
4    
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10.3 The main public health activities and achievements 
The Unit is not involved in any direct public health activities but it frequently provides expert 
opinions on major chronic diseases, their risk factors and prevention for various mass me-
dia. A summary of the Unit's public health output is presented in Table 10.2
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Table 10.2. Summary of output with public health impact of the Cancer Prevention Unit during 1997-2006. 
Public health output  N  Comments 
Articles and reviews in  non-peer-review journals  10    
TV, radio and newspaper interviews  Several annually   
Membership in domestic committees with public health impact 3    
10.4 Funding for research and public health programmes 
The ATBC Study has been supported by the U.S. National Cancer Institute; a contract for 
the period from September 1994 through March 2003 amounting to USD 3 906 593 and 
from April 2003 through March 2008 amounting to USD 3 612 910. Negotiations with NCI 
are in progress for a new contract after March 2008. 
10.5 Personnel 
The number of employees in the Unit has varied from 7 to 12 during the last ten years. Cur-
rently, one professor, one senior researcher, one researcher conducting doctoral studies, 
and four other people (biostatistician, data manager, and research assistants) are employed 
by the Unit. 
The current key senior researchers are: 
Jarmo Virtamo, MD, PhD, research professor, Head of the Unit 
Satu Männistö, MSc, PhD, senior researcher. Works 20% for the Unit. Nutrition and obesity 
10.6 National and international collaboration 
National 
The ATBC Study has collaborated with many institutions such as Departments of Public 
Health, Oncology, Medicine, and Surgery, and the Institute of Dentistry in the University of 
Helsinki, and the Finnish Institute of Occupational Health. The Study also collaborates 
closely with the Finnish Cancer Registry to retrieve data on new cancer cases. At the mo-
ment the study is involved in a project of many partners led by the Department of Bacteriol-
ogy and Immunology, University of Helsinki, to study the association between H. pylori 
eradication and subsequent risk of gastric cancer.
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International 
The MORGAM project, coordinated by the International Cardiovascular Disease Epidemiol-
ogy Unit of KTL, aims to determine in a prospective setting whether variation in genes, ei-
ther by itself or in combination with lifestyle, is a significant predictor of incident coronary 
heart disease, stroke, or total mortality. Since the end-of-trial collection of the whole blood 
sample, the placebo group of the ATBC Study (n = 5073)has been involved in the 
MORGAM Project for the follow-up of coronary heart disease and stroke. 
A lot of international collaboration takes place with the NCI collaborators. Currently most 
collaboration is with Demetrius Albanes, M.D.; Philip Taylor M.D., Sc.D.; Stephanie 
Weinstein, Ph.D.; Rachael Stolzenberg-Solomon, Ph.D.; Farin Kamangar, M.D., Ph.D; and 
Unhee Lim, Ph.D. Through NCI collaborators there is also much further collaboration with 
other U.S. scientists outside NCI. 
DIETSCAN, coordinated by TNO Nutrition and Food Research, Zeist, Netherlands, was an 
EU-supported project to develop and apply a common methodologic approach to study die-
tary patterns and cancer in 4 European cohorts. 
The Pooling Project of Prospective Studies of Diet and Cancer, coordinated by Harvard 
School of Public Health, aims to examine associations between dietary factors and cancer 
through combining data of up to 27 prospective studies. 
The Pooling Project of Cohort Studies on Diet and Coronary Disease, coordinated by the 
Harvard School of Public Health, aims to examine associations between dietary factors and 
major coronary heart disease events by pooling the primary data of up to 11 major cohort 
studies. 
Cancer Control using Population-based Registries and Biobanks is a network of European 
cancer registries and biobanks coordinated by the Department of Medical Microbiology, 
Lund University, Sweden. The network aims at using the samples of the biobanks in large-
scale cancer research searching for genetic and infectious causes to cancer. 
The National Cancer Institute Breast and Prostate Cancer Cohort Consortium includes nine 
large cohort studies. The goal of the consortium is to characterize variations in approxi-
mately 50 genes that mediate two pathways that are associated with breast and prostate 
cancer - the steroid-hormone metabolism pathway and the insulin-like growth factor signal-
ling pathway - and to associate these variations with cancer risk. 
The Pancreatic Cancer Cohort Consortium (PanScan), funded by NCI, involves 12 prospec-
tive epidemiological cohorts and 1 case-control study to conduct whole genome scans of 
common genetic variants in order to identify markers of susceptibility to pancreatic cancer. 
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In addition, the ATBC Study is participating in two large consortia applying for funds to start 
their research: 
The Genetics of Vulnerability to Nicotine Addiction project, coordinated by Washington Uni-
versity, to identify genetic predictors of long-term persistent smoking; and the European 
Cancer Cohort Consortium for Gene, Environment and Metabolism Studies, coordinated by 
Imperial College London and IARC, Lyon, to investigate genetic predisposition, environ-
mental, lifestyle, and metabolic factors and their complex interactions in the development of 
the common cancers. 
10.7 Proposal for future work and expected benefits 
To continue the postintervention follow-up for cancer and cardiovascular disease to disclose 
possible late effects of supplemental alpha-tocopherol and beta-carotene on these endpoints 
To continue collaboration with current large-scale consortia and possibly join new ones to 
exploit the ATBC Study material in a more powerful entity which allows the study of associa-
tions of exposure and endpoint data also in smaller subgroups 
To study new endpoints from the ATBC Study material. Currently we have completed the 
assessment of incident diabetes cases diagnosed through 1997 and are analysing the ef-
fects of supplemental antioxidants on the risk of diabetes as well as examining the associa-
tions between a large number of risk factors and diabetes. Dementia is a disease whose 
incidence is increasing strongly. The ATBC Study material could also be exploited in the 
study of risk factors for dementia but this activity is dependent on finding the necessary 
manpower and funding. 
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11 CHRONIC DISEASE PREVENTION UNIT 
11.1 Research and public health significance of the area 
The Chronic Disease Prevention Unit was established in 2001. Several already ongoing 
projects related to chronic disease prevention were relocated to this new unit. The first new 
activity was the centralization of tobacco control, as tobacco activities had been scattered in 
other units and departments. The Unit carries out research, monitoring and expert activities 
related to chronic diseases, their risk factors and prevention. Equity in health over the life 
course and international comparisons are common themes in the research projects. By ac-
tively participating in international cooperation, the Unit transfers Finnish expertise in 
chronic disease prevention and monitoring to other countries and brings new ideas and 
views from abroad to Finnish prevention activities. The main areas of activity are: health, 
lifestyles and inequalities, tobacco control and research, healthy ageing and international 
health promotion. 
11.1.1 Health lifestyles and inequalities 
Unhealthy behaviours are important risk factors for several chronic diseases. Knowledge of 
factors influencing health behaviours is a prerequisite for effective interventions and policies 
to improve public health. The projects within the area "health, lifestyles and inequalities" in-
clude, in addition to research, expert functions of public health. The goal is to produce scien-
tific knowledge on health behaviours and their determinants and to distribute up-to-date 
knowledge to public health experts and decision makers. As unhealthy behaviours and 
chronic diseases are unequally distributed among population groups, the activities of the area 
focus on socio-demographic differences in health behaviours and on their changes over time. 
Other relevant themes are interactions between the various domains of health behaviour and 
the contribution of health behaviours to socio-economic inequalities in mortality.  
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11.1.2 Tobacco control and research 
Tobacco use is a major public health threat causing about 2 million premature deaths in 
Europe annually and it is a strong determinant of socio-economic differences in morbidity 
and mortality. In Finland, every fifth adult and every third 16-year-old is a daily smoker. 
Prevalence of tobacco use depends on three processes: 1) initiation rate at adolescence, 2) 
maintenance since adolescence and early adulthood and 3) smoking cessation and mortal-
ity in adulthood. In order to influence smoking behaviour, all three processes need to be 
covered both at population and at individual level. The basis for preventing tobacco use has 
been legislative measures, health education and providing aid for smoking cessation. Re-
search has provided feedback from legislative processes, provided grounds for treatment 
and actions and showed new areas of public health and further research. However, smok-
ing has become more socially discriminating, which requires new views, approaches and 
tools for successful tobacco use prevention and cessation treatment. The National Public 
Health Institute KTL is a national centre of tobacco studies with wide collaboration with uni-
versities and research institutes and has an obligation to implement research into policy and 
practice. In 2001 the tobacco control group built a network within KTL and nationally. The 
network consists of research communities and different levels of professionals working with 
tobacco or participating in tobacco control. For these purposes, a KTL strategy of tobacco 
control and research was produced. Research areas and activities are divided into three 
entities: smoking prevention, tobacco control (including monitoring tobacco use and dis-
eases), tobacco use prevention and tobacco dependency and cessation. More details from 
www.ktl.fi/tobaccocontrol. 
11.1.3 Healthy ageing 
Because of the worldwide ageing phenomenon of the population, the functional capacity 
and cognition of the elderly population has increasing public health relevance. Research on 
health and functional capacity among the ageing population is done in several projects in 
collaboration with national and international partners. Large population-based surveys in 
KTL enable the aetiological research on functional capacity especially on cognition and 
memory and their association with cardiovascular disease risk factors. 
11.1.4 International health promotion  
The Unit is involved in several international research projects and health promotion pro-
grammes and networks. It works in close collaboration especially with the WHO Regional 
Office for Europe and with the European Union in chronic disease prevention activities and 
health promotion. The Department of Health Promotion and Chronic Disease Prevention is 
a WHO Collaborating Centre for Noncommunicable Disease Prevention, Health Promotion 
and Monitoring. The Chronic Disease Prevention Unit mainly coordinates the joint activities. 
Research and health promotion collaboration is most active with the Baltic countries and 
neighbouring areas in Russia. One of the main objectives in collaboration is to develop 
health monitoring systems and utilization of health research data in disease prevention 
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planning. Data gathered in health surveys are also used for epidemiological research on 
prevalence and aetiology of chronic diseases. Planning and implementation of chronic dis-
ease prevention interventions, training and other expert functions are also an important part 
of collaboration. 
11.2 The main scientific achievements 
11.2.1 Health lifestyles and inequalities 
The first research projects of the group "Health Lifestyles and Inequalities" focused on food 
habits and on the interactions between smoking, food habits, alcohol consumption and 
physical activity. Lately, more attention has been paid to physical activity, because physical 
activity and food habits are equally important for the prevention of obesity. The food studies 
have been dealing with areas not fully covered by other units of KTL. Due to the increasing 
public health relevance of health inequalities, the scope of research on health behaviours 
has been broadened. The current research focuses on the contribution of health behaviour 
and psychological distress to socio-economic differences in mortality. 
11.2.2 Interrelationships among health behaviours (1995-2002) 
Previous research was concentrated on one or two health behaviours at a time. Therefore, 
studies on the associations between smoking, alcohol consumption, physical activity and 
food habits were initiated. It was assumed that while few people behave consistently in a 
healthy or unhealthy way, health behaviours are not independent of each other. Further-
more, it was assumed that health behaviours are closely linked with various socio-
demographic factors. The project focused on risk behaviours rather than on health-
promoting behaviours. The goal of the project was to obtain a comprehensive account of 
the associations among the daily health behaviours. 
    The data consisted of men and women participating in postal surveys conducted annually 
among a random sample of Finnish adults since 1978. Smoking played a primary role in 
determining the associations between and co-occurrence of health behaviours. As smoking 
also predicted other unhealthy behaviours, smoking could act as a behaviour that promotes 
the adoption or inhibits the abandonment of other healthy behaviours. Hence, intervening in 
smoking, we could possibly hope for favourable side-effects in other behaviours. In future 
research and health promotion, special attention should be paid to the association between 
smoking and other health behaviours. 
11.2.3 Behavioural and psychosocial determinants of health inequalities (1998-) 
In all European countries low socio-economic position is associated with poor health and 
short life expectancy. In Finland socio-economic differences in mortality have increased 
during the last decades. 
This project consists of several consecutive studies initiated in 1998. A larger study on be-
104
  
 
havioural and psychosocial determinants of health inequalities was launched in 2003. A 
sub-study focusing on the various domains of physical activity was started in 2006. The 
project will examine the associations of occupation, education and income with health be-
haviours and psychosocial factors and their contribution to the socio-economic mortality 
differentials. The overall goal of the project is to search for potential entry points to interven-
tions and policies to reduce health inequalities. The project is based on the assumption that 
socio-economic position has a causal effect on health through specific behavioural and psy-
chosocial determinants. 
    The study design combines repeated cross-sectional surveys with a mortality follow-up 
(over 20 years) of cohorts invited to the surveys in 1978-2002. The Finnish survey data 
have been linked with socio-economic and mortality data from two registers.  The Finnish 
health behaviour and socio-economic data will be used in the comparative study of over 20 
European countries. The surveys include questions on health behaviours (e.g. smoking, 
alcohol consumption, food habits, physical activity) and psychosocial factors (e.g. depress-
iveness, family status). Physical activity has been assessed by questionnaires and recalls, 
including questions on occupational, leisure-time, and commuting physical activity, as well 
as self-rated physical fitness and energy expenditure. 
    Sociodemographic differences in psychological distress exist but the strength and direc-
tion of the association depends on the measurements used. People from higher socio-
economic groups have healthier behaviours. Educational level is the most important deter-
minant of most health behaviours. However, income and occupation have independent ef-
fects on physical activity and the use of fresh vegetables. The socio-economic patterns of 
health behaviours are relatively stable over time, with the exception of vegetables. The most 
significant health behaviours contributing to socio-economic differences in all-cause and 
cardiovascular mortality are smoking, physical activity and the use of fresh vegetables. 
    The decreasing socio-economic differences in the use of vegetables, at the same time as 
vegetable consumption is increasing in the population, is one of the few cases demonstrat-
ing that socio-economic differences in health or its determinants can diminish. For future 
mortality differentials, the direction in which socioeconomic differences in health behaviours 
develop is of crucial importance. 
11.2.4 Comparing health behaviours in Estonia, Finland, Latvia and Lithuania - Finbalt 
Health Monitor (1994-) 
The Baltic countries share public health problems typical of most Eastern European transition 
economies: morbidity and mortality from non-communicable diseases is higher than in West-
ern European countries. This situation has many similarities with Finland of the late 1960s. 
Health disadvantage may be increasing among the less advantaged population groups in the 
Baltic countries. The Finbalt Health Monitor is a system for monitoring health-related behav-
iour, practices and lifestyles in Finland and in the Baltic countries. The collaborative work has 
been carried out since 1994. The Finbalt Health Monitor has both practical and theoretical 
goals. In terms of research the goal is to compare changes and variations in health behav-
iours and their social determinants in the four countries. 
    The data consist of similar cross-sectional postal surveys conducted every second year on 
adult populations in Estonia, Latvia, Lithuania and Finland since 1994. Perceived health is 
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worse in the Baltic countries than in Finland. Poor health is associated with older age and 
lower education in all countries studied. The educational inequalities in health remained stable 
over time from 1994 to 2004. In the Baltic countries, however, improvement in perceived 
health was mainly found among the better educated. Food habits have changed in a healthier 
direction in all the countries, especially in the Baltic countries, where the use of vegetables 
and vegetable oil has increased remarkably. Women in higher educational groups make 
healthier food choices than men in lower educational groups. Daily smoking is associated with 
lower education in all countries. Among Lithuanian women, the educational gradient in smok-
ing was weakest, and the overall prevalence of smoking increased over time. 
The Baltic countries resemble Western European countries rather than other transition socie-
ties. While health inequalities have not markedly changed and substantial inequalities do re-
main, there are indications of favourable developments mainly among the better educated. 
Pressures towards increasing health inequalities may therefore be visible in the future. 
11.2.5 Food habits, meal patterns and eating outside home (1995-) 
A common trait to the food research of the group is the interest in food patterns and their 
social determinants. The study objects include meals and foods relevant for public health 
(e.g. dietary fats, vegetables). 
Disparities in Food Habits in Europe (1997-2003) 
 
The Disparities project reviewed, on the basis of existing studies and reports, socio-
economic differences in food habits in 15 European countries. The underlying hypothesis 
was that socio-economic status affects the healthiness of the diet. The aim of the project 
was to provide a comprehensive overview of existing data sources on socio-economic 
differences in food habits in Europe in 1985-1997, and to give a description of the 
similarities and differences in the patterns of food-related disparities. There were data 
available on socio-economic differences in food consumption and nutrient intake, but very 
limited data on meal patterns. People belonging to higher social classes tended to have 
healthier diets. Those with higher education with the exception of the South consumed more 
vegetables and fruits and less fats and oils.  However, they also ate more cheese. The 
socioeconomic differences in food consumption were not homogenous across Europe. The 
nature and magnitude of food-related disparities should be taken into account in planning 
food and nutrition policies and dietary interventions aimed at promoting health among 
underprivileged population groups.
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Meal patterns and eating outside home (1995-) 
 
Food is eaten as meals and snacks, not as single food items or nutrients. Therefore, 
knowledge on meal patterns is relevant for nutritional educators and health policy planners. 
The first meal projects, launched in the mid-90s, dealt with the definitions of the meal and 
other eating occasions and with the association of daily meal patterns with food 
consumption and nutrient intake. In Finland there is a long tradition of eating at a staff 
canteen which may be related to women's participation in the workforce. Frequent 
consumption of foods prepared outside home can lead to unhealthy diets. However, staff 
canteens can improve employees' diets by offering servings that are balanced according to 
dietary guidelines. The project "Eating patterns during working hours among Finnish adults" 
was launched in 2002. The project will explain variation between population groups in 
eating patterns by socio-demographic factors (education, family status, place of residence) 
and working conditions. The prevalence of staff canteen use in 1979-2001 and associations 
between canteen use and quality of diet will be assessed. 
     The data derive from repeated cross-sectional surveys collected by the National Public 
Health Institute and the Institute for Occupational Health. The Finnish habit of having a mid-
day lunch at the canteen of one's respective workplace has resisted major changes in 
working and living conditions and social structures during the past two decades. Socio-
demographic differences in the use of staff canteen have remained stable. The use of staff 
canteen is largely determined by the size of workplace and by the employee's education: 
staff canteens are used more often at large workplaces and in higher educational groups. 
The analyses suggest that lunches eaten at the workplace canteen can improve the nutrient 
quality of the diet. 
11.2.6 Tobacco use, prevention and cessation 
The main tobacco research areas in KTL are: tobacco use and diseases, tobacco use pre-
vention and tobacco dependency and cessation. KTL monitors tobacco dependency and 
use among adults at the national level, carries out several risk assessment and mortality 
studies on tobacco-related diseases, e.g. smoking as independent risk factor of diabetes, 
and studies the differences in tobacco use (both smoked and snuff) between Finland and 
Sweden. The aim has been to respond to the current tobacco control needs. Vulnerable 
groups have been identified and specific studies directed at these groups (e.g. pregnancy 
period, young adults). In several studies methods for prevention of smoking have been 
evaluated (European Smoking Prevention Framework approach, ESFA and co-morbidity 
prevention programme SYKE). These studies have shown that tobacco use is linked with a 
wide range of environmental and behavioural risk factors like poor schooling or low parental 
attendance. Tobacco dependency and cessation is a new area with both quantitative ap-
proaches to measure physiological, psychological and social dimensions of addiction at 
population level, and qualitative methods that deepen our understanding of the underlying 
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mechanisms of tobacco use at individual level. In addition attitudes toward smoking and 
cessation skills of health professionals have been studied. 
Tobacco use and diseases 
The tobacco research group widely utilizes the existing data sources that include data on 
smoking and addiction, e.g. the National FINRISK Study, the Health Behaviour among Fin-
nish Adult Population Study and the Health 2000 Study. Tobacco use has marginalised and 
tobacco has become more of an indicator as well as an independent risk factor for diseases 
like diabetes or depression. For instance, in diabetes, smoking had a graded association with 
the risk of type 2 diabetes, and it remained significant after controlling for age and major risk 
factors. The adjusted hazard ratio was 1.22 (95% CI 1.04-1.43) among men smoking less 
than 20 cigarettes per day and 1.57 (1.34-1.84) among men smoking 20 or more cigarettes 
per day. Tobacco use is more common among people with lower socioeconomic status. 
There are also specific groups of interest. Athletes do not smoke and they serve as role mod-
els for children and adolescents on healthy lifestyles. However, in the mid-1990´s the use of 
snuff became popular in certain sports and seemed to spread within sports. There became a 
need to assess tobacco use more widely. The Health 2000 study gave an opportunity to com-
pare the tobacco use of athletes to that of a population-based sample of young adults. Snuff 
use was reported by 24.6% of the athletes (9.6% daily and 15.0% occasionally) and 3.7% of 
the controls (1.8% and 1.9%). Currently we are exploring the phase of young adulthood in 
respect of tobacco use, which is often neglected. Specific interest areas are psychosocial 
stress and its association to smoking. Another link to new threats, like snuff use, has been 
collaboration with the Swedish Public Health Institute to compare tobacco use between these 
two countries. This study shows that in Sweden, a new group of tobacco users has formed, 
never-smoking males using snuff, which underlines the importance of comprehensive tobacco 
control, not just a smoking policy. Tobacco can affect health throughout the life span. Vulner-
able groups include children, and parental smoking is the major source of environmental to-
bacco smoke for children of all ages. Understanding processes underlying parental smoking 
during the child´s growth will form a ground for preventive actions. There are two ongoing 
studies on the environmental exposure of children in Finland. 
Tobacco use prevention 
The first adolescents' smoking prevention programme was carried out in North Karelia in the 
1970´s with six schools participating. This two-year school and community-based smoking 
prevention programme had a significant effect on smoking between intervention and control 
groups. The 8-year follow-up results showed that at the age of 21 youths in the intervention 
group still smoked less compared to the control group. In 1997 the three-year smoking pre-
vention programme European Smoking Framework Approach (ESFA) was implemented in 27 
secondary schools in the Helsinki area (13 as intervention and 14 as control groups). The 
community-element of the programme included participation of parents, parish confirmation 
camps and dentists. Among baseline never-smokers, the programme had a significant effect 
on the onset of weekly smoking in the intervention group [OR=0.63 (0.45-0.90) p=0.009] 
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when compared to the control group. The third preventive programme concentrated on the 
known link between childhood mental disorders and smoking. SYKE was a school-based 
childhood life skills developing and problem solving programme based on a programme called 
FRIENDS, which is about preventing childhood anxiety and depression through the applica-
tion of firm cognitive behavioural principles and the building of emotional resilience. This pro-
gramme was implemented in three primary schools in the Helsinki area between 2006 and 
2007. The programme fit well into Finnish schools. Based on students' feedback, results 
showed that students learnt to recognize feelings and problem solving skills. 
Tobacco dependency and cessation 
Tobacco use is a dependence syndrome constituting of physiological, psychological and 
social components. The addictive substance in tobacco, nicotine, changes the structure of 
the central nervous system and initiates synaptic and cellular changes that underlie the mo-
tivational and behavioural alterations that culminate in addiction. Conditioned learning, so-
cial and psychosocial factors contribute to the formation and maintenance of tobacco addic-
tion connected with nicotine addiction. Psychological addiction develops slowly as the 
smoker starts to use tobacco for coping in emotionally difficult situations and as a reward 
from work or stressful events. The components of addiction interact and mediate with each 
other throughout the life course. In the National FINRISK 2007 Study, we have had a sepa-
rate, specific questionnaire for smokers and quitters (n=3500) with questions on tobacco 
and nicotine dependency, and internationally recognised instruments for assessing various 
aspects of tobacco dependency (e.g. NDSS, HONC). These will be validated for use in 
Finland. Along with this, a qualitative study of tobacco addiction with 70 interviews will study 
the interpretations of smoking, addiction and their health effects among smokers and ex-
smokers, with special interest in smoking-related pleasures during the life course. 
Cessation services are currently located within the health care system. The quality and con-
tent of the services have not been studied in Finland and therefore it was necessary to carry 
out multiprofessional research within health professions to locate the blockades for provid-
ing cessation and assess the need for new tools. Smoking prevalence among Finnish phy-
sicians is very low and the attitudes towards smoking are surprisingly neutral and the practi-
cal skills needed in order to encourage and help smokers to quit is lacking to a surprisingly 
high degree. Currently a new sample of working physicians and nurses is under analysis. 
Tobacco dependency and cessation studies aim at the development of tools for both smok-
ers and professionals. Therefore it is necessary to understand the underlying mechanisms 
of smoking and treatment of tobacco dependency. 
11.2.7 Healthy ageing 
Because of the worldwide ageing phenomenon of the population, Alzheimer's disease (AD) 
and other illnesses decreasing the functional capacity of the elderly have increasing public 
health relevance. Until recently, there have been no strategies available for e.g. the preven-
tion of AD. Definition of modifiable risk factors for impaired functional capacity and devel-
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opment of effective prevention models are needed. Recent projects concentrate on the as-
sociation between cardiovascular risk factors at midlife, and dementia and Alzheimer's dis-
ease at late life, the aetiology of cardiovascular disease among women and the health and 
functional capacity of war veterans. 
Cardiovascular risk factors, Aging and Dementia (CAIDE) (1998-) 
The CAIDE study examines the role of environmental factors from midlife to old age to-
gether with genetic factors on the development of cognitive impairment and Alzheimer's 
disease, and sheds some light on the pathophysiological processes leading to dementia. 
The ultimate goal of this research project is to find modifiable risk factors for Alzheimer's 
disease and to open new avenues for its prevention. 
    The CAIDE study is a large, longitudinal, population-based study investigating the role of 
vascular, lifestyle, and genetic factors in the development of dementia/Alzheimer's disease 
and mild cognitive impairment (MCI). Since the baseline assessments of vascular risk fac-
tors and health behaviour in 1972-1992, two follow-up studies have been carried out. The 
CAIDE study is one of the very few studies in the world having a large and representative 
population-based cohort including both males and females, a long follow-up time, and 
measurements of several risk factors and health-related outcomes from midlife and late-life. 
    The CAIDE study has shown that high systolic blood pressure and high serum total cho-
lesterol at midlife are significant risk factors for late-life Alzheimer's disease. Our recent find-
ings indicate that midlife obesity, high cholesterol, and systolic blood pressure were all sig-
nificant risk factors for dementia with ORs of around 2 for each factor, and they increased 
the risk additively (OR 6.2 for the combination). We have also recently reported that per-
sons participating in leisure-time physical activity at least twice a week at midlife had a 50% 
lower risk for dementia and a 60% lower risk for AD compared to the sedentary persons. 
    Based on the risk factors that are found to be significantly associated with the risk of de-
mentia, a composite dementia risk score was developed. The risk score is similar to existing 
cardiovascular or diabetes risk scores. The aim is to provide a tool for estimating the risk of 
dementia for an individual, and thereby also to increase the awareness of what can be done 
in terms of prevention of Alzheimer's disease/dementia. The research is a scientific collabo-
ration between KTL and the University of Kuopio from Finland and Karolinska Institutet from 
Sweden and funded by the Academy of Finland, the American Alzheimer Association, the 
University of Kuopio, Karolinska Institutet and KTL. 
Ageing Women in Eastern Finland (ITSYT) study (1992-) 
Due to the lack of knowledge about cardiovascular health and related health behaviour 
among ageing women in the 1990's, the project started to examine the development of life-
style-related biological and behavioural risk factors of cardiovascular health among ageing 
women. The 10, 12 and 20 year follow-up examinations of a cohort of 50 to 60 year old 
women, who participated in the FINRISK Study in 1972, have included comprehensive as-
sessments of health behaviour and biological risk factors, and most recently also mental, 
physical and social capacity. The recent results show that the metabolic syndrome increased 
110
  
 
from 13% to 46 % among 60 to 70 year old women in 12 year follow-up, and the increase in 
carotid intima-media thickness was two times greater in those who developed metabolic syn-
drome. Furthermore, even a slight (0-1mg/l) increment in serum high sensitivity C-reactive 
protein level was associated with an increased (4.5 fold higher) risk of developing metabolic 
syndrome. The focus of future analysis is on functional capacity and nutrition. The study has 
contributed to the knowledge on the determinants of cardiovascular health on ageing women. 
However, more research is needed on the factors influencing female ageing. The project has 
been carried out in collaboration with the National Public Health Institute, the Kuopio Re-
search Institute of Exercise Medicine and the University of Kuopio. 
FINE-study in collaboration with the SEVEN COUNTRIES and the EAST-WEST studies 
(1984-) 
Two cohorts of Finnish men born in 1900-1919 were included in the Seven Countries Study, 
which started in the late 1950's. The Study demonstrated the link between dietary-related 
serum total cholesterol and coronary heart disease. The follow-up of the original Seven 
Countries Study is still continuing. The regular follow-up of the Finnish cohorts (the EAST-
WEST study) has been organized since 1959, and the results have been widely reported in 
scientific journals. The FINE study (Finnish, Italian and the Netherlands Elderly Study) 
started in the late 1980's in collaboration with the three countries. The aim was to find the 
lifestyle and biological factors, collected in the framework of the Seven Countries Study at 
middle-age, that predict cardiovascular health and functional capacity at old age. The re-
sults from the pooled data show e.g. differences in coronary heart disease and in physical, 
mental and social capacities between men born in different parts of Europe. Along the age-
ing of the men the focus of the analysis has changed towards older age. The FINE study 
has been part of the European HALE project in the late 1990's. 
The Veteran Project 
In 1992, a survey on Finnish war veterans initiated by the Ministry of Social Affairs and 
Health was carried out. The aim was to collect information on war veterans' living condi-
tions, health, use of health and rehabilitation services and their additional service needs. 
The survey was linked to a development project where the aim was to find those veterans 
whose rehabilitation, social and health services were inadequate and to inform the local 
authorities in municipalities about their needs. The Veteran Project was continued in 2004 
when a follow-up survey was conducted among a randomly selected sub-sample of veter-
ans. The follow-up study showed that the health, functional capacity and living conditions of 
war veterans had improved. 
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11.2.8 Chronic disease risk factors and prevention 
Cardiovascular disease risk factors and related health behaviour in the Republic of Karelia, 
Russia (1991-) 
The border between Finland and Russia marks one of the sharpest differences in living 
standards and also in health in the world. Before the break-up of the Soviet Union, the Re-
public of Karelia in Russia was a very isolated area. Non-communicable diseases (NCD) 
and especially cardiovascular diseases (CVD) represent the major health burden in the 
area. In 1991, collaboration on NCD prevention between the Republic of Karelia and 
Finland was started. One of the main aims in the collaboration was to build up an interna-
tionally comparable health monitoring system to serve the needs of health promotion and 
health policy planning in the republic. Survey activities are carried out in the selected dem-
onstration area, the Pitkäranta district, aiming at a monitoring system in the whole republic 
later. In addition to policy and health promotion purposes, the collected data have been ac-
tively used for epidemiological research. 
    Risk factor surveys conducted in Pitkäranta in 1992, 1997, 2002 and 2007 have followed 
the WHO MONICA protocol and later the new recommendations of the European Health 
Risk Monitoring project.  According to the population surveys in Pitkäranta, the cardiovascu-
lar risk factor levels in the area are high, i.e. about 65 % of men were daily smokers, more 
than 50 % of population could be regarded as hypertensives and 12 % of men and 34 % of 
women could be regarded as obese (BMI > 30 kg/m2) with no real improvement in the 
situation in ten year follow-up. 
    Health behaviour surveys following the idea of the Finnish Health Behaviour among Adult 
Population Survey were carried out in Pitkäranta in 1994, 1996, 1998, 2000 and 2004. Sur-
veys were conducted by mailed self-administered questionnaire. In the Pitkäranta region, 
some unfavourable trends in health behaviour can be observed. Smoking among women is 
increasing, total physical activity is decreasing and obesity rates are increasing. 
    Similar risk factor and health behaviour surveys have also been carried out among the 
youth in Pitkäranta in 1995 and 2004. Surveys show that the biological cardiovascular risk 
factor levels are not yet very high, but some unfavourable trends are seen in health behav-
iours. For example, smoking among girls has doubled from 7% to 15% in Pitkäranta in ten 
years and alcohol consumption has increased both among boys and girls. 
Karelian asthma and allergy survey (1997-) 
An intense search has been going on to find factors responsible for the asthma and atopy 
epidemic in Western societies. Saprophytic bacteria in the gut and environment might play a 
crucial role in immunomodulation in early life. Not only viable microbes but also nonviable 
microbial components, such as LPS, peptidoglycan, and bacterial DNA, are recognized by 
the innate immune system, leading to immune responses that might have immunomodula-
tory potential. In affluent Western societies characterized by living in apartment houses in 
environments heavily covered with asphalt, exposure to such micro-organisms has been 
dramatically reduced. In 1998, we carried out a study among adults in the province of North 
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Karelia, Finland, and in the Pitkäranta district, the Republic of Karelia, Russia, to examine 
the occurrence of atopy and atopic disease. These areas are geographically adjacent but 
differ fundamentally in living conditions. We found significant differences between the Finns 
and the Russians in the occurrence of asthma and atopy. In Finland 34.3% and in Russia 
23.3% of the study population was atopic (p<0.001). Also, the association between markers 
of infections and occurrence of atopy was investigated, revealing that H. pylori alone can 
explain 32% of the difference in atopy between the countries. 
    The study was continued in 2003 by surveying 7-15 year old children and their mothers to 
examine the occurrence of atopy and atopic disease. We wanted to examine whether any 
signs of increasing prevalence of atopy, a proxy for westernization, are discernible in the 
Republic of Karelia, Russia, by assessing generational differences in atopy prevalence. In 
children a 4-fold higher risk for atopy (positive prick test result) was found in Finland com-
pared with Russia. Sensitization rates in Finland were generally higher among children 
compared with those of their mothers, whereas in Russia the opposite trends emerged. Pa-
rental farming in early life (<1 year) in Finland (OR 0.53; 95%CI 0.28-0.99) and in Russia 
(OR 0.47; 95%CI 0.22-1.03) and currently in Finland (OR 0.45; 95%CI 0.22-0.91) conferred 
protection against atopy. In this study, genetical analyses are also carried out, and samples 
of dust from households and water from main water supplies in the area (schools, wells 
etc.) were collected. 
    In 2007, the study is continued by surveying 25 to 54 year old adults in North Karelia and 
Pitkäranta. The survey includes a questionnaire similar to the one used in 1998 survey, 
blood sampling for IgE analyses and as a new component a measurement of nitrogen oxide 
from exhaled air. The aim of this study is to follow-up using comparable data sets the de-
velopment of the prevalence of asthma and allergy in these two geographically adjacent 
areas with fundamental differences in living conditions and lifestyles. This study has been 
carried out in collaboration between the Helsinki University Skin and Allergy Hospital and 
the National Public Health Institute.
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Table 11. 1 Summary of main scientific achievements during 1997-2006 
Scientific output  N  Comments  
Original articles and re-
views in international peer-
review journals  
225    
Original articles and re-
views in domestic peer-review 
journals  
44    
Textbooks and chapters 
in textbooks, reports and 
proceedings  
93  e.g. Finbalt, Quit and Win and ENYPAT reports  
Theses  PhD 4 Master 8  
E Roos 1998, T Laatikainen 2000, M Laaksonen 2002, M Paavola 2006 
S Juka 1997, L Uusitalo 1997, E Mäkipää 1998, K Koski 2000, T Kinnunen 
2001, M Kallio 2006, T Vlasoff 2001, H Konttinen 2007  
Organization of scien-
tific meetings and conferences  5  
Monitoring health behaviours 2001, Research and expert meeting on 
Health lifestyles 2004, WCTOH pre-conference 2003, WCTOH 2003, 
EURONCD 2005  
Presidencies and mem-
berships in scientific commit-
tees of international meetings  
7  
AGEV, public health and nutrition (Berlin 1997), Global behavioural 
monitoring (Tuusula 2001, Uruguay 2005), WCTOH (Helsinki 2003), 
EURONCD (Helsinki 2005), International Association of Intellectual Disability 
Studies (European Conference 2006), Nordic Conference on Public Health 
(Östersund 2008)  
Presidencies and mem-
berships in other scientific 
committees  
6  
Finnish Physical Exercise Scientific Board, Research Advisory Board of 
Social Insurance Institution of Finland, Women's Research Fund, North Karelia 
Project Research Foundation Board, Scientific board of the Finnish Centre for 
Health Promotion, Executive board of the DPPH doctoral programme  
Invited lectures and 
chairmanships in international 
meetings  
32  
e.g. Global Behavioural Monitoring (Atlanta, Noosa), WCTOH 2003, 
Conference of the Asia-Pacific Academic Consortium for Public Health 2004 
(APACPH), Scandinavian Pulmonology Conference 2007, the European Union 
for School and University Health and Medicine (EUSUHM) 2007, World Con-
gress of Behavioural and Cognitive Therapies in Barcelona 2007 (WCBCT)  
Lectures in domestic 
scientific meetings  
about 
100    
Editorial tasks in inter-
national peer-review journals  2  
Editorial board of the Journal of Food Service, Editorial group for the 
short scientific reviews in Finnish Medical Journal  
Opponent of dissertati-
on  7  6 PhD + 1 Lic Thesis  
Supervision of disserta-
tions  28   
Review of PhD thesis, 
evaluation of docentship or 
professorship  
18  10 PhD theses, 6 docentships and 2 professorships  
Review of scientific pa-
pers  
about 
100  
e.g. for journals like Eur J Public Health, Appetite, Public Health Nutri-
tion, Scand J Public Health, Nicotine & Tobacco Research, Patient Counseling. 
Alcohol and Alcoholism, Alcohol Clin Exp Research  
Research visits to/from 
international research insti-
tutes or universities  
6  
Tiina Laatikainen, University of Deakin and University of Flinders, Aus-
tralia,Marjaana Pennanen, University of Maastricht, Norbet Hirschhorn, Univer-
sity of Minnesota, Olanre Onibogi, Nigeria, Aida Pilav, Federal Public Health 
Institute of Bosnia and Herzegovina  
Iveta Pudule, Latvian Public Health Institute  
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11.3 The main public health achievements 
11.3.1 Health lifestyles and inequalities 
The research project "Behavioural and Psychosocial Determinants of Health Inequalities" 
contributes to the planning of Finnish health policies. The researchers of the group have 
several expert functions in the TEROKA (Reducing Socioeconomic Health Inequalities in 
Finland) project. TEROKA, launched in 2004, aims to increase awareness of health differ-
ences and develop measures for promoting health equality in practice. One task is to collate 
information for the assessment of the current state and trends in inequalities in 
health. TEROKA includes a partnership network that disseminates information to decision 
makers and other actors both at the local and the national level. 
    TEROKA has catalysed various activities. A memorandum prepared by TEROKA was 
presented to the group of ministers responsible for social policy. In 2006 the group of minis-
ters delegated the Ministry of Social Affairs and Health preparations for a national action 
plan to tackle health inequalities in Finland. The national plan aims to identify the policy ar-
eas and measures required to achieve the national target to reduce socioeconomic differ-
ences in health. Representatives from several administrative sectors, local government, the 
health service system, NGOs and professional organisations, and health research institutes 
are involved in the preparation. TEROKA is also taking part in the preparation. Expertise 
provided by the research project on behavioural and psychosocial determinants of health 
inequalities is utilized in writing the corresponding chapters of the action plan. 
  For the public health achievements of food research and the Finbalt health monitor 
see "Development of Health Monitoring Systems" and "International Health Promotion". 
11.3.2 Tobacco control  
KTL experts are involved in many tobacco control activities and carry out various expert 
functions in this field. They serve as experts in policy preparations in tobacco control carried 
out by the Ministry of Social Affairs and Health. KTL produces annual figures indicating to-
bacco consumption that are available in Tobacco Statistics and Health Behaviour and 
Health among Finnish Adult Population and publishes Tobacco Control Report every third 
year. One of the key functions is also to support and provide expert help to public health 
organisations by passing latest research information and developing tools for health profes-
sionals and for the people. 
The public health tasks for tobacco dependency and cessation are to inform the population 
about the health hazards of tobacco, support quitting, provide tools for the population and 
professionals, and support the maintenance of smoke-free life. KTL has been active in 
building networks to produce information channels for the population. National Quitline 
Stumppi and web-cessation site www.stumppi.fi have been built by the KTL tobacco group. 
Also, an information site has been built on the KTL web-pages and the team is actively par-
ticipating in the construction of a citizen's health portal. Other activities include participation 
in campaigns by non-governmental organizations, developing tools for quitters and taking 
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part in actions promoting smoke-free adolescence. Training health professional to screen 
smokers who are willing to quit and then advising them properly has been one major task 
for tobacco control work. These items support each other and our vision is to build a seam-
less chain of care for those willing to try quitting. 
Tobacco control work is highly international. Current WHO/ EU activities include: 1) 
WHO/GARD (a comprehensive approach to fight chronic respiratory diseases, where KTL is 
a national representative, 2) SCIII-WHO Collaborating Centre for the Epidemiology of Envi-
ronment Related Diseases, where KTL acts as an expert in environmental tobacco smoke 
and 3) WHO/EURO, Children's Environment and Health Action Plan for Europe (CEHAPE), 
where expertise in environmental tobacco smoke is provided. 
11.3.3 International tobacco control networks run by KTL 
Tobacco control work and research demands close collaboration with European Community 
and EU programmes and WHO. KTL has been responsible for several international collabo-
ration programmes. 
The International Quit&Win network consisted of national coordinators representing ap-
proximately 130 countries all over the world. The network was coordinated from KTL in 
years 1994 - 2006. In 1994, 13 countries belonging to the WHO CINDI (Countrywide Inte-
grated Noncommunicable Diseases Intervention Programme) network participated in the 
first International Quit&Win. In 1996, 25 countries and a total of 70,000 smokers partici-
pated, and in May 1998 already 48 countries and over 200,000 smokers all over the world 
took part in the contest. Quit&Win 2000 was the largest practical global smoking cessation 
campaign ever carried out with a total of 426,000 participants from 69 countries. Since then 
Quit&Win grew even further with the number of participants reaching 675,000 in 2002, 
690,000 in 2004 and 630,000 participants from 86 countries representing all WHO regions 
in Quit&Win 2006. Evaluation of Quit&Win campaigns has shown Quit&Win to be a very 
cost effective smoking cessation method. 
The European Network on Young People and Tobacco (ENYPAT) was hosted by the Na-
tional Public Health Institute (KTL) during 1996-2006. ENYPAT was a network for special-
ists working in the area of tobacco control among youth and it aimed to prevent tobacco use 
by young people through Europe-wide collaboration, information exchange and programme 
building. It was co-funded by the Public Health Programme of the European Union. 
ENYPAT coordinated smoking prevention and cessation programmes concerning young 
people. ENYPAT programmes were interventions organized in all European Union Member 
States and every year more than half a million youngsters participated in them. With the 
programmes and research projects ENYPAT organized a one-week Spring School for pub-
lic health experts six times, produced common tools and methods for tobacco control in 
Europe, published a bilingual newsletter, Internet site, reports and information sheets. The 
network had about 2,000 members. 
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Smoking cessation on the internet in the European Union Countries from the Public Health 
Programme of the European Union: "A web-based Evaluation Tool for evaluating quality of 
smoking cessation websites and best practices guidelines" has been run in years 2005-07. 
The project consisted of an overview of smoking cessation websites in the European Union 
area in 2005; an analysis of smoking cessation websites in some European Union coun-
tries; a web-based Evaluation Tool for evaluating quality of smoking cessation websites and 
best practices guidelines for identifying background, definition, justifications and high quality 
standards for smoking cessation websites. 
11.3.4 Development of health monitoring systems  
Development of Child Health Monitoring System (LATE) (2006-) 
There is a lack of information on the health status of Finnish children. At the moment the 
development of a system to monitor health in childhood is one of the priorities in Finland. 
The National Public Health Institute is accomplishing the Development of Child Health Moni-
toring -project, which is a part of a larger project conducted by the Ministry of Social Affairs 
and Health. This project aims to develop a comprehensive children's health monitoring sys-
tem in Finland, including data collection from child health clinics and school health care set-
tings and separate health surveys conducted among children. The purpose of the project is 
to develop recommendations and practical tools for data collection. One main target of the 
project is to test the system of standardized data collection in different circumstances in 
child health clinics and school health care settings. The LATE project aims to define indica-
tors which are important in regard to children's health and public health and are based on 
earlier studies of children's health, on national recommendations for child health care and 
school health care and on expert opinion. The National Public Health Institute will conduct a 
pilot study in 10 municipalities around Finland to evaluate standardized data collection in 
spring 2007. The purpose is to have a systematic data collection system of children's health 
and welfare in Finland which allows collecting comparable data over time and looking at 
national trends in the status of children's health. 
In 2002, the government made a decision that Finland should have a nationally interoper-
able electronic patient data system by the end of the year 2007. Based on experiences re-
ceived in the LATE pilot study, the definitions of the nationally recommended core informa-
tion of children's growth and development will be made. 
Development of a monitoring system of catering services (2002-) 
    The Finnish large-scale catering kitchens of schools, cafeterias, restaurants, old people's 
and children's homes, hospitals, workplaces etc. serve some 150 meals per person per 
year. In order to evaluate and improve the quality of the meals, the providers of catering 
services and the decision makers of nutrition policies have expressed the need for timely 
information on meals served outside the home. The project on catering services, launched 
in 2002, will describe the use and quality of food services provided by institutional kitchens 
and develop monitoring of these services. The project is based on existing data. The na-
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tional health surveys chosen for secondary analyses cover age groups from school children 
to the elderly and include questions on meals eaten outside the home. The surveys are 
regularly conducted by KTL, the Finnish Institute of Occupational Health and STAKES. The 
ongoing project has shown that it is feasible to produce information requested by providers 
and planners of catering services from current health monitoring systems. Analysing and 
complementing the existing data with a few additional measures is a cost-effective way to 
serve the experts, to broaden the use of monitoring data and to create new forms of col-
laboration between the food and health sectors. 
11.3.5 International Health Promotion 
CINDI Finland (1984-) 
Finland is a member state in the WHO EURO CINDI programme. The CINDI Programme 
(Countrywide Integrated Noncommunicable Disease Intervention) was developed in 1984. 
The aim of the CINDI programme is to develop and evaluate intervention strategies and 
methods for chronic disease prevention. Finland has been part of the CINDI network since 
the beginning in 1984. In Finland, the CINDI programme is coordinated in KTL in the De-
partment of Health Promotion and Chronic Disease Prevention, which is also a WHO Col-
laborating Centre for Noncommunicable Disease Prevention, Health Promotion and Moni-
toring. The Finnish CINDI Director is Professor Erkki Vartiainen. Practical coordination of 
the programme is carried out in his department in the Chronic Disease Prevention Unit. The 
Unit coordinates several CINDI activities such as the development of a health monitoring 
system in CINDI countries (CINDI Health Monitor) and the International training seminar on 
integrated noncommunicable disease strategies and prevention (Noncommunicable Dis-
ease Seminar). 
Finbalt and CINDI Health Monitor (1994-) 
The Finbalt Health Monitor is a system for monitoring health behaviour and its determinants 
in Finland and the Baltic countries. The collaboration was initiated in the early 1990s. The 
Health Behaviour and Health among the Finnish Adult Population survey (AVTK) provided a 
model for the Baltic countries. The collaboration has promoted exchange of information be-
tween researchers and public health experts and developed a feasible and cost-effective 
system for monitoring health behaviours. The Finbalt data are used to provide information 
for health policy decisions in all the partner countries. The results contribute to the evalua-
tion of health promotion and policies. They also increase public awareness on the national 
and local health situation when presented in the mass media. In addition, the data and the 
results are widely used in the education and training of public health experts. The Finbalt 
model has provoked wide interest elsewhere in Europe and also on other continents. The 
model has been applied for example in the CINDI project coordinated by the WHO Regional 
Office for Europe. The CINDI Health Monitor system is based on the Finbalt Health Monitor. 
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Public health collaboration in Russia (1991-) 
The neighbourhood area collaboration in the area of chronic diseases was started between 
the National Public Health Institute and the Ministry of Health in the Republic of Karelia in 
1991. The Pitkäranta district has been the special demonstration and collaboration area in 
the health promotion programme. Mortality and morbidity from non-communicable diseases 
(NCD's) and injuries are markedly higher in Russia than in Western-European countries and 
in the remote areas like the Republic of Karelia the situation is even worse. High NCD mor-
tality is explained mainly by cardiovascular diseases (CVD). Injuries are the main killer 
among young and middle-aged adults. In addition to National Public Health Institute and the 
Karelian Health Ministry, the North Karelia Centre for Public Health in Finland and the Cen-
tral Hospital of Pitkäranta have been the key stakeholders in the collaboration. The aims of 
this collaboration are to reduce chronic disease mortality and morbidity, to develop a health 
monitoring system (risk factors and health behaviour) and to increase the capacity of the 
local authorities to plan and implement preventive action and health promotion. Several 
research, educational and intervention activities have been organized in collaboration in-
cluding risk factor surveys, health behaviour surveys, school surveys, asthma and allergy 
surveys, medical conferences and other training seminars and sessions, pilot interventions 
including for example Quit and Win smoking cessation contests and intervention in non-
pharmaceutical treatment of cholesterol and hypertension. One of the recent intervention 
activities is an ongoing school and community-based "Together Against Substance Misuse" 
project (2006-2008) that aims to prevent the use of alcohol and tobacco among youth and 
to develop a frame of action that can be utilized in the whole republic in the future. Some of 
the activities are described in section 11.2. 
Public Health project in Bosnia and Herzegovina (2002-2003) 
A development project for capacity building, establishment of health monitoring systems 
and development of tobacco control strategy for the Federal Institute of Public Health in 
Bosnia and Herzegovina was coordinated by KTL. The project included four major compo-
nents: management support, development of mortality register, establishment of health 
monitoring system among both adults and children and development of tobacco control 
strategy. Several experts from different departments in KTL, the Ministry of Health and So-
cial Affairs and the Cancer Society collaborated in the project. During the project for exam-
ple the first risk factor survey and health behaviour among school children survey were car-
ried out. Research collaboration with the Federal Public Health Institute in BiH continues. 
11.3.6 International conferences and training 
The 12th World Conference on Tobacco or Health (WCTOH) and pre-conference training 
(2003) 
The 12th World Conference on Tobacco or Health (WCTOH) took place in Helsinki, Finland, 
on 3-8 August 2003. The three main organisers of the conference were the National Public 
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Health Institute, the Cancer Society of Finland and the Finnish Centre for Health Promotion. 
The mission of the WCTOH 2003 was to carry on the important task of motivating and em-
powering advocates, policy makers, researchers and academics involved in tobacco con-
trol. KTL was responsible, among other things, for the scientific programme and organising 
of the pre-conference training of the 12th World Conference on Tobacco or Health for 72 
students from developing countries. The programme was organised jointly by KTL and the 
US Public Health Service represented by the Centers for Disease Control and Prevention, 
the Office of Smoking and Health (CDC) and the American Cancer Society (ACS). The net-
working and coalition-building started prior to the training and still continues. The global 
FCTC treaty took important steps toward implementation. Strategic work will continue, bet-
ter equipped and with new leaders in tobacco control. 
As a part of the WCTOH 2003 pre-conference training, a networking meeting, "Strengthen-
ing collaboration and networking in tobacco control", for neighbouring countries (Estonia, 
Finland, Latvia, Lithuania, and Russia) was organized on August 7, 2003 in Helsinki, 
Finland and a follow-up meeting, "EU-coordination Meeting in Tobacco Control", took place 
on February 28, 2004, in Tallinn, Estonia. At these meetings issues like prospective strate-
gic measures and current challenges in tobacco control were discussed. Tobacco pro-
grammes in the EU Public Health programme were introduced, as the Baltic countries were 
joining EU at that time. This project strengthened the close collaboration between Finland, 
the Baltic countries and Russia in public health with a special focus on tobacco. 
Monitoring Health Behaviour - Towards Global Surveillance (2001) 
The 2nd global conference on behavioural monitoring was organized in Tuusula, Finland on 
October 1-3, 2001. The aim of the conference was to promote global networking of re-
searchers, public health experts and institutions, as well as to discuss theoretical and prac-
tical uses of health behaviour monitoring/surveillance systems. The conference was organ-
ised by KTL in collaboration with CDC (USA). 
European NCD Conference (2006) 
The conference was organised by the National Public Health Institute and held in Helsinki, 
Finland on 8th-10th December 2005. By reviewing the progress and experience of chronic 
disease prevention in the European region over the past, the conference gathered the best 
available knowledge on good practices, pros and cons of in-depth health impact assess-
ment, and how to improve the use of other policies to enhance health and reduce dispari-
ties. The conference discussed the theory and practice of chronic disease prevention in the 
population, proposed effective strategies and actions for chronic disease prevention on dif-
ferent levels, contributed to the development of the new WHO European NCD strategy in 
2006, and as such, provided background information for the Finnish EU presidency work on 
health. The Helsinki conference hosted 193 participants from 45 countries. First and fore-
most the audience consisted of public health experts, researchers and decision makers 
from around the world. 
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North Karelia Project and WHO CINDI network training seminars (1982-) 
The North Karelia Project is a well known example of a community-based chronic disease 
prevention programme. The experience of the North Karelia Project has been of great inter-
est internationally. Since 1979 training seminars called the North Karelia Project interna-
tional visitors' programme have been organized twice a year to share the experiences and 
results of the North Karelia Project. The seminar reviews the experiences of the North Kare-
lia Project in planning, implementation and evaluation of prevention interventions. Between 
1997 and 2006 twenty training seminars were organized. In each seminar there were be-
tween 20 and 45 participants. 
As part of the collaboration with the WHO/EURO office and as an activity of WHO collabo-
rating centre WHO CINDI Winter School seminars have been organized once a year since 
1997. The last seminar was organized in 2006. These training seminars have concentrated 
on practical aspects of chronic disease prevention, including programme planning, imple-
mentation of interventions, health policy and national and international collaboration. Train-
ing has been planned and organized by the international faculty. Between 1997 and 2006 
ten one-week training seminars were organized. There were 20-45 participants in each 
seminar. 
As the new European NCD strategy was launched in 2006, the North Karelia project visitors' 
programme and the WHO CINDI Winter School were reformulated into a new concept to 
better address the new strategy and the need for its implementation. The NCD Seminar is 
an international training seminar on integrated noncommunicable disease strategies and 
prevention. The seminar is organized yearly in collaboration with the WHO Regional Office 
for Europe and the North Karelia Centre for Public Health. The programme includes a three-
day interactive training in the National Public Health Institute in Helsinki and a two-day site 
visit in North Karelia. During the first three days examples of the global, European and na-
tional NCD strategies are reviewed and theories, methods and examples of chronic disease 
prevention are discussed using also the North Karelia Project experiences as an example. 
The seminar is aimed at health authorities and health professionals working with national 
NCD strategies and prevention programmes. Training is given in English by international 
experts. This new concept was launched in January 2007 and in the future will be organized 
once a year.
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Table 11.2 Summary table of committee memberships, coordination and proceedings with 
public health impact 
Public health output  N  Comments  
Articles and reviews in 
non-peer-review journals  
over 
50  
  
TV, radio, newspaper 
interviews  
over 
100  
issues like smoking cessation methods, environmental tobacco smoke, 
health consequences of smoking, trends in cardiovascular risk factors, results 
from risk factor surveys, Russian health situation, food habits, health inequalities 
Health education mate-
rial, websites, information 
databases  
20  www-pages of research and development projects, project handbooks, in-
tervention manuals and materials  
Membership in interna-
tional committees with public 
health impact  
11  e.g. Member of EFMA Tobacco Action Group, National Medical Associa-
tions in Europe 2006-, WHO/EURO CINDI Programme, WHO commission on 
social determinants of health, Nordic sub-group, 2006-, Nordic group on indica-
tors of health monitoring  
Membership in domes-
tic committees with public 
health impact  
about 
40  
e.g. Board of Finnish Health Promotion Association, Expert group for 
monitoring of catering services, Working Groups for Strategy and Action Plan to 
Tackle Health Inequalities in Finland, Working group for statute in child health 
clinics and school and student health care  
Coordination and/or 
implementation of develop-
ment projects  
15  e.g. Finbalt Health Monitor, Monitoring of catering services, TEROKA (to-
gether with KTL/ TTO, STAKES, TTL), Development of Child Health Monitoring 
System, Bosnia and Herzegovina Public Health project  
Coordination of public 
health networks  
3  EU network of Web cessation, ENYPAT, International Quit and Win  
Organization of interna-
tional training with public 
health impact  
47  
e.g. North Karelia Project International Visitors' Programme, CINDI Winter 
School, ENYPAT Spring School, International Quit and Win training seminars, 
Training seminars for behavioural monitoring, AMNET (Americas' Network for 
Chronic Disease Surveillance, Honduras 2006, Mexico, 2007), Baltic collabora-
tion network 2003-04  
Organization of domes-
tic training with public health 
impact  
8  
e.g. Global Health School, Health professionals and tobacco training 
seminars  
Lectures and training in 
expert meetings, universities 
and polytechnics  
about 
250  
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11.4 Funding for research and public health programmes 
Two senior posts in the Unit are funded by KTL budgetary funds. Other personnel costs are covered with external, mainly competitive funds. 
Some development funding from the Ministry of Health and Social Affairs is received for tobacco control and development of health monitoring 
activities. 
The sources of funding for all research and public health programmes are presented in the table belowin table 11.3 
 
Areas 
of research 
and public 
health activi-
ties 
N
ational 
public 
Health 
Insti-
tute 
Finlan
d 
Mini
stry of 
Social 
Affairs 
and 
Health 
Mi-
nistry of 
Education 
Mi-
nistry of 
Foreign 
Affairs 
Fin-
nish Insti-
tute of 
Occupa-
tional 
Health 
Aca
demy of 
Finland 
Eu-
ropean 
Union 
WHO 
Doc-
toral Pro-
gram for 
Public 
Health 
Corpo-
rate Funding
Inter-
national 
Collaborator
Research 
Foundation 
Health 
lifestyles and 
inequalities 
X X X  X X X  X   X 
To-
bacco use, 
prevention 
and cessation 
 X     X X  X X X 
Healthy 
ageing X X  X  X     X X 
Interna-
tional re-
search pro-
jects and 
health promo-
tion 
X   X  X X X    X 
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11.5 Personnel 
Since the establishment of the Unit in 2001 the amount of staff has varied between 14 and 
20. Most of the senior researchers working in the Unit have earlier been working in other 
units in the Department. 
Current Staff (May 2007) 
Tiina Laatikainen, MD, PhD, Adjunct professor/docent, Head of Unit, chronic disease epi-
demiology, health monitoring, Jan 1996- 
Samu Hakala, M.Soc.Sc., statistician, March 2006- 
Elina Hirvikallio, secretary, coordination of international training seminars, March 1991- 
Health lifestyles and inequalities 
Ritva Prättälä, PhD, Adjunct professor/docent, senior researcher, nutrition, sociology, Aug 
1995- 
Päivi Mäki, health education, M.Sc, specialist, March 2006-  
Tomi Mäkinen,  M.Soc.Sc., PhD-student, researcher, social policy, March 2006- 
Laura Paalanen,  M.Sc., PhD student, researcher,  nutrition, Aug 2003- (on maternity leave) 
Susanna Raulio, M.Sc.,  PhD student, researher,  nutrition, Nov 2002- 
Kirsi Talala, M.Soc.Sc., PhD-student,  researcher, social psychology,  Aug 2003- 
Tobacco control and research 
Kristiina Patja, MD PhD, medical specialist in health care, senior researcher, tobacco re-
search and control, Jan 2001- 
Hanne Heikkinen, M.Sc. in sociology, PhD student, researcher, Dec 2003- 
Marjaana Pennanen, M. Sc. in health sciences, PhD student, researcher, adolescents 
smoking prevention and cessation, Oct 2003- 
Patrick Sandström, BM, PhD student, researcher, health professionals and smoking cessa-
tion, Quit&Win (medical expert), Jan 2000- 
Ellen Tuomaala, M.Sc. in sociology, project coordinator March 2005- Jun 2007 
Sari Yrjölä, M.Sc., press officer (ETEO), ENYPAT project Manager 2004-2006 
Healthy ageing 
Aulikki Nissinen, MD, PhD, professor, retired, cardiovascular disease epidemiology, March 
2001 (retired June 2005) ( 
Sinikka Äijänseppä, MD, researcher, Jan 2004- (on maternity leave) 
International health promotion 
Hanna Heikkilä, M.Ed., project coordinator, Feb 2007- 
Miia Mannonen, project coordinator, May 2006- (on maternity leave) 
Anastasiya Rogacheva, MD, PhD student, researcher, health behaviour among youth, May 
2004- 
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11.6 National and international collaboration 
One of the main features of the Chronic Disease Prevention Unit is wide national and inter-
national collaboration. As a major part of the main activities in all areas (tobacco control, 
health inequalities and healthy ageing) is formed by expert functions in different working 
groups, committees and networks, a wide spectrum of national collaboration is required. 
The Unit coordinates several international research projects and public health networks 
such as ENYPAT, Quit and Win and Finbalt, and researchers also act as active members in 
various networks and research teams. 
11.6.1 Health lifestyles and inequalities 
All the projects of the group 'Health lifestyles and inequalities' include collaboration with 
other Finnish research institutes or public health bodies, the most important of them being 
the University of Helsinki, the other health research institutes (STAKES, TTL, UKK) and  the 
Ministry of Social Affairs and Health. The majority of the projects include a strong interna-
tional component, such as comparative research between European countries. The most 
important international partners are the Erasmus University of Medicine (Netherlands), the 
Kaunas University of Medicine and the Latvian and Estonian public health institutes (previ-
ously health promotion centres), the WHO Regional Office for Europe, and the Global Net-
work of Behavioural Monitoring. In research collaboration the Universities and research in-
stitutes have a significant role. In regard to public health activities the NGOs (e.g. the Fin-
nish Heart Association and the Centre for Health Promotion), the Ministries and local public 
health actors are more important.  The forms of collaboration include coordinating of and 
participating in projects, preparing scientific papers and collaborative reports, producing 
drafts for policy papers,  organising national and international conferences and training 
seminars, serving as advisors, teaching in the universities and giving expert lectures, as 
well as supervising and reviewing theses. 
11.6.2 Tobacco control 
Research projects on tobacco use and diseases are carried out together with the Depart-
ment of Public Health at the University of Turku and the Department of Mental Health and 
Alcohol at KTL as well as Karolinska Institutet and the Swedish Public Health Institute in 
Sweden. Studies on preventing tobacco use are carried out in collaboration with the De-
partment of Social Psychology at the University of Helsinki and studies on tobacco depend-
ency with the Department of Sociology and the Department of Public Health, University of 
Helsinki. Collaborators abroad include University of Edinburgh, UK, and University of Maas-
tricht, the Netherlands. 
Tobacco policy from legislative process to everyday practice is based on wide collaboration 
with organisations. The National Public Health Institute is an expert institute for the Ministry 
of Social Affairs and Health (STM) but collaborates with other ministries. There are devel-
opmental projects with municipalities, hospital districts and provinces. In public health, non-
governmental organisations (NGOs) are important collaborators and we have several initia-
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tives and programmes with public health NGOs and sports associations. We have devel-
oped tools for the general population which have been implemented and developed further 
in collaboration with NGOs, like the national Quitline and web cessation site with the Pul-
monary Association Heli and an adolescence web cessation site with the Cancer Society of 
Finland. In smoking prevention, the smoke-free class competition has originated from KTL 
and is now run by the Finnish Health Association. There is long-term collaboration with 
sports associations. Hospital districts have announced themselves smoke-free in recent 
years and KTL has been supporting this development by consulting and training. There has 
also been collaboration with large private companies when building smoking restrictions and 
support systems for quitting in companies. This work has been conducted in collaboration 
with the Finnish Occupational Institute and pharmaceutical companies. 
Tobacco-related training of health professionals is among the major tasks. In 2004, KTL 
initiated a collaboration project between KTL, the University of Kuopio and Savonia Univer-
sity of Applied Sciences in Kuopio. The project is financed by the Ministry of Health and 
Social Affairs. International cooperation with King Charles University, Czech republic, is 
ongoing, investigating international applications of the interactive internet-based smoking 
cessation tool for health professionals that have been developed in Finland. 
KTL tobacco personnel are represented in several working bodies of the EU and WHO such 
as the European Network of Quitlines (ENQ), the European Forum of Medical Associations 
and WHO (EFMA). 
11.6.3 Healthy ageing 
Healthy ageing research has been done in wide collaboration with both national and inter-
national research teams and institutions. The CAIDE Study is a scientific collaboration be-
tween KTL and the University of Kuopio from Finland and Karolinska Institutet from Swe-
den. The ITSYT study has been carried out in collaboration with the Kuopio Research Insti-
tute of Exercise Medicine and the University of Kuopio. The FINE study has been part of the 
larger European HALE project with collaborators from various European countries. Re-
search utilizing the data gathered in the Veteran Project is done in collaboration with Oulu 
Central Hospital and the University of Helsinki. 
11.7 Proposal for future work and expected benefits 
KTL has large population samples, which give good grounds for research. However, in de-
veloping preventive measures and tools, there is a continuous need for more detailed 
analyses of changes in lifestyles and chronic disease risk factors. Active development of 
pilot interventions and their evaluation as well as broader comparative analyses of the long-
term effects of interventions and national policies aiming to prevent chronic diseases and 
reduce inequalities in them are needed. 
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11.7.1 Tobacco control and research 
Tobacco control in Finland has been a success story and rates are in constant decline. 
However, smoking has become more socially discriminating, which requires new views, 
approaches and tools for successful tobacco prevention and cessation treatment. Future 
tasks for research include deepening our understanding of tobacco dependency syndrome 
and development of tools for smokers and professionals to support cessation and preven-
tion. A life-span approach to tobacco is urgent in both research and policy. New technolo-
gies will provide support, but their applicability, effect and efficacy are uncertain. KTL has 
been active in the development of new tools, and the task is to evaluate their effectiveness 
and role in tobacco control. The WHO Framework Convention on Tobacco Control, FCTC, 
and the EU tobacco policy will provide new tasks to cope with multinational tobacco industry 
activities. The aim is to maintain the declining trend and at the same time narrow the gap 
between socio-economic groups in all ages. 
11.7.2 Health lifestyles and inequalities 
The ongoing research on specific determinants of health inequalities analyses whether the 
effect of socio-economic position on mortality is mediated through behavioural and psycho-
social factors. Working conditions are closely related to socio-economic factors, such as 
occupation. The current funding does not allow analyses of the contribution of working con-
ditions. However, the data prepared for the project would require only minor editing to suit 
further analyses. As research on the contribution of working conditions to health at different 
stages of life is currently relevant in Finland, further studies are planned, in collaboration 
with the Finnish Institute of Occupational Health, on this theme. Working conditions will also 
be included in the future research on the nutritional significance of workplace lunches. 
    The earlier studies of the group have not analysed in detail the association between 
physical activity and other health behaviours, the main reason being weaknesses in meas-
urements of physical activity. The future studies will use data including more accurate 
measurements of physical activity. New studies will also be conducted on trends and socio-
economic differences in psychological distress. The combined effect of behavioural and 
psychosocial determinants on health inequalities is a future area that will require more re-
sources. 
    The major public health challenge of the group 'Health lifestyles and inequalities' is to 
contribute actively to the policies on health inequalities. The group contributes to the prepa-
ration of the national strategy and action plan to tackle health inequalities. After the comple-
tion of the strategy (Dec 2007), the group is prepared to provide information and expert 
consultations about the implementation of the action plan. 
11.7.3 Healthy ageing 
With the ageing of the population, preserving the functional capacity of the elderly popula-
tion has increasing public health relevance. Further knowledge on biological and behav-
ioural factors contributing to cognition and especially development of effective strategies to 
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prevent functional impairment are needed. In KTL a future challenge is to create a compre-
hensive research and development strategy on healthy ageing in collaboration with several 
departments. 
11.7.4 Development of health monitoring and risk prediction 
KTL has a long history in developing and organizing health monitoring. Experience gathered 
in the institute has also been utilized in international networks, and KTL consultants have 
assisted in developing similar health monitoring systems in various countries. Our future 
challenge is to improve the health monitoring of different population groups in Finland such 
as children and adolescents. The new public health law in Finland also mandates munici-
palities to follow the health of their population even by socioeconomic groups. This evidently 
creates challenges for KTL to develop standardized indicators, data collection systems and 
consultation networks to support the municipalities. 
The importance of forecasting future threats in public health like lung cancer and COPD 
among women, increasing health inequalities and deterioration of children's lifestyles will 
increase in next decade. In addition to health monitoring, the large population samples and 
cohorts can be more effectively utilized in the prediction of future health threats based on 
recent trends in risk factors and behaviour. 
11.8 Main publications 
The main publications are selected to widely represent the research carried out in the Unit, 
not only papers published in high-impact journals. 
Borodulin K, Mäkinen T, Fogelholm M, Lahti-Koski M, Prättälä R. Trends and socioeco-
nomic differences in overweight among physically active and inactive Finns in 1978-2002. 
Prev Med 2007; EPub. (Impact factor 2.195) 
Giskes K, Kunst AE, Benach J, Borrell C, Helmert U, Judge K, Lahelma E, Moussa K, Os-
tergren, Patja K, Platt S, Prättälä R, Willemsen M, Mackenbach JP. Applying an equity lens 
to tobacco-control policies and their uptake in six Western-European countries. J Public 
Health Policy 2007;in press. (Impact factor 1.405 ) 
Helakorpi S, Martelin T, Torppa J, Patja K, Vartiainen E, Uutela A. Did Finland's Tobacco 
Control Act of 1976 have an impact on ever smoking? An examination based on male and 
female cohort trends. J Epidemiol Community Health 2004;8(8):649-54. (Impact factor 
3.003) 
Kastarinen M, Laatikainen T, Salomaa V, Jousilahti P, Antikainen R, Tuomilehto J, Nissinen 
A, Vartiainen E. Trends in lifestyle factors affecting blood pressure in hypertensive and 
normotensive Finns during 1982 to 2002. J Hypertens 2007;25:299-305. (Impact factor 
5.218) 
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Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for 
the prediction of dementia risk in 20 years among middle aged people: a longitudinal, popu-
lation-based study. Lancet Neurol 2006 Sep;5(9):735-41. (Impact factor 11.231) 
Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the 
Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997. Am J Epi-
demiol 2005;162:1-10. (Impact factor 5.068) 
Laatikainen T, Manninen L, Poikolainen K, Vartiainen E. Increased mortality related to 
heavy alcohol intake pattern. J Epidemiol Community Health 2003;57:379-384. (Impact fac-
tor 3.003) 
Mackenbach, J. P. and M. J. Bakker for the European Network on Interventions and Poli-
cies to Reduce Inequalities in Health (R Prättälä). "Tackling socioeconomic inequalities in 
health: analysis of European experiences." Lancet 2003;362(9393):1409-14. (Impact factor 
23.878) 
Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of smoking, obesity and 
physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. J Int 
Med 2005;258(4):356-361. (Impact factor 4.040) 
Pelkonen M, Notkola I-L, Tukiainen M, Tervahauta J, Tuomilehto J, Nissinen A. Smoking cessa-
tion, decline in pulmonary funtion and total mortality: a 30 year follow up study among the Finnih 
cohorts of the Seven Countries Study. Thorax 2001;56:703-707. (Impact factor 6.150) 
Prättälä R, Paalanen L, Grinberga D, Helasoja V, Kasmel A, Petkevicience J. Gender dif-
ferences in the consumption of meat, fruit and vegetables are similar in Finland and the 
Baltic countries. Eur J Publ Health 2006;EPub.(Impact factor 1.118) 
Raulio S, Roos E, Mukala K, Prättälä R. Can working conditions explain differences in eat-
ing patterns during working hours? Public Health Nutrition 2007;in press.(Impact factor 
2.123) 
Roos E, Talala K, Helakorpi S, Laaksonen M, Rahkonen O, Uutela A, Prättälä R. 2007. 
Trends of socioeconomic differences in daily vegetable consumption,  1979-2002. Eur J 
Clin Nutr 2007;EPub. (Impact factor 2.163) 
Vartiainen E, Pennanen M, Haukkala A, Dijk F, Lehtovuori R, De Vries H. The effects of a 
three-year smoking prevention programme in secondary schools in Helsinki. Eur J Publ 
Health 2007;17(3):249-56.(Impact factor 1.118) 
von Hertzen L, Mäkelä M, Petäys T, Jousilahti P, Kosunen TU, Laatikainen T, Vartiainen E, 
Haahtela T. Growing disparities in atopy between the Finns and the Russians: A compari-
son of 2 generations. J Allergy Clin Immunol 2006;117(1):151-157. (Impact factor 7.667) 
129
  
 
12 INJURY PREVENTION UNIT 
12.1 Research and public health significance of the area 
The statistics on injury deaths show that deaths due to home and leisure-time injuries are 
more frequent in Finland than in the EU15 countries. Each year almost 3000 Finnish people 
die due to unintentional injuries, which translates into around 6 per cent of all deaths. Acci-
dents in the home and in leisure-time activities account for around 80 per cent of all these 
injurious deaths. All together, about 700,000 accidents in the home and in leisure time lead 
to injuries every year. Injuries at home, in sports and in other leisure-time activities are a 
major cause of death, lost working days, medical treatment and treatment costs. This rec-
ognition has raised an urgent need to strengthen the national capacity for injury prevention 
in new settings. 
During the past 30 years the injury situation in Finland has changed dramatically. Whereas 
over 1200 people were killed in road traffic accidents in 1970, the annual number of deaths 
has been below 400 in 2003 and the following years. Furthermore, the number of deaths due 
to occupational accidents has remained at a low level (around 50 annually). The challenge is 
to duplicate this positive development also in the area of home and leisure-time injuries. 
In August 2004, the Injury Prevention Unit was established at the National Public Health 
Institute (KTL). Scientists and officers representing universities, research organizations, 
insurance companies, NGOs (such as the Traffic Safety Association) and government de-
partments were invited to the Unit's advisory board. The advisory board meets twice a year 
to critically overview the activities and future plans of the Unit, promote networking and take 
national initiatives. 
The Injury Prevention Unit has its focus on promoting the prevention of home and leisure-
time injuries and raising awareness of injuries as a public health concern. The Unit pro-
duces and disseminates information on the incidence, risk factors and prevention of injuries. 
Priority areas include development of an information system for comprehensive injury moni-
toring and conducting interventions with other national parties, promoting and facilitating 
capacity building and supporting local work in the framework of WHO's Safe Community 
programme and improving multichannel communication and dissemination of information. 
The Unit has been an active partner in working groups and committees formulating national 
targets, action plans and strategies. In addition, the Unit ensures that policymakers and 
other decision makers in society as well as ordinary citizens have the best possible knowl-
edge for preventing injuries. When the Unit began its work, there was a lack of infrastructure 
support for this kind of activity in the field of home and leisure-time injuries, and it has been 
important to work with government departments and non-governmental organizations to 
establish such support. 
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12.2 The main scientific achievements 
12.2.1 Finjury - Monitoring of injury situation in Finland 
The establishment of appropriate injury databases has been the first step in the Unit's injury 
prevention research. Currently data from two national registers and from one national sur-
vey are used for research. The availability of data has created research cooperation within 
KTL and with other research organizations. 
12.2.2 Register-based study 
The goal of the study is to evaluate the incidence of serious injuries in Finland since 1971. In 
addition to incidence research, other major goals of the study are: evaluation of the reliability 
of information in national registries, development of indicators and of reporting formats. The 
main activity currently in this study is the development of a database that contains injury-
related information from the hospital discharge registry maintained at the National Research 
and Development Centre for Welfare and Health and the statistics on causes of death main-
tained at Statistics Finland. While these data contain valuable information on injuries, their 
limitations are widely recognized. Our aim is to investigate the value of other registries for our 
purposes in the future. The registries could be linked together by using the national ID number 
of Finnish citizens. By combining data from multiple registries, a unique database can be 
formed to serve as a basis for increasing information on long-term changes in injury incidence 
and identifying specific risks to develop well-targeted prevention programmes. The first ver-
sion of the database has been completed and it is currently being used internally in our group 
for the production of statistical information. We are planning to implement a public Internet-
based version of the database during the first half of 2007. 
12.2.3 National Victimisation Survey (Kansallinen UHRI tutkimus) 
The National Victimisation Survey is an interview study in which a statistical sample of the 
Finnish population is interviewed about injuries and crimes. The surveys have been con-
ducted in 1980, 1988, 1993, 1997, 2003 and 2006. The data were collected by telephone or 
face-to-face interviews with about 8,300 people aged 15 years or over. The interview ques-
tions in victimisation surveys relate to accidents, violence and attitudes concerning safety 
issues. The surveys conducted in 2003 and 2006 have been reported by the Injury Preven-
tion Unit and have been published in KTL's Publication Series B (B15/2005 and B4/2007). 
Based on these data, the Finnish population aged 15 and over experienced more than 
980,000 accidents or assaults that resulted in physical injury in 2006. Most of the cases 
were home, sports or other leisure-time accidents. The number of traffic accidents that re-
sulted in physical injury was about 58,000 and the number of work accidents about 194,000. 
In addition to several statistical reports produced for decision makers and for the general pub-
lic in print and on the Unit's internet pages, two master's theses has been written, one scien-
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tific article published (Lunetta et al 2006), two accepted (Lunetta et al 2006, Tiirikainen et al 
2007) and two submitted (Tiirikainen et al 2007, Lunetta et al 2007) based on the above data.  
12.2.4 Local injury prevention work 
To increase safety promotion activities at the local level is a long-term goal in several 
strategies, target programmes and action plans adopted by the Finnish government or by 
the government departments. These policy documents recognize that municipalities are 
responsible by law for local health and safety promotion, but the structures for such activi-
ties are not well developed. Furthermore the output evaluations carried out in Sweden and 
in Norway, in municipalities using the WHO Safe Community approach, have been encour-
aging. The WHO Safe Communities model provides a comprehensive approach to injury 
prevention and safety promotion in which a local infrastructure is created to address injury 
prevention and safety promotion initiatives. This approach emphasizes a structured way to 
conduct injury prevention activities, long-term sustainable programmes and targets aiming 
to reduce injuries and safety hazards in areas defined by the community itself and using 
local data to monitor changes. 
In 2006 the Injury Prevention Unit started a study to trace activity and organizational 
changes as well as health effects in two Finnish municipalities which have participated in 
national pilot programmes and developed injury prevention activities using WHO's Safe 
Community principles as their framework. The major goals of this research are to trace ac-
tivity changes in selected key areas of injury prevention work: 1) the creation of a local data 
source and monitoring system for documenting the frequency and causes of injury, 2) the 
formation of a cross-sectional group to govern and organize injury prevention and safety 
promotion activities locally, 3) the activation of local professionals and 4) to assess and dis-
cuss the health effects possibly due to organizational and activity changes at local level. 
The research is in the data collection phase. 
12.2.5 IKINÄ-Prevention of falls and fractures among older people 
Falls are a major cause of disability and the leading cause of mortality resulting from injury 
in people aged over 50 in Finland. One third to one half of people aged over 65 fall each 
year. Annually up to 1200 older adults die as a result of a fall and approximately 7000 older 
people sustain a hip fracture. Falling, therefore, has a great impact on the quality of life, 
health and healthcare costs. 
Effective evidence-based fall prevention interventions need to be developed and imple-
mented into the health care system throughout Finland. The IKINÄ (Prevention of falls and 
fractures among older people) programme aims to improve the identification of older adults 
with high risk for falling and provides information on effective prevention methods using mul-
tifaceted approaches. The IKINÄ programme includes the development of evidence-based 
national guidelines and clinical tools for falls prevention in primary health care and in institu-
tions. A guidelines publication including CD material for prevention of falls and fractures 
among older adults was published in 2006 in KTL B-series (8/2006). 
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Research concerning falls prevention methods has been carried out with research groups in 
KTL and the Universities of Jyväskylä, Helsinki and Turku. 
The study on "Muscle strength and power in old age: special emphasis on lower limb 
asymmetry, mobility and balance" was carried out with the Department of Health Sciences / 
Finnish Centre for Interdisciplinary Gerontology, University of Jyväskylä (directed by Sar-
ianna Sipilä, PhD, docent) and the Central Finland Central Hospital. The aim of the study 
was to investigate whether difference in muscle function between the lower limbs is an im-
portant determinant of mobility, postural balance, bone characteristics, falls and fear of fal-
ling in older people. In addition, the effects of intensive strength-power training on muscle 
strength and power, mobility, postural balance, falls, fear of falling and overall health in 60-
85-year-old people with lower limb asymmetry was assessed. 
The results of the study showed that the majority of older people with hip fracture history 
(84%) had mobility problems and up to 50% reported decreased outdoor mobility. In addi-
tion, 60 % had difficulties walking 500m and negotiating stairs, whereas in the age-matched 
controls the corresponding percentages were 9% and 16%. The balance confidence, which 
is a marker of fear of falling, was also lower in the hip fracture group compared to the con-
trols. The intensive strength-power training of three months resulted in improvement in 
lower limb muscle strength and increased lower limb function in tasks requiring high-speed 
power production. Three articles on the study, one accepted (Kulmala et al. 2007), two 
submitted (Portegijs et al. 2007, Sihvonen et al.2007), have been thus far reported. 
The Injury Prevention Unit has participated in the GOAL (Good Ageing in Lahti region) 
Functional Capacity Intervention study directed by Health Promotion Unit, KTL and Palme-
nia Centre for Continuing Education, University of Helsinki. This intervention study seeks to 
promote healthy ageing among old-aged (over 70 years of age) clients of the municipal 
homecare. The specific objectives of the study are to develop a measurement kit for and 
practical methods to promote the functional capacity of the elderly to be used by homecare 
personnel. In the first phase of the study, clients were randomly selected to one of the three 
arms of the study: standard care; group-based strength and balance exercise; or home-
based strength and balance exercise. In the second phase, clients were randomized either 
to a goal-oriented activity programme with group-based strength and balance exercise or to 
a goal-oriented activity programme with home-based strength and balance exercise. Before 
the intervention, intensive training seminars on the use of functional assessments for physi-
cal capacity and exercise methods for home care and health care personnel was carried 
out. In the first phase, each study group included 40 participants. In the second wave, the 
number of participants per study arm was 24. This intervention study started in the year 
2005, with the interventions running in 2006. In 2007, the one-year follow-up data collection 
will be completed and the analysis and reporting started. 
Dr Sihvonen has also participated in reporting the results of the study "Prevention of falls 
among the home-dwelling elderly" conducted in University of Turku, Institute of Clinical 
Medicine, General Practice (directed by prof. Sirkka-Liisa Kivelä). This study implemented a 
prevention intervention on falls among older persons living at home to evaluate its effects 
on falls, injurious falls, functional abilities and quality of life. Two manuscripts have been 
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submitted concerning the effects of risk-based fall prevention on postural balance (Salminen 
et al. 2007a) and on maximal isometric muscle strength (Salminen et al. 2007b). 
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Table 12.1 Summary of main scientific achievements during 2004-2007 
Scientific output  N  Comments  
Original articles and reviews in in-
ternational peer-review journals  
7  
 
plus 6 original articles submitted  
 
Original articles and reviews in do-
mestic peer-review journals  
1   
Textbooks and chapters in text-
books, reports and proceedings  
8   
Theses  
1 Doc-
toral Thesis 
2 Master's 
Theses  
Sihvonen S  
Koskinen M, Tiirikainen K  
 
Presidencies and memberships in 
scientific committees of international 
meetings  
1  
Member of Scientific Committee 14th Interna-
tional Conference on Safe Communities, June 2005, 
Bergen, Norway 
Invited lectures and chairmanships 
in international meetings  
4   
Lectures in domestic scientific meet-
ings  
4   
Opponent of dissertation     
Supervision of dissertations  2  
2 Master's theses  
1 ongoing Doctoral Thesis 
Review of scientific papers  
5  
 
 
Research visits to/from international 
research institutes or universities  
2  
Sanna Sihvonen, Prince of Wales Medical Re-
search Institute and University of North South Wales, 
Sydney, Australia  
Prof. Lucie Laflamme and research group, Depart-
ment of Health Sciences, Karolinska Institutet, Swe-
den 
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12.3 The main public health activities and achievements 
12.3.1 IKINÄ-Prevention of falls and fractures among older people 
The educational intervention in the IKINÄ programme is targeted for social and health care 
professionals working with older adults. The education intervention was started in fall 2006 
and is carried out in close co-operation with health care districts, county administrative 
boards, municipalities, NGOs (such as Age Institute, Centre Union for the Welfare of the 
Aged, and Finnish Osteoporosis Association) and polytechnics for social and health care. 
Evaluation and development of assessment tools have been conducted with health care 
professionals from Espoo municipality and the Teknosko (utilization of technology in home 
care services) project in Pirkanmaa Polytechnic in the Tampere region. By the end of May 
2007, 50 seminars and lectures have been organized and 2500 social and health care 
workers, administrators and students have participated in the training.    
12.3.2 AdRisk 
The AdRisk - Community Action on Adolescents and Injury Risk - project responds to the 
call for an integrated approach to reduce the injury risk among adolescents aged 15-24 in 
Europe. The project as whole focuses on national policy and strategy development, situa-
tion analysis, network development and the provision of tools and good practices. AdRisk 
refers to the 2006 EC Communication "Actions for a safer Europe" which defines injury and 
accident prevention as a priority for the Public Health Programme. The project is co-
ordinated by the Austrian Road Safety Board and carried out in collaboration with four other 
European institutions. 
The Injury Prevention Unit at KTL is responsible for the Work Package "Development of the 
European Situation Analysis Report". The project period is September 2006-February 2008. 
The objective is to produce a comprehensive European situation analysis of injury risks 
among adolescents and their prevention and to use the resulting report for developing an evi-
dence-based national response to youth risk-taking behaviour on behalf of the Member 
States. The main deliverable of this work package will be a document on the major injury risks 
adolescents in Europe are exposed to, assessing the main determinants of risk exposure and 
identifying models of good practices in injury prevention in adolescence. This report will be 
addressed to European and national authorities and interest groups that have a role to play in 
preventing predictable and avoidable injuries among adolescents. Based on the situation 
analysis, strategy recommendations will be provided to the governments. National and youth-
related agencies will be encouraged to develop national programmes for action on injury pre-
vention among adolescents and integrate the youth into existing programmes. 
12.3.3 Injury portal 
The aim of the portal is to gather information, tools, guidelines, policies and actors on pre-
vention of home and leisure-time injuries for the use of professionals and people interested 
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in safety promotion. 
The injury portal was built up and content-developed during summer 2005. The internet 
pages (www.ktl.fi/tapaturmat) were published in the autumn and the informational content 
has been added and updated regularly. In 2006, educational material of the prevention of 
falls and fractures among older people was published in the injury portal. There have been 
700 to 1300 visitors per month at the web pages. 
Table 12.2. Summary table of committee memberships, coordination and proceedings with public health impact 
2004-2007 
Public health output  N  Comments  
Articles and reviews 
in  non-peer-review journals  
11    
TV and radio inter-
views  
12  plus several contacts monthly from journalists  
Health education ma-
terial, websites, information 
databases  
6  
e.g. injury portal, www-pages on national victimisation survey, 
injury deaths 2005, injuries as numbers, assessment tools for fall 
risk evaluation, material for balance training for Age Institute, www-
pages to edu.fi and to Vision Zero pages for the Centre for Occupa-
tional Safety  
Membership in inter-
national committees with 
public health impact  
3  
Task force leader, EuroSafe Association: Adolescents and 
risk-taking Member, Working Party on Accidents and Injuries. 
EU/DG SANCO Member, European Child Safety Alliance 
Membership in do-
mestic committees with 
public health impact  
10  
e.g. the Advisory Committee for the Prevention of Home and 
Leisure Accidents within the Ministry of Social Affairs and Health 
Coordination and/or 
implementation of devel-
opment projects  
1  
Implementation of preventive methods in Ikinä (falls prevention 
among older adults) programme  
Coordination of public 
health networks  
1  Network on local injury prevention  
Organization of do-
mestic training with public 
health impact  
Around 
55  
e.g. falls prevention seminars and lectures for social and 
health care professionals  
12.4 Funding for research and public health programMEs 
Funding for the Unit has been received from the Ministry of Social Affairs and Health, Minis-
try of the Interior and Ministry of Education. The Ad-Risk project is funded by the EC Public 
Health Programme. 
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12.5 Personnel 
The Unit was started by three full-time employees in August 2004 (Head of the Unit, Senior 
Researcher and Planner). Currently, the Unit has 3 Senior Researchers (1 working part-
time), 1 project manager, 1 Web Information Officer, 5 Researchers (1 working part-time), 1 
Data Manager and 1 Secretary (working part-time). Three researchers are currently enrolled 
in PhD studies. 
Anne Lounamaa, M.Soc.Sc, BSc, OTR, Senior Researcher, Head of the Unit 
Terhi Hulkko, MSc, RN (public health), Web Information Officer 
Antti Impinen, MSc, Researcher 
Heli Kumpula, M.Soc.Sc, Researcher 
Mirka Koskinen, MSc, RN (public health), Researcher 
Sakari Kääriäinen, Data Manager 
Philippe Lunetta, MD, PhD, Senior Researcher, part-time 
Nina Martikainen, Secretary of the Unit, part-time 
Minna Mänty, MSc, Researcher, part-time 
Meri Paavola, PhD, Project Manager 
Sanna Sihvonen, PhD, pt, Senior Researcher 
Kati Tiirikainen, M.Soc.Sc, Researcher 
12.6 Collaboration 
Collaboration and co-projects within KTL and within the Department provide opportunities 
for injury prevention and, vice versa, opportunities for the Unit as a whole and for each indi-
vidual researcher at the Unit to develop research and public health skills. Ongoing coopera-
tions include: with the Mental Health and Alcohol Department research on Alcohol, drugs 
and driving supported by the Academy of Finland, with the Department of Health and Func-
tional Capacity on research and on the development of tools to measure functional capacity, 
and within the Department with the Health Promotion Unit on GOAL research and with the 
Chronic Disease Prevention Unit on LATE, the Development of Child Health Monitoring 
project.
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12.6.1 National collaboration 
Elderly safety  
University of Jyväskylä, Department of Health Sciences / Finnish Centre for Interdisciplinary 
Gerontology (docent, PhD Sarianna Sipilä) research project on Muscle strength and power 
in old age: special emphasis on lower limb asymmetry, mobility and balance. 
Palmenia Centre for Continuing Education, University of Helsinki, The GOAL (Good Ageing 
in Lahti region) Functional Capacity Intervention study 
University of Turku, Institute of Clinical Medicine, General Practice (PhD Marika Salminen) 
reporting research project on prevention of falls among the home-dwelling elderly people. 
Pirkanmaa Polytechnic, Teknosko project for piloting and implementing preventive activities 
for falls prevention among older adults using home care services.   
Age Institute, Centre Union for the Welfare of the Aged, and Finnish Osteoporosis Associa-
tion in organising educational seminars for social- and health care professionals on falls 
prevention among older adults. 
Child Safety  
Helsinki University Central Hospital (HUCH), Hospital for Children and Adolescents, re-
search collaboration: Mortality and hospitalization due to injuries in Finnish children 0 - 18 
years and regional differences in treatment practices. 
University of Tampere/Tampere School of Public Health and the UKK institute, research 
collaboration: Poisonings, and their risk factors in Finnish children and adolescents. 
Injury Prevention Unit is a partner and a member of the steering group in "Safety for Chil-
dren", Lapsen Turvaksi - project, coordinated by the Mannerheim League for Child Welfare. 
The goals of this project are to develop working methods for prevention, for mental and 
physical first aid and for mental support after trauma experience of injuries among children.  
The development project is carried out in two geographical areas together with local actors: 
NGOs, maternity and child welfare clinics, day care centres and schools. 
Sports safety  
Sports Medicine Centre of Tampere (operates in the premises of the UKK Institute), health 
promotion collaboration: Prevention of sports injuries, nationwide LiVE project (MD, PhD, 
Docent Jari Parkkari)
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Monitoring 
START project (PhD, Project Manager Ilona Nurmi) developing information technology 
based system to gather detailed information on all unintentional injuries in the area of North 
Kymenlaakso to act as a reference area for national injury surveillance. 
Communications, Awareness raising & Capacity building 
The Finnish Virtual Polytechnic and 7 polytechnics (South Karelian Polytechnic, Laurea, 
Arcada, North Karelian Polytechnic, Savonia/Pelastusopisto, Kajaani Polytechnic and Oulu 
Polytechnic), web-based injury prevention and safety promotion education for polytechnic 
students in Finland, development of comprehensive introductory course ( 15 cus). 
The National Injury Prevention Working Group and the Home Accident Prevention Cam-
paign "You have only one life"  that are national networks consisting of several national bod-
ies (e.g. Ministry of Social Affairs and Health, Ministry of the Interior, Finnish National Res-
cue Association, Federation of Finnish Insurance Companies, Finnish Centre for Health 
Promotion, Finnish Red Cross, Association of Finnish Local and Regional Authorities, Fin-
nish Institute of Occupational Health, Central Organization for Traffic Safety in Finland, 
Consumer Safety Institute). The National Injury Prevention Working Group is a network of 
all safety sectors, whose mission is to develop a positive and comprehensive safety-minded 
culture, and according to their strategy they organize training, arrange conferences, semi-
nars, exhibitions and fairs (e.g. National Injury Prevention Day "Friday the 13th" annually). 
The Home Accident Prevention Campaign prepares material for home and leisure-time in-
jury prevention e.g. leaflets, educational materials, check-lists and videos, arranges semi-
nars and is active in media communications. 
The Finnish Centre for Health Promotion, a project on preventing home and leisure-time 
injuries through participating member associations focusing on producing education mate-
rial and disseminating information on injury prevention and safety promotion using media 
and organising national seminars. 
12.6.2 International collaboration 
The Injury Prevention Unit actively participates in international cooperation through several 
networks, including e.g. EU/DG SANCO's accidents and injuries network (AINW), EuroSafe 
network, the European Network of Safety and Health Practitioner Organisations (ENSPHO), 
Prevention of Falls Network Europe (ProFaNE) and WHO Collaborating Centre on Commu-
nity Safety Promotion. 
The Injury Prevention Unit is representing Finland in the European networks EuroSafe and 
Child Safety Alliance. EuroSafe is an umbrella network which aims to reduce both inten-
tional and unintentional injuries through increased coordination and strategies that combine 
and build upon existing strengths and capacities in Europe. The focus of the Child Safety 
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Alliance is on child safety. Both networks organise European meetings and make joint 
European statements for injury prevention. The representatives of the Injury Prevention Unit 
participate in the meetings and write articles in the newsletters. 
12.7 Proposal for future work and expected benefits 
During its first three years the Unit has grown in the encouraging and stimulating atmos-
phere that KTL provides. All the expertise in the Department and in KTL has been valuable 
and available when developing a team of injury prevention experts in KTL. Our goal is to be 
a significant national actor to support citizens, professionals and the government to elimi-
nate serious health losses due to injury. For this, improvements in injury surveillance, 
greater scientific and public health expertise among the Unit's employees and continuous 
financial resources are needed.  
In its work, the Unit has emphasized the public health impact of all injuries, unintentional 
and intentional, but limited the preventive activities to unintentional home and leisure-time 
injuries. So far, the major emphasis has been on elderly safety. In the coming years promot-
ing injury prevention among children and adolescents will be strengthened. 
In the near future, the Unit will finalize the first phase of the monitoring system for injury 
surveillance. The endpoint at this stage is to have databases for two registers and for one 
repeated survey. These data can already be broadly used to monitor the injury situation at 
national level. The database is also expected to increase interest for cooperative research 
projects within KTL and other research organizations to further study the occurrence and 
severity of injuries in the Finnish population. 
However, the currently available data are not sensitive enough to measure all important 
changes at national level and not detailed enough for local actors. The Unit will continue the 
co-operation with the START project and municipalities in developing usable ways to moni-
tor injuries locally. Further work is needed in indicator development from the current data-
base, to develop current register-based data systems together with responsible statistical 
organizations and to develop additional data collection methods to fill the data gaps. This 
includes detailed data on injury risk factors and injury mechanisms. 
Because of a considerable increase in the proportion of the population aged over 65 in the 
future, there is a high need for effective preventive strategies for falls prevention among 
older adults. The IKINÄ programme on falls prevention among older adults will continue to 
enhance the translation of research into practice and policy. Evaluation of long-term effects 
of preventive activities is developed and disseminated to policy makers and other stake-
holders. Unless preventive strategies are put in place, this will result in increased demands 
for health services for fall-related injuries. 
The scope for injury prevention in areas and settings other than on the road or at the work-
place is great because there are many proven measures which are yet to be implemented. 
Research can assist in identifying measures which are likely to achieve the greatest effect 
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per euro invested, as well as in fine-tuning, targeting and evaluating specific injury preven-
tion programmes. The Injury Prevention Unit will continue its work in co-operation with the 
responsible government agencies, community organizations and the private sector to assist 
in achieving further injury reductions. 
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